Processing 00000000.tx.1: Determinants of 4-Repeat Tau Expression COORDINATION BETWEEN ENHANCING AND INHIBITORY SPLICING SEQUENCES FOR EXON 10INCLUSION* Ian D'Souza and Gerard David Schellenberg From the Geriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle Division, Seattle, Washington 98108,the Divisions of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington, Seattle, Washington 98195,and the Departments of Neurology and Pharmacology, University of Washington, Seattle, Washington 98195 Received for publication, November 30,1999, and in revised form, March 27,2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Mutations in the tau gene are pathogenic causing autosomal dominant frontotemporal dementia with Parkinsonism-chromosome 17type (FTDP-17). 

Phrase: "Determinants of 4-Repeat Tau Expression COORDINATION"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1521761:Determinant [Functional Concept]

Phrase: "BETWEEN ENHANCING"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2349975:Enhance [Activity]

Phrase: "AND"

Phrase: "INHIBITORY SPLICING SEQUENCES FOR EXON 10INCLUSION"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0162326:Sequences [Nucleotide Sequence]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]

Phrase: "* Ian"

Phrase: "D'"

Phrase: "Souza"

Phrase: "and"

Phrase: "Gerard David Schellenberg From the Geriatric Research Education"

Phrase: "and"

Phrase: "Clinical Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2347782:Clinical Center [Organization]
   861   C0205099:Center [Spatial Concept]

Phrase: "Veterans Affairs Puget Sound Health Care System,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   861   C2936316:Veterans Health [Group Attribute,Idea or Concept]
   845   C0018696:System, Health Care [Health Care Related Organization]
   829   C1456613:Health System [Governmental or Regulatory Activity]
   818   C0086388:Health Care [Health Care Activity]
   795   C0018684:Health [Idea or Concept]
   795   C0449913:System [Functional Concept]
   795   C1553451:System [Manufactured Object]
   795   C1704459:System [Medical Device]
   795   C1947933:Care [Activity]
   724 E C0205373:Systemic [Functional Concept]

Phrase: "Seattle Division,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1293097:Division [Therapeutic or Preventive Procedure]
   861   C2919030:Division [Organization]
   861   C2919031:Division [Activity]

Phrase: "Seattle,"

Phrase: "Washington 98108,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043038:Washington [Geographic Area]

Phrase: "the Divisions of Gerontology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1293097:Division [Therapeutic or Preventive Procedure]
   770   C2919030:Division [Organization]
   770   C2919031:Division [Activity]

Phrase: "and"

Phrase: "Geriatric Medicine,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0017469:Geriatric medicine [Biomedical Occupation or Discipline]
  1000   C1555747:Geriatric Medicine [Professional or Occupational Group]
  1000   C1555760:Geriatric Medicine [Professional or Occupational Group]
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]
   861   C1704440:Geriatric [Qualitative Concept]
   861   C1999167:geriatric [Population Group]

Phrase: "Department of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "University of Washington,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041740:University [Manufactured Object,Organization]
   827   C0043038:Washington [Geographic Area]

Phrase: "Seattle,"

Phrase: "Washington 98195,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043038:Washington [Geographic Area]

Phrase: "and"

Phrase: "the Departments of Neurology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0587475:Neurology department [Health Care Related Organization]
   737   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Pharmacology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031330:Pharmacology [Biomedical Occupation or Discipline]
  1000   C1524059:pharmacology [Functional Concept]
   928 E C0205464:Pharmacologic [Functional Concept]

Phrase: "University of Washington,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041740:University [Manufactured Object,Organization]
   827   C0043038:Washington [Geographic Area]

Phrase: "Seattle,"

Phrase: "Washington 98195"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043038:Washington [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "November 30,"

Phrase: "1999,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "March 27,"

Phrase: "2000  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mutations in the tau gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "pathogenic causing autosomal dominant frontotemporal dementia with Parkinsonism-chromosome 17type (FTDP-17)."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   782   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   760   C0236642:frontotemporal dementia [Disease or Syndrome]
   739   C0011265:dementia [Mental or Behavioral Dysfunction]
   739   C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.2: Some mutations in tau exon 10(E10) and immediately adjacent sequences cause disease by altering E10 splicing. 

Phrase: "Some mutations in tau exon 10"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(E10"

Phrase: ")"

Phrase: "and"

Phrase: "immediately adjacent sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "disease by altering E10 splicing."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0012634:Disease [Disease or Syndrome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.3: To determine the mechanism of normal E10 splicing regulation and how FTDP-17 mutations alter splicing, mutational analysis of E10 was performed. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the mechanism of normal E10 splicing regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "how FTDP-17 mutations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   800   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   770   C0236642:frontotemporal dementia [Disease or Syndrome]
   744   C0011265:dementia [Mental or Behavioral Dysfunction]
   744   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "splicing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]

Phrase: "mutational analysis of E10"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0796357:mutation analysis [Laboratory Procedure]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.4: The results show that E10 contains a complex array of both enhancer and inhibitor cis-acting elements that modulate usage of a weak 5' splice site. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that E10"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a complex array of both enhancer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1510941:Array [Spatial Concept]

Phrase: "and"

Phrase: "inhibitor cis-acting elements"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   912   C0599780:cis acting element [Nucleotide Sequence]
   812   C0013879:Elements [Element, Ion, or Isotope]
   779 E C1705248:Element [Conceptual Entity]

Phrase: "that"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "usage of a weak 5' splice site."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0457083:Usage [Functional Concept]
Processing 00000000.tx.5: The 5' end of E10 contains a previously unrecognized multipartite exon splicing enhancer (ESE) composed of an SC35-like binding sequence, a purine-rich sequence, and an AC-rich element. 

Phrase: "The 5' end of E10"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0444930:End [Spatial Concept]
   760   C2746065:End [Temporal Concept]
   704 E C0205088:Terminal [Temporal Concept]
   704 E C1705314:Terminal [Manufactured Object]
   704 E C1705315:Terminal [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a previously unrecognized multipartite exon splicing enhancer (ESE)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "composed of an SC35-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1419992:SC35 [Gene or Genome]
   770   C3538863:SC35 [Gene or Genome]

Phrase: "like binding sequence,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "a purine-rich sequence,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "an AC-rich element."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0001246:Ac element [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C1705248:Element [Conceptual Entity]
Processing 00000000.tx.6: Downstream of this ESE is a purine-rich exon splicing inhibitor. 

Phrase: "Downstream of this ESE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "a purine-rich exon splicing inhibitor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.7: Intronic sequences immediately downstream of E10 also are inhibitory. 

Phrase: "Intronic sequences immediately downstream of E10 also"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0162326:Sequences [Nucleotide Sequence]
   714 E C0004793:Sequence [Nucleotide Sequence]
   714 E C0162327:Sequence [Nucleotide Sequence]
   714 E C1519249:Sequence [Functional Concept]

Phrase: "are"

Phrase: "inhibitory."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3463820:Inhibitory [Activity]
Processing 00000000.tx.8: The results support an alternative model in which I10 inhibitory sequences appear to function as a linear sequence. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "an alternative model in which I10 inhibitory sequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3161035:Model [Intellectual Product]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "function as a linear sequence."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0031843:function [Physiologic Function]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0205132:Linear [Spatial Concept]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1519249:Sequence [Functional Concept]
   760   C1705273:Function [Intellectual Product]
Processing 00000000.tx.9: The cis-elements described are not redundant, and all appear required for normal E10 splicing. 

Phrase: "The cis-elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013879:Elements [Element, Ion, or Isotope]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "are"

Phrase: "not redundant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0425087:Redundant [Finding]
   861   C1313915:Redundant [Functional Concept]

Phrase: "and"

Phrase: "all"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "required for normal E10 splicing."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0035687:Splicing [Genetic Function]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1514873:Required [Functional Concept]
   760   C2347086:% Normal [Quantitative Concept]
   760   C2610186:splicing [Genetic Function]
Processing 00000000.tx.10: Results with double mutations demonstrate that the ESE and the intronic inhibitory element collaborate to regulate splicing. 

Phrase: "Results with double mutations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the ESE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the intronic inhibitory element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C1705248:Element [Conceptual Entity]

Phrase: "collaborate"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "splicing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]
Processing 00000000.tx.11: Thus splicing of tau E10 is regulated by a complex set of cis-acting elements that span nearly the entire exon and also include intronic sequences.  

Phrase: "Thus"

Phrase: "splicing of tau E10"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0035687:Splicing [Genetic Function]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
   770   C2610186:splicing [Genetic Function]

Phrase: "is"

Phrase: "regulated by a complex set of cis-acting elements"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   779   C0599780:cis acting element [Nucleotide Sequence]
   742   C0013879:Elements [Element, Ion, or Isotope]
   742   C0036849:Set [Mental Process]
   742   C0439855:Complex [Qualitative Concept]
   742   C0851285:Regulated [Governmental or Regulatory Activity]
   742   C1442518:Set [Functional Concept]
   742   C1504308:Cis [Eukaryote]
   742   C1704241:Complex [Chemical Viewed Structurally]
   742   C1705195:Set [Conceptual Entity]
   708   C0079613:ACT [Therapeutic or Preventive Procedure]
   708 E C1705248:Element [Conceptual Entity]

Phrase: "that"

Phrase: "span"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1711300:Span [Conceptual Entity]
  1000   C2700613:Span [Quantitative Concept]

Phrase: "nearly"

Phrase: "the entire exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "also"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "intronic sequences."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   861   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.12: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Tau is a microtubule-associated protein that in vitro promotes microtubule assembly and stability. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "a microtubule-associated protein"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0026046:Micro-tubule [Cell Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]

Phrase: "that in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "microtubule assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1706853:Assembly [Activity]
   861   C1879748:Assembly [Manufactured Object]

Phrase: "and"

Phrase: "stability."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205360:Stability [Qualitative Concept]
  1000   C2347098:Stability [Qualitative Concept]
   928 E C1547311:Stable [Intellectual Product]
Processing 00000000.tx.13: In vivo, tau is important in neuronal morphogenesis, axon polarity, and axonal transport (1, 2). 

Phrase: "In vivo, tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "is"

Phrase: "important in neuronal morphogenesis,"

Phrase: "axon polarity,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0596963:Polarity [Quantitative Concept]
   789 E C0813983:polar [Quantitative Concept]
   761 E C0337815:Poles [Population Group]
   761 E C0935623:Pole [Body Location or Region]
   761 E C1418729:POLE [Gene or Genome]

Phrase: "and"

Phrase: "axonal transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0004462:Axonal Transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]
   789   C0004461:Axon [Cell Component]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: In the central nervous system, tau is expressed primarily in neurons, although it is also present in glial cells at lower levels. 

Phrase: "In the central nervous system,"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "expressed"

Phrase: "primarily in neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "although"

Phrase: "it"

Phrase: "is"

Phrase: "also"

Phrase: "present in glial cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0027836:Glial Cells [Cell]
           Glial
   770   C0007634:Cells [Cell]
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "at lower levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.15: During central nervous system development, the gene encoding tau (tau) is highly regulated by alternative exon splicing. 

Phrase: "During central nervous system development,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C1160339:central nervous system development [Organ or Tissue Function]
   923   C0598282:Nervous System Development [Organ or Tissue Function]
   861   C1744604:system development [Biologic Function]
   817   C1818230:nerve development [Organ or Tissue Function]
   813 E C0814002:Neural Development [Cell Function,Organism Function]
   812   C0243107:development [Physiologic Function]
   812   C0678723:Development [Organism Function]
   812   C1527148:Development [Functional Concept]
   756   C0927232:Central Nervous System [Body System]
   756   C1269563:Central nervous system [Body System]
   741 E C0458003:Developmental [Qualitative Concept]

Phrase: "the gene encoding tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "(tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: ")"

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "regulated by alternative exon splicing."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0002345:Alternative Splicing [Genetic Function]
   760   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0035687:Splicing [Genetic Function]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1523987:Alternative [Conceptual Entity]
   760   C2610186:splicing [Genetic Function]
Processing 00000000.tx.16: In the human fetal brain, a single tau isoform is produced consisting of exons 1,4,5,7,9,and 11-13 (3). 

Phrase: "In the human fetal brain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0440731:Fetal brain [Embryonic Structure]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "a single tau isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "produced"

Phrase: "consisting of exons 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   737   C0332529:CONSIST [Qualitative Concept]

Phrase: "4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "9,"

Phrase: "and"

Phrase: "11-13"

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.17: In the adult human central nervous system, 6tau isoforms are made from the same exons plus alternative splicing of exons 2,3,and 10(4). 

Phrase: "In the adult human central nervous system,"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   884   C0927232:Central Nervous System [Body System]
   884   C1269563:Central nervous system [Body System]
   840   C0027763:Nervous System [Body System]
   840   C0422837:NERVOUS SYSTEM [Finding]
   840   C1269560:Nervous system [Body System]
   804   C0027769:Nervous [Sign or Symptom]
   804   C0205099:Central [Spatial Concept]
   804   C0449913:System [Functional Concept]
   804   C0599851:Nervous [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   804   C1879652:Central - [Laboratory Procedure]
   784 E C0205494:Neurologic [Qualitative Concept]
   747 E C0027855:Neurology [Biomedical Occupation or Discipline]
   733 E C0205373:Systemic [Functional Concept]
   728 E C2707261:Neurological [Clinical Attribute]

Phrase: "6tau isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "are"

Phrase: "made from the same exons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0445247:Same [Qualitative Concept]
   726   C1881534:Make [Functional Concept]

Phrase: "plus alternative splicing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002345:Alternative Splicing [Genetic Function]
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]

Phrase: "of exons 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "10"

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.18: tau exon 10(E10)1 encodes a microtubule-binding motif that is repeated 3times in tau isoforms lacking E10 sequences (3repeat or 3R tau) and 4times when E10 is present (4R tau). 

Phrase: "tau exon 10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "(E10"

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a microtubule-binding motif"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514562:Motif [Amino Acid Sequence]
   734   C1149274:microtubule binding [Molecular Function]

Phrase: "that"

Phrase: "is"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "3times in tau isoforms"

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "E10 sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "(3repeat"

Phrase: "or"

Phrase: "3R tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: ")"

Phrase: "and"

Phrase: "4times"

Phrase: "when"

Phrase: "E10"

Phrase: "is"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "(4R tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: ")."
Processing 00000000.tx.19: Mutations in tau cause frontotemporal dementia with Parkinsonism-chromosome 17type (FTDP-17) (5-7), a group of autosomal dominantly inherited neurodegenerative disorders with varied clinical and neuropathologic phenotypes. 

Phrase: "Mutations in tau"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0026882:Mutations [Genetic Function]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "frontotemporal dementia with Parkinsonism-chromosome 17type"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   833   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   790   C0236642:frontotemporal dementia [Disease or Syndrome]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "(FTDP-17"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   833   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   790   C0236642:frontotemporal dementia [Disease or Syndrome]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: ")"

Phrase: "(5-7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "a group of autosomal dominantly"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0441835:a group [Classification]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "inherited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:Inherited [Functional Concept]

Phrase: "neurodegenerative disorders with varied clinical"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
   806   C1522560:Neurodegenerative Disorders [Functional Concept]
   760   C0012634:Disorders [Disease or Syndrome]

Phrase: "and"

Phrase: "neuropathologic phenotypes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031437:Phenotypes [Organism Attribute]
   827 E C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.20: A common consequence of most if not all tau mutations is abnormal filamentous aggregates of tau in central nervous system neurons and in some cases in glial cells (8). 

Phrase: "A common consequence of most"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "if"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all tau mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "abnormal filamentous aggregates of tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205418:aggregates [Qualitative Concept]

Phrase: "in central nervous system neurons"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   886   C0682701:Central neuron [Cell]
   812   C0027882:Neurons [Cell]
   756   C0927232:Central Nervous System [Body System]
   756   C1269563:Central nervous system [Body System]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and in some cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0868928:Cases [Functional Concept]
   770   C1515981:And [Idea or Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "in glial cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0027836:Glial Cells [Cell]
           Glial
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C1087003:Glia [Plant]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.21: For some mutations, the aggregated tau is present as paired helical filaments in neurofibrillary tangles. 

Phrase: "For some mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "the aggregated tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "present as paired helical filaments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "in neurofibrillary tangles."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]
Processing 00000000.tx.22: These tangles are composed of all 6tau isoforms and are structurally and biochemically indistinguishable from those found in Alzheimer's disease (AD) (9, 10). 

Phrase: "These tangles"

Phrase: "are"

Phrase: "composed of all 6tau isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "are"

Phrase: "structurally"

Phrase: "and"

Phrase: "biochemically indistinguishable from those"

Phrase: "found in Alzheimer's disease"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(AD) (9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.23: For other FTDP-17 mutations, tau is present as paired straight filaments (11) or paired helical filaments with different dimensions than those of AD filaments (12, 13). 

Phrase: "For other FTDP-17 mutations,"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   849   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   827   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   817   C0598172:chromosome mutations [Cell or Molecular Dysfunction]
   807   C0236642:frontotemporal dementia [Disease or Syndrome]
   791   C0008633:Chromosome [Cell Component]
   791   C0011265:dementia [Mental or Behavioral Dysfunction]
   791   C0026882:Mutations [Genetic Function]
   791   C0242422:Parkinsonism [Disease or Syndrome]
   791   C0497327:Dementia [Mental or Behavioral Dysfunction]
   791   C0521125:For [Qualitative Concept]
   781 E C0948447:chromosomal mutations [Cell or Molecular Dysfunction]
   758 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "present as paired straight filaments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "(11"

Phrase: ")"

Phrase: "or"

Phrase: "paired helical filaments with different dimensions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   753   C1709450:Paired [Qualitative Concept]
   719   C0010851:Filament [Cell Component]

Phrase: "than those"

Phrase: "of AD filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "(12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.24: Also the isoform ratio can be different from that found in AD. 

Phrase: "Also"

Phrase: "the isoform ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "can"

Phrase: "be"

Phrase: "different from that"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1705242:Different [Qualitative Concept]
   718 E C1705241:*Difference [Quantitative Concept]

Phrase: "found in AD."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]
Processing 00000000.tx.25: tau missense mutations fall into 2categories as follows: mutations that alter protein function, and mutations that affect alternative splicing of E10. 

Phrase: "tau missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0599155:Mutations, Missense [Genetic Function]
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "fall into 2categories"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0085639:Fall [Finding]
   790   C0238715:Fall [Temporal Concept]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "protein function,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0815043:protein function [Amino Acid, Peptide, or Protein]
  1000   C1527118:Protein Function [Molecular Function]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "alternative splicing of E10."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0002345:Alternative Splicing [Genetic Function]
   770   C0035687:Splicing [Genetic Function]
   770   C2610186:splicing [Genetic Function]
Processing 00000000.tx.26: Mutations G272V (E9), P301L, P301S, 280K (E10), V337M (E12), and R406W (E13) reduce the affinity of tau binding to microtubules (14) and/or reduce the ability of tau to promote microtubule assembly when compared with normal tau (11, 14-17). 

Phrase: "Mutations G272V"

Phrase: "(E9"

Phrase: ")"

Phrase: ","

Phrase: "P301L,"

Phrase: "P301S,"

Phrase: "280K"

Phrase: "(E10"

Phrase: ")"

Phrase: ","

Phrase: "V337M"

Phrase: "(E12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422634:E12 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "R406W"

Phrase: "(E13"

Phrase: ")"

Phrase: "reduce"

Phrase: "the affinity of tau binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "to microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "(14"

Phrase: ")"

Phrase: "and/or"

Phrase: "reduce"

Phrase: "the ability of tau to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "microtubule assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1706853:Assembly [Activity]
   861   C1879748:Assembly [Manufactured Object]

Phrase: "when"

Phrase: "compared with normal tau"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1707455:Compared [Activity]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "(11,"

Phrase: "14-17"

Phrase: ")."
Processing 00000000.tx.27: Thus, these mutations alter tau protein function. 

Phrase: "Thus,"

Phrase: "these mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "tau protein function."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   901   C0815043:protein function [Amino Acid, Peptide, or Protein]
   901   C1527118:Protein Function [Molecular Function]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
   734   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.28: Since E9, E12, and E13 are constitutively included in tau transcripts, mutations in these exons affect all tau isoforms, whereas E10 mutations P301L and P301S only affect 4R tau function. 

Phrase: "Since"

Phrase: "E9,"

Phrase: "E12,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422634:E12 [Gene or Genome]

Phrase: "and"

Phrase: "E13"

Phrase: "are"

Phrase: "constitutively"

Phrase: "included in tau transcripts,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0332257:included [Functional Concept]
   770   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "mutations in these exons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "all tau isoforms,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "whereas"

Phrase: "E10 mutations P301L"

Phrase: "and"

Phrase: "P301S only"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "4R tau function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.29: E10 mutations N279K and S305N do not alter the ability of tau to interact with microtubules but do affect the regulation of E10 splicing (15, 18). 

Phrase: "E10 mutations N279K"

Phrase: "and"

Phrase: "S305N"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the ability of tau to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "interact with microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0026046:Microtubules [Cell Component]

Phrase: "but"

Phrase: "do"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the regulation of E10 splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "(15,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.30: In splicing assays, the N279K and S305N mutations result in almost constitutive inclusion of E10. 

Phrase: "In splicing assays,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "the N279K"

Phrase: "and"

Phrase: "S305N mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "result in almost constitutive inclusion of E10."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1274040:Result [Functional Concept]
   748   C1512693:Inclusion [Qualitative Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]
Processing 00000000.tx.31: Similarly, the L284L E10 silent mutation and intron 10(I10) mutations immediately adjacent to the 3' end of E10 also increase E10 inclusion (6, 15). 

Phrase: "Similarly,"

Phrase: "the L284L E10 silent mutation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C1519323:Silent Mutation [Genetic Function]
   812   C0026882:Mutation [Genetic Function]
   812   C0443304:Silent [Qualitative Concept]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]
   741 E C0858952:silence [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "intron 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(I10"

Phrase: ")"

Phrase: "mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "immediately adjacent to the 3' end of E10 also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0205117:Adjacent to [Spatial Concept]
           Adjacent

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "E10 inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]

Phrase: "(6,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.32: Another FTDP-17 mutation, an in-frame 3-base deletion in E10 (280K), is unique in that it alters tau protein function and also completely abolishes E10 inclusion in tau transcripts (15, 17). 

Phrase: "Another FTDP-17 mutation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   800   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   770   C0236642:frontotemporal dementia [Disease or Syndrome]
   744   C0011265:dementia [Mental or Behavioral Dysfunction]
   744   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "an in-frame 3-base deletion in E10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1442161:Deletion [Cell or Molecular Dysfunction]
   744   C1511760:Deletion [Genetic Function]
   744   C1880274:Deletion [Activity]

Phrase: "(280K"

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "unique in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1710548:Unique [Qualitative Concept]

Phrase: "that"

Phrase: "it"

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "tau protein function"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   901   C0815043:protein function [Amino Acid, Peptide, or Protein]
   901   C1527118:Protein Function [Molecular Function]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
   734   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "also completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205197:Completely [Qualitative Concept]

Phrase: "abolishes"

Phrase: "E10 inclusion in tau transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1512693:Inclusion [Qualitative Concept]

Phrase: "(15,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.33: The effect of 280K on splicing is presumed to be the disease-causative mechanism since, with E10 being completely excluded, no 280K protein would be produced. 

Phrase: "The effect of 280K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]

Phrase: "is"

Phrase: "presumed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the disease-causative mechanism since,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0441712:Mechanism [Functional Concept]
   812   C1706376:Mechanism [Manufactured Object]

Phrase: "with E10"

Phrase: "being"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: ","

Phrase: "no 280K protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "would"

Phrase: "be"

Phrase: "produced."
Processing 00000000.tx.34: The mutations that affect E10 splicing cause FTDP-17 by altering the 4R/3R tau ratio, and in some cases, the elevated 4R tau produced has the normal tau amino acid sequence (e.g. L284L and I10 mutations; Fig. 1) (14, 19). 

Phrase: "The mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "E10 splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "FTDP-17"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   833   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   790   C0236642:frontotemporal dementia [Disease or Syndrome]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "by altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   907   C0392747:Altered [Functional Concept]

Phrase: "the 4R/3R tau ratio,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "and in some cases,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0868928:Cases [Functional Concept]
   770   C1515981:And [Idea or Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "the elevated 4R tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "produced"

Phrase: "has"

Phrase: "the normal tau amino acid sequence"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   884   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   840   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C2917660:Amino Acid [Pharmacologic Substance]
   804   C0001128:Acid [Chemical]
   804   C0004793:Sequence [Nucleotide Sequence]
   804   C0162326:Sequence [Nucleotide Sequence]
   804   C0162327:Sequence [Nucleotide Sequence]
   804   C0202406:Acid [Laboratory Procedure]
   804   C1519249:Sequence [Functional Concept]
   733 E C1548958:Sequential [Idea or Concept]
   733 E C1705294:Sequential [Qualitative Concept]

Phrase: "("

Phrase: "e.g. L284L"

Phrase: "and"

Phrase: "I10 mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "; Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "(14,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.35: As expected, when E10 usage is increased, the aggregated tau formed has excess 4R tau isoforms (7, 14, 19). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "when"

Phrase: "E10 usage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0457083:Usage [Functional Concept]

Phrase: "is"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "the aggregated tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "has"

Phrase: "excess 4R tau isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "(7,"

Phrase: "14,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.36: Different mutations that increase E10 usage result in different clinical and neuropathologic phenotypes, presumably because these mutations affect different cis-acting regulatory elements controlling E10 splicing. 

Phrase: "Different mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "E10 usage result in different clinical"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "and"

Phrase: "neuropathologic phenotypes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031437:Phenotypes [Organism Attribute]
   827 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "presumably"

Phrase: "because"

Phrase: "these mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "different cis-acting regulatory elements"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   877   C0599780:cis acting element [Nucleotide Sequence]
   806   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Elements [Element, Ion, or Isotope]
   804   C0220905:regulatory [Regulation or Law]
   804   C1704735:Regulatory [Conceptual Entity]
   771 E C1705248:Element [Conceptual Entity]

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "E10 splicing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]
Processing 00000000.tx.37: Thus, understanding the mechanisms that regulate E10 usage is important to understanding FTDP-17. 

Phrase: "Thus,"

Phrase: "understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "regulate"

Phrase: "E10 usage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0457083:Usage [Functional Concept]

Phrase: "is"

Phrase: "important to understanding FTDP-17."
Processing 00000000.tx.38: Our previous work examining the effects of FTDP-17 mutations on tau E10 splicing indicated that multiple cis-acting sequences regulate E10 alternative splicing (15). 

Phrase: "Our previous work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "examining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332128:examining [Finding]
  1000   C2004054:Examining [Activity]

Phrase: "the effects of FTDP-17 mutations"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   806   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   782   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   760   C0236642:frontotemporal dementia [Disease or Syndrome]
   757   C0598172:chromosome mutations [Cell or Molecular Dysfunction]
   739   C0008633:Chromosome [Cell Component]
   739   C0011265:dementia [Mental or Behavioral Dysfunction]
   739   C0026882:Mutations [Genetic Function]
   739   C0242422:Parkinsonism [Disease or Syndrome]
   739   C0497327:Dementia [Mental or Behavioral Dysfunction]
   739   C1280500:effects [Qualitative Concept]
   722 E C0948447:chromosomal mutations [Cell or Molecular Dysfunction]
   706 E C1705285:Mutation [Cell or Molecular Dysfunction]
   706 E C2348382:Effect [Qualitative Concept]

Phrase: "on tau E10 splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035687:Splicing [Genetic Function]
   827   C2610186:splicing [Genetic Function]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that multiple cis-acting sequences"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   912   C1516561:Cis-Acting Sequence [Nucleotide Sequence]
   812   C0162326:Sequences [Nucleotide Sequence]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: "regulate"

Phrase: "E10 alternative splicing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0002345:Alternative Splicing [Genetic Function]
   827   C0035687:Splicing [Genetic Function]
   827   C2610186:splicing [Genetic Function]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.39: An additional intronic inhibitory element immediately adjacent to the end of E10 in I10 was revealed by other FTDP-17 mutations (6, 7). 

Phrase: "An additional intronic inhibitory element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C1705248:Element [Conceptual Entity]

Phrase: "immediately adjacent to the end of E10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0205117:Adjacent to [Spatial Concept]
           Adjacent

Phrase: "in I10"

Phrase: "was"

Phrase: "revealed by other FTDP-17 mutations"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   806   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   782   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   760   C0236642:frontotemporal dementia [Disease or Syndrome]
   757   C0598172:chromosome mutations [Cell or Molecular Dysfunction]
   739   C0008633:Chromosome [Cell Component]
   739   C0011265:dementia [Mental or Behavioral Dysfunction]
   739   C0026882:Mutations [Genetic Function]
   739   C0242422:Parkinsonism [Disease or Syndrome]
   739   C0443289:Revealed [Qualitative Concept]
   739   C0497327:Dementia [Mental or Behavioral Dysfunction]
   722 E C0948447:chromosomal mutations [Cell or Molecular Dysfunction]
   706 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.40: Here we examine exon and intron sequences that control tau E10 inclusion. 

Phrase: "Here"

Phrase: "we"

Phrase: "examine"

Phrase: "exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "intron"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "that control tau E10 inclusion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.41: We performed mutation and deletion studies to identify splicing regulatory sequences that control E10 splicing and to explore the functional interactions between elements in orchestrating E10 usage. 

Phrase: "We"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "splicing regulatory sequences"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   867   C0314642:Regulatory sequence [Nucleotide Sequence]
   827   C0162326:Sequences [Nucleotide Sequence]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "that control E10 splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035687:Splicing [Genetic Function]
   827   C2610186:splicing [Genetic Function]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "the functional interactions between elements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "in orchestrating E10 usage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0457083:Usage [Functional Concept]
Processing 00000000.tx.42: Our results reveal that there are at least 4cis-acting regulatory sequences within E10 that are non-redundant and that function cooperatively to regulate E10 inclusion. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "that there"

Phrase: "are at least 4cis-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1551058:Are [Quantitative Concept]

Phrase: "acting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "regulatory sequences within E10"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   799   C0314642:Regulatory sequence [Nucleotide Sequence]
   770   C0162326:Sequences [Nucleotide Sequence]
   770   C0220905:regulatory [Regulation or Law]
   770   C1704735:Regulatory [Conceptual Entity]
   737 E C0004793:Sequence [Nucleotide Sequence]
   737 E C0162327:Sequence [Nucleotide Sequence]
   737 E C1519249:Sequence [Functional Concept]

Phrase: "that"

Phrase: "are"

Phrase: "non-redundant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0425087:Redundant [Finding]
   861   C1313915:Redundant [Functional Concept]
   861   C1518422:Non [Functional Concept]

Phrase: "and"

Phrase: "that function cooperatively to"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "regulate"

Phrase: "E10 inclusion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.43: These E10 cis-elements interact with a novel I10 inhibitory element that potentially acts by forming a complex secondary structure, although evidence that the inhibitory element appears to function as a linear sequence is presented here. 

Phrase: "These E10 cis-elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013879:Elements [Element, Ion, or Isotope]
   793 E C1705248:Element [Conceptual Entity]

Phrase: "interact with a novel I10 inhibitory element"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0013879:Element [Element, Ion, or Isotope]
   748   C0205314:Novel [Temporal Concept]
   748   C0679622:novel [Intellectual Product]
   748   C1705248:Element [Conceptual Entity]
   748   C3463820:Inhibitory [Activity]

Phrase: "that potentially"

Phrase: "acts by forming"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0079613:ACT [Therapeutic or Preventive Procedure]
   790   C0205431:Forming [Functional Concept]
   790   C1522492:Forming [Functional Concept]
   756 E C0348078:Form [Qualitative Concept]
   756 E C0376315:Form [Manufactured Object]

Phrase: "a complex secondary structure,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0162807:Secondary Structure [Spatial Concept]
   827   C0027627:secondary [Neoplastic Process]
   827   C0175668:Secondary [Temporal Concept]
   827   C0205436:Secondary [Quantitative Concept]
   827   C0678594:Structure [Spatial Concept]

Phrase: "although"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the inhibitory element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "function as a linear sequence"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0031843:function [Physiologic Function]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0205132:Linear [Spatial Concept]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1519249:Sequence [Functional Concept]
   760   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here."
Processing 00000000.tx.44: Correct regulation of tau E10 is the result of contributions from each of these elements.  

Phrase: "Correct regulation of tau E10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "is"

Phrase: "the result of contributions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "from each"

Phrase: "of these elements."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013879:Elements [Element, Ion, or Isotope]
   966 E C1705248:Element [Conceptual Entity]
Processing 00000000.tx.45: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Plasmid Construction and DNA Mutagenesis-- Vector pSPL3 (Life Technologies, Inc.) contains an HIV genomic fragment with truncated tat exons 2and 3inserted into rabbit -globin coding sequences (20). 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Plasmid Construction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441513:Construction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "DNA Mutagenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079866:Mutagenesis [Molecular Function]
   861   C3146302:Mutagenesis [Laboratory Procedure]

Phrase: "--"

Phrase: "Vector pSPL3"

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.)"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an HIV genomic fragment with truncated tat exons 2and 3inserted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0332255:fragment [Functional Concept]
   739   C1708096:Fragment [Qualitative Concept]

Phrase: "into rabbit -globin coding sequences"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   827   C0079941:Coding Sequence [Gene or Genome]
   812   C0009219:Coding [Occupational Activity]
   812   C0162326:Sequences [Nucleotide Sequence]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C0805701:Code [Intellectual Product]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.46: The resulting hybrid exons in pSPL3 are globin E1E2-tat exon 2and tat exon 3-globin E3 separated by more than 2.5kilobase pairs of tat intron sequence. 

Phrase: "The resulting hybrid exons in pSPL3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "globin E1E2-tat exon 2and tat exon 3-globin E3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1537525:E3 [Gene or Genome]

Phrase: "separated by more"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "than 2.5kilobase"

Phrase: "pairs of tat intron sequence."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]
   760   C1709450:Pair [Qualitative Concept]
Processing 00000000.tx.47: pSPL3 contains a multiple cloning sequence (MCS) around 300nucleotides downstream of the tat exon 25' splice site. 

Phrase: "pSPL3"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a multiple cloning sequence (MCS) around 300nucleotides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]

Phrase: "downstream of the tat exon 25' splice site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0205145:Site [Spatial Concept]
   804   C1515974:Site [Body Location or Region]
   804   C2825164:Site [Spatial Concept]
Processing 00000000.tx.48: The SV40 promoter and polyadenylation signal allow for enhanced expression in COS-7 cells. 

Phrase: "The SV40 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "polyadenylation signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "allow for enhanced expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0683607:allow [Social Behavior]
   770   C2349975:Enhanced [Activity]

Phrase: "in COS-7 cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.49: pSPL3 was further modified here by deleting a 500-base pair (bp) tat intronic fragment between the EcoRV (nucleotide 1050) and StuI (nucleotide 1550) sites (GenBankTM accession number U19867) to generate pSPES. 

Phrase: "pSPL3"

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "here by deleting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1880274:Delete [Activity]

Phrase: "a 500-base pair (bp) tat intronic fragment between the EcoRV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0332255:fragment [Functional Concept]
   739   C1708096:Fragment [Qualitative Concept]

Phrase: "(nucleotide 1050"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "and"

Phrase: "StuI"

Phrase: "(nucleotide 1550"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "(GenBankTM accession number U19867"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "pSPES."
Processing 00000000.tx.50: This deletion removes a previously identified cryptic exon (20). 

Phrase: "This deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "removes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "a previously"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "cryptic exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.51: Note that the portion of HIV tat exon 3used in pSPL3 does not contain the splicing inhibitory sequence TTAG (21) that is also present in tau E10. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the portion of HIV tat exon 3used"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449719:Portion [Spatial Concept]

Phrase: "in pSPL3"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the splicing inhibitory sequence TTAG"

Phrase: "(21"

Phrase: ")"

Phrase: "that"

Phrase: "is"

Phrase: "also"

Phrase: "present in tau E10."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
Processing 00000000.tx.52: A 177-bp genomic fragment containing human tau E10 with 33and 51bp of flanking intron sequences was amplified from P1 artificial chromosome clone 4139by PCR using forward and reverse primers I9X2 (5'-CCACTCGAGCGTGTCACTCATCCTTTTTC-3') and I10B2 (5'-CGGGATCCTAATAATTCAAGCCACAG-3') that contain an XhoI and BamHI site, respectively. 

Phrase: "A 177-bp genomic fragment containing human tau E10 with 33and 51bp"

Phrase: "of flanking intron sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "amplified from P1 artificial chromosome clone 4139by PCR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0872017:Chromosome, Artificial [Research Device]
   744   C0008633:Chromosome [Cell Component]
   744   C0009013:Clone [Cell]
   744   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0677874:pCR [Finding]
   744   C1522642:Clone [Tissue]
   744   C2004457:Artificial [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: "and"

Phrase: "reverse primers I9X2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]

Phrase: "(5'-CCACTCGAGCGTGTCACTCATCCTTTTTC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "I10B2"

Phrase: "(5'-CGGGATCCTAATAATTCAAGCCACAG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "that"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an XhoI"

Phrase: "and"

Phrase: "BamHI site,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "respectively."
Processing 00000000.tx.53: The XhoI/BamHI-digested PCR product was inserted into the pSPES MCS (XhoI/BamHI) to generate hN (Fig. 1). 

Phrase: "The XhoI/BamHI-digested PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "inserted into the pSPES MCS"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0009015:Cloning [Research Activity]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0439064:Multiple [Quantitative Concept]
   748   C0441587:Inserted [Health Care Activity]
   748   C1519249:Sequence [Functional Concept]
   714 E C0009013:Clone [Cell]
   714 E C1522642:Clone [Tissue]
   714 E C1743766:Insert [Medical Device]
   714 E C1883719:Insert [Functional Concept]

Phrase: "(XhoI/BamHI"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "hN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.54: Similarly, a 174-bp mouse genomic fragment containing E10 with 30and 51bp of flanking I9 and I10, respectively, was amplified from mouse genomic DNA by PCR and inserted into the XhoI/BamHI sites of pSPES to generate mWT. 

Phrase: "Similarly,"

Phrase: "a 174-bp mouse genomic fragment containing E10 with 30and 51bp"

Phrase: "of flanking I9"

Phrase: "and"

Phrase: "I10,"

Phrase: "respectively,"

Phrase: "was"

Phrase: "amplified from mouse genomic DNA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0017428:Genomic [Gene or Genome]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "inserted into the XhoI/BamHI sites of pSPES to"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   748   C2945843:Site of [Qualitative Concept]
   742   C0205145:Sites [Spatial Concept]
   742   C0441587:Inserted [Health Care Activity]
   728   C1705686:Insert Site [Nucleotide Sequence]
   708 E C1515974:Site [Body Location or Region]
   708 E C1743766:Insert [Medical Device]
   708 E C1883719:Insert [Functional Concept]
   708 E C2825164:Site [Spatial Concept]

Phrase: "generate"

Phrase: "mWT."
Processing 00000000.tx.55: The mouse and human 3' ends of E10 (the last 13nucleotides beginning at a SmaI site) along with the first 51nucleotides of I10 (ending at a BamHI site) were exchanged by excising this section as a SmaI-BamHI fragment. 

Phrase: "The mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "human 3' ends of E10"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0444930:ends [Spatial Concept]
   726 E C2746065:End [Temporal Concept]

Phrase: "("

Phrase: "the last 13nucleotides"

Phrase: "beginning at a SmaI site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205145:Site [Spatial Concept]
   760   C0439659:Beginning [Temporal Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: ")"

Phrase: "along with the first 51nucleotides"

Phrase: "of I10"

Phrase: "(ending at a BamHI site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0444930:ending [Spatial Concept]
   760   C2746065:Ending [Temporal Concept]

Phrase: ")"

Phrase: "were"

Phrase: "exchanged by excising"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0678640:exchange [Social Behavior]

Phrase: "this section as a SmaI-BamHI fragment."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205155:Section [Spatial Concept]
   748   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   748   C1522472:Section [Substance]
   748   C1552923:Section [Quantitative Concept]
   748   C1705191:Section [Physical Object]
Processing 00000000.tx.56: All nucleotide changes and deletions in tau sequences were performed by standard PCR using a mutagenized primer with primers I9X2 or I10B2. 

Phrase: "All nucleotide changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "deletions in tau sequences"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   802   C0162773:Sequence Deletions [Cell or Molecular Dysfunction]
   770   C1880274:Deletions [Activity]
   737 E C1442161:Deletion [Cell or Molecular Dysfunction]
   737 E C1511760:Deletion [Genetic Function]

Phrase: "were"

Phrase: "performed by standard PCR"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1550369:Performed By [Qualitative Concept]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   770   C0884358:Performed [Functional Concept]
   770   C1442989:Standard [Qualitative Concept]
   770   C2828392:Standard [Intellectual Product]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a mutagenized primer with primers I9X2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "I10B2."
Processing 00000000.tx.57: PCR products were digested with XhoI/BamHI and ligated into pSPES. 

Phrase: "PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "digested with XhoI/BamHI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "ligated into pSPES."
Processing 00000000.tx.58: The DNA sequence of the normal human and mouse inserts and all sequence alterations were confirmed by dye terminator cycle sequencing with TaqFS DNA polymerase (Perkin-Elmer) using an ABI377 DNA sequencer. 

Phrase: "The DNA sequence of the normal human"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0162326:DNA Sequence [Nucleotide Sequence]
           Sequence
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "mouse inserts"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0813036:Inserts [Medical Device]
   827 E C0441587:Insert [Health Care Activity]
   827 E C1743766:Insert [Medical Device]
   827 E C1883719:Insert [Functional Concept]

Phrase: "and"

Phrase: "all sequence alterations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0596611:Sequence Alteration [Genetic Function]
   827   C1515926:Alteration [Idea or Concept]

Phrase: "were"

Phrase: "confirmed by dye terminator cycle sequencing"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   753   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   753   C0750484:Confirmed [Idea or Concept]
   753   C0851166:TERMINATOR [Pharmacologic Substance]
   753   C1511572:Cycle [Temporal Concept]
   753   C1553778:Sequencing [Intellectual Product]
   753   C1561491:Sequencing [Functional Concept]
   753   C1705818:Terminator [Manufactured Object]
   753   C3205287:Terminator [Pharmacologic Substance]
   719 E C1456348:Confirm [Qualitative Concept]

Phrase: "with TaqFS DNA polymerase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Perkin-Elmer"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an ABI377 DNA sequencer."
Processing 00000000.tx.59: When the cryptic exon present in pSPL3 was removed to create pSPES, splicing experiments revealed an additional cryptic splice site between the cloning site and tat exon 3.

Phrase: "When"

Phrase: "the cryptic exon present in pSPL3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "pSPES,"

Phrase: "splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]

Phrase: "experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "an additional cryptic splice site between the cloning site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1720838:Splice Site, Cryptic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   762   C1705686:Cloning Site [Nucleotide Sequence]
   742   C0205145:Site [Spatial Concept]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "tat exon 3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.60: This new site is not used when no test exon is placed in pSPES. 

Phrase: "This new site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "when"

Phrase: "no test exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "placed in pSPES."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0442504:Place [Spatial Concept]
   756   C1704765:Place [Functional Concept]
   756   C1882509:Place [Activity]
   756   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.61: When the normal tau E10 or mutant E10 with a weak 5' splice site is inserted, small amounts of E10 join with this cryptic site yielding a ~60-bp product, although most of E10 is joined to tat exon 3,yielding a 354-bp product. 

Phrase: "When"

Phrase: "the normal tau E10"

Phrase: "or"

Phrase: "mutant E10 with a weak 5' splice site"

Phrase: "is"

Phrase: "inserted"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0441587:Inserted [Health Care Activity]
   966 E C1743766:Insert [Medical Device]
   966 E C1883719:Insert [Functional Concept]

Phrase: ","

Phrase: "small amounts of E10 join"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "with this cryptic site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "yielding"

Phrase: "a ~60-bp product,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]

Phrase: "although"

Phrase: "most of E10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205393:Most [Quantitative Concept]

Phrase: "is"

Phrase: "joined"

Phrase: "to tat exon 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1883351:To [Qualitative Concept]

Phrase: "yielding"

Phrase: "a 354-bp product."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1514468:product [Entity]
   812   C1704444:Product [Quantitative Concept]
Processing 00000000.tx.62: In calculating the amount of E10 included in the final transcript, the amount of E10 joined to the cryptic site was included in the total. 

Phrase: "In calculating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculating [Activity]

Phrase: "the amount of E10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "included in the final transcript,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0205088:Final [Temporal Concept]
   760   C0332257:included [Functional Concept]
   760   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1546485:Final [Idea or Concept]
   760   C3538986:INCLUDED [Gene or Genome]
   726 E C1552866:include [Idea or Concept]
   726 E C2700399:Include [Activity]

Phrase: "the amount of E10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "joined to the cryptic site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205145:Site [Spatial Concept]
   760   C0535936:CRYPTIC [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1332788:CRYPTIC [Gene or Genome]
   760   C1515974:Site [Body Location or Region]
   760   C1705780:CRYPTIC [Gene or Genome]
   760   C2825164:Site [Spatial Concept]

Phrase: "was"

Phrase: "included in the total."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0332257:included [Functional Concept]
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]
Processing 00000000.tx.63: Cell Culture, Transient Transfection, and RNA Isolation-- Cell culture and transfection reagents were from Life Technologies, Inc. 

Phrase: "Cell Culture,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "Transient Transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "RNA Isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0204727:Isolation [Therapeutic or Preventive Procedure]
   861   C0205409:Isolation [Functional Concept]
   861   C0220862:isolation [Laboratory Procedure]
   789 E C1548221:Isolated [Idea or Concept]

Phrase: "--"

Phrase: "Cell culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "transfection reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were from Life Technologies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0039421:technologies [Occupation or Discipline]
   770   C0376558:Life [Idea or Concept]

Phrase: "Inc."
Processing 00000000.tx.64: COS-7 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. 

Phrase: "COS-7 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained in Dulbecco's modified Eagle's medium"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagle [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1314677:Maintained [Functional Concept]
   753   C1551720:Eagle [Population Group]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719 E C0024501:Maintain [Activity]

Phrase: "supplemented with 10% fetal calf serum."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.65: Transient transfections were performed in triplicate using 1g of plasmid DNA with 6l of LipofectAMINE in a total of 700l of Opti-MEM per 35-mm well. 

Phrase: "Transient transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "performed in triplicate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "1g of plasmid DNA"

Phrase: "with 6l"

Phrase: "of LipofectAMINE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]

Phrase: "in a total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "of 700l"

Phrase: "of Opti-MEM"

Phrase: "per 35-mm well."
Processing 00000000.tx.66: Cells were exposed to the lipid-DNA complex for 5h at 37C in a 5% CO2 incubator and allowed to recover with 700l of Dulbecco's modified Eagle's medium containing 20% fetal calf serum. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to the lipid-DNA complex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0023779:Lipid [Lipid]
   753   C0439855:Complex [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "for 5h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442467:5H [Temporal Concept]

Phrase: "at 37C"

Phrase: "in a 5% CO2 incubator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0021178:Incubator [Manufactured Object]

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "recover with 700l of Dulbecco's modified Eagle's medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0009458:Medium [Intellectual Product]
   744   C0325564:Eagle [Bird]
   744   C0392747:Modified [Functional Concept]
   744   C0439536:Medium [Quantitative Concept]
   744   C0521108:recover [Qualitative Concept]
   744   C1551720:Eagle [Population Group]
   744   C1705217:Medium [Substance]
   744   C2004454:recover [Organism Function]
   744   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "20% fetal calf serum."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]
Processing 00000000.tx.67: Total cellular RNA was isolated 48h later with TRIzol (Life Technologies, Inc.). 

Phrase: "Total cellular RNA"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0007634:Cellular [Cell]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0178539:Cellular [Functional Concept]
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]
   755 E C1516377:Cellularity [Qualitative Concept]

Phrase: "was"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "48h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "later with TRIzol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0205087:Late [Temporal Concept]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.68: RNA samples were DNase I-treated (Amersham Pharmacia Biotech) prior to reverse transcription. 

Phrase: "RNA samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "DNase I-treated"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0332293:treated [Therapeutic or Preventive Procedure]
   827   C1522326:Treated [Functional Concept]
   793 E C1292734:TREAT [Functional Concept]
   734   C0011519:DNAase I [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1148702:DNase I [Genetic Function]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "prior to reverse transcription."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035380:Reverse Transcription [Genetic Function]
   861   C0040649:Transcription [Genetic Function]
   861   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.69: Quantitation of Tau E10 Splicing by Reverse Transcription-PCR (RT-PCR)-- Splicing was assayed essentially as described previously (15). 

Phrase: "Quantitation of Tau E10 Splicing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantitation [Quantitative Concept]

Phrase: "by Reverse Transcription-PCR (RT-PCR)-- Splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0035687:Splicing [Genetic Function]
   812   C2610186:splicing [Genetic Function]

Phrase: "was"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "essentially"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.70: Total RNA (2-2.5 g) was reverse-transcribed with random hexamers using the GeneAmp RNA PCR kit (Perkin-Elmer). 

Phrase: "Total RNA (2-2.5 g)"

Phrase: "was"

Phrase: "reverse-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "transcribed with random hexamers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0034656:RANDOM [Research Activity]
   770   C0439605:Random [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the GeneAmp RNA PCR kit (Perkin-Elmer"

Phrase: ")."
Processing 00000000.tx.71: PSPES-spliced products were amplified by PCR using forward and reverse primers SD6 and SA2, respectively (Life Technologies, Inc.), that are specific for rabbit -globin sequences in the vector. 

Phrase: "PSPES-spliced products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: "and"

Phrase: "reverse primers SD6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "SA2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1420449:SA2 [Gene or Genome]
  1000   C3541915:SA2 [Gene or Genome]

Phrase: "respectively"

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc."

Phrase: ")"

Phrase: ","

Phrase: "that"

Phrase: "are"

Phrase: "specific for rabbit -globin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: "sequences in the vector."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C0442335:Vector [Spatial Concept]
   770   C1519249:Sequence [Functional Concept]
   770   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.72: 1ng of 32P-labeled SA2 was included in PCRs that were performed for 18cycles to obtain linear amplification. 

Phrase: "1ng of 32P-labeled SA2"

Phrase: "was"

Phrase: "included in PCRs"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0332257:included [Functional Concept]
   790   C3538986:INCLUDED [Gene or Genome]
   756   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   756   C0677874:pCR [Finding]
   756 E C1552866:include [Idea or Concept]
   756 E C2700399:Include [Activity]

Phrase: "that"

Phrase: "were"

Phrase: "performed for 18cycles to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "linear amplification."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1517480:Amplification [Molecular Biology Research Technique]
   861   C1521871:Amplification [Phenomenon or Process]
   861   C1705759:Amplification [Cell or Molecular Dysfunction]
Processing 00000000.tx.73: Products were resolved on 5% acrylamide gels and quantitated using a PhosphorImager. 

Phrase: "Products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "resolved on 5% acrylamide gels"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0017243:Gels [Biomedical or Dental Material]
   760   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]
   760   C1514893:Resolved [Idea or Concept]
   760   C2699488:Resolved [Conceptual Entity]
   726 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "quantitated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a PhosphorImager."
Processing 00000000.tx.74: For the normal tau E10 construct hN, the percent E10 inclusion is the mean value from eight independent transfection experiments performed on different days. 

Phrase: "For the normal tau E10 construct hN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0086418:Human [Human]

Phrase: "the percent E10 inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512693:Inclusion [Qualitative Concept]

Phrase: "is"

Phrase: "the mean value from eight independent transfection experiments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0444504:Mean [Quantitative Concept]
   744   C1522609:Value [Quantitative Concept]
   744   C2347634:Mean [Quantitative Concept]
   744   C2348143:Mean [Quantitative Concept]

Phrase: "performed on different days."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0439228:days [Temporal Concept]
   770   C0884358:Performed [Functional Concept]
   770   C1705242:Different [Qualitative Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.75: For each mutant construct, values presented are the average of at least three different transfection experiments. 

Phrase: "For each mutant construct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "are"

Phrase: "the average of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1510992:Average [Quantitative Concept]
   790   C2825518:AVERAGE [Quantitative Concept]

Phrase: "at least three different transfection experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0681814:Experiments [Research Activity]
   771 E C1706386:Experiment [Conceptual Entity]
   721 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.76: Also, for each transfection experiment, hN was transfected in parallel, and the experiment was considered valid if the value for hN was 2 S.D. of 45% (36.6-51.5%). 

Phrase: "Also,"

Phrase: "for each transfection experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "hN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "was"

Phrase: "transfected"

Phrase: "in parallel,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C2348042:Parallel [Qualitative Concept]
   861   C2826345:PARALLEL [Research Activity]

Phrase: "and"

Phrase: "the experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "valid"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2349099:Valid [Qualitative Concept]
   928 E C2349101:Validity [Quantitative Concept]

Phrase: "if"

Phrase: "the value for hN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "2 S.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C1705052:2-D [Spatial Concept]

Phrase: "of 45%"

Phrase: "(36.6-51.5%"

Phrase: ")."
Processing 00000000.tx.77: Statistical comparisons were made using a two-tailed Student's t test. 

Phrase: "Statistical comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707455:Comparison [Activity]

Phrase: "were"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a two-tailed Student's t test."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0022885:Test [Laboratory Procedure]
   804   C0038492:student [Professional or Occupational Group]
   804   C0039593:Test [Functional Concept]
   804   C0392366:test [Intellectual Product]
   804   C1551041:student [Idea or Concept]
   804   C1552573:student [Intellectual Product]
Processing 00000000.tx.78: Criteria for significance were calculated using a Bonferroni correction for multiple comparisons by dividing the initial p value of 0.05by the number of comparisons made. 

Phrase: "Criteria for significance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0243161:criteria [Intellectual Product]

Phrase: "were"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Bonferroni correction for multiple comparisons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705565:CORRECTION [Intellectual Product]
   753   C1947976:Correction [Functional Concept]

Phrase: "by dividing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332849:dividing [Functional Concept]

Phrase: "the initial p value of 0.05by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1709380:P-Value [Quantitative Concept]
   748   C1522609:Value [Quantitative Concept]

Phrase: "the number of comparisons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "made."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]
Processing 00000000.tx.79: RNA Structure Analyses-- RNA secondary structures and free energies were predicted using the GCG version of the MFOLD program (22). 

Phrase: "RNA Structure Analyses"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   896   C0872262:RNA Analysis [Laboratory Procedure,Research Activity]
   848   C0204514:Structural analysis [Therapeutic or Preventive Procedure]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "--"

Phrase: "RNA secondary structures"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   867   C0162807:Secondary Structure [Spatial Concept]
   827   C0027627:secondary [Neoplastic Process]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0175668:Secondary [Temporal Concept]
   827   C0205436:Secondary [Quantitative Concept]
   827   C0678594:structures [Spatial Concept]

Phrase: "and"

Phrase: "free energies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C0678591:Free Energy [Natural Phenomenon or Process]
   861   C0542479:energies [Natural Phenomenon or Process]
   827 E C0424589:Energy [Finding]
   827 E C1442080:Energy [Quantitative Concept]

Phrase: "were"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the GCG version of the MFOLD program"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0333052:Version [Functional Concept]
   748   C2607870:Version [Spatial Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.80: The free energies of the most stable structures computed for each sequence were compared.  

Phrase: "The free energies of the most stable structures"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   754   C0678591:Free Energy [Natural Phenomenon or Process]
   744   C0542479:energies [Natural Phenomenon or Process]
   711 E C0424589:Energy [Finding]
   711 E C1442080:Energy [Quantitative Concept]

Phrase: "computed for each sequence"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1441526:Computed [Laboratory Procedure]
   770   C1519249:Sequence [Functional Concept]
   770   C1880157:Computed [Activity]

Phrase: "were"

Phrase: "compared."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]
Processing 00000000.tx.81: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Previous work on the effects of FTDP-17 mutations on tau E10 splicing showed that mutations at nucleotides 15-18 within a purine-rich region in E10 and a mutation at nucleotide 30altered splicing of this exon (15). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Previous work on the effects of FTDP-17 mutations"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   784   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   766   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   750   C0236642:frontotemporal dementia [Disease or Syndrome]
   749   C0598172:chromosome mutations [Cell or Molecular Dysfunction]
   735   C0008633:Chromosome [Cell Component]
   735   C0011265:dementia [Mental or Behavioral Dysfunction]
   735   C0026882:Mutations [Genetic Function]
   735   C0043227:Work [Occupational Activity]
   735   C0205156:Previous [Temporal Concept]
   735   C0242422:Parkinsonism [Disease or Syndrome]
   735   C0497327:Dementia [Mental or Behavioral Dysfunction]
   735   C1280500:effects [Qualitative Concept]
   735   C1552607:previous [Temporal Concept]
   713 E C0948447:chromosomal mutations [Cell or Molecular Dysfunction]
   702 E C1705285:Mutation [Cell or Molecular Dysfunction]
   702 E C2348382:Effect [Qualitative Concept]

Phrase: "on tau E10 splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035687:Splicing [Genetic Function]
   827   C2610186:splicing [Genetic Function]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that mutations at nucleotides 15-18"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "within a purine-rich region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "in E10"

Phrase: "and"

Phrase: "a mutation at nucleotide 30altered splicing of this exon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0026882:Mutation [Genetic Function]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.82: To identify the regulatory elements affected by these mutations and to reveal other potential regulatory sequences, we generated in-frame 3nucleotide deletions from the beginning of E10 exon to nucleotide 33(E1-E11). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the regulatory elements"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0013879:Elements [Element, Ion, or Isotope]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "affected by these mutations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0026882:Mutations [Genetic Function]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   737 E C0001721:Affect [Mental Process]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "other potential regulatory sequences,"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   867   C0314642:Regulatory sequence [Nucleotide Sequence]
   827   C0162326:Sequences [Nucleotide Sequence]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "in-frame 3nucleotide deletions from the beginning of E10 exon"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   739   C1880274:Deletions [Activity]
   706 E C1442161:Deletion [Cell or Molecular Dysfunction]
   706 E C1511760:Deletion [Genetic Function]

Phrase: "to nucleotide 33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(E1-E11"

Phrase: ")."
Processing 00000000.tx.83: Nine nucleotide deletions were generated from nucleotide 34to the end of the exon (E12-E17) (Fig. 1). 

Phrase: "Nine nucleotide deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1880274:Deletions [Activity]
   793 E C1442161:Deletion [Cell or Molecular Dysfunction]
   793 E C1511760:Deletion [Genetic Function]

Phrase: "were"

Phrase: "generated from nucleotide 34to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C3146294:Generated [Activity]

Phrase: "the end of the exon"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0444930:End [Spatial Concept]
   760   C2746065:End [Temporal Concept]
   704 E C0205088:Terminal [Temporal Concept]
   704 E C1705314:Terminal [Manufactured Object]
   704 E C1705315:Terminal [Spatial Concept]

Phrase: "(E12-E17"

Phrase: ")"

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.84: Additional substitutions were used to identify critical nucleotides and to determine if effects seen with deletions were due to removal of critical sequences or caused by changes in distances between other cis-acting elements. 

Phrase: "Additional substitutions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1555721:Substitution [Idea or Concept]
   827   C1706204:Substitution [Activity]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "critical nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "seen with deletions"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0205397:Seen [Qualitative Concept]
   790   C1880274:Deletions [Activity]
   756 E C0042789:see [Organism Function]
   756 E C1442161:Deletion [Cell or Molecular Dysfunction]
   756 E C1511760:Deletion [Genetic Function]
   756 E C1947903:See [Activity]

Phrase: "were due to removal of critical sequences"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0015252:Removal [Therapeutic or Preventive Procedure]
   748   C0162326:Sequences [Nucleotide Sequence]
   748   C0728940:Removal [Therapeutic or Preventive Procedure]
   748   C1511545:Critical [Qualitative Concept]
   748   C3146286:Due [Idea or Concept]
   714 E C0004793:Sequence [Nucleotide Sequence]
   714 E C0162327:Sequence [Nucleotide Sequence]
   714 E C1519249:Sequence [Functional Concept]

Phrase: "or"

Phrase: "caused by changes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in distances"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012751:distances [Quantitative Concept]
   916 E C0443203:Distant [Spatial Concept]

Phrase: "between other cis-acting elements."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   988   C0599780:cis acting element [Nucleotide Sequence]
   827   C0013879:Elements [Element, Ion, or Isotope]
   793 E C1705248:Element [Conceptual Entity]
Processing 00000000.tx.85: Splicing was assayed by inserting the normal or modified E10 with 33nucleotides of I9 and 51nucleotides of I10 (Fig. 1) between HIV tat exons 2and 3.

Phrase: "Splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]

Phrase: "was"

Phrase: "assayed by inserting"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C0441587:Insert [Health Care Activity]
   756   C1510438:Assay [Laboratory Procedure]
   756   C1743766:Insert [Medical Device]
   756   C1883719:Insert [Functional Concept]

Phrase: "the normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "or"

Phrase: "modified E10 with 33nucleotides of I9"

Phrase: "and"

Phrase: "51nucleotides of I10"

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "between HIV tat exons 2and 3."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0858513:hiv-3 [Disease or Syndrome]
   804   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0019682:HIV [Virus]
   804   C0019699:HIV+ [Finding]
Processing 00000000.tx.86: When the normal E10 is assayed in COS-7 cells, 45% of the transcripts contain E10 (Fig. 1). 

Phrase: "When"

Phrase: "the normal E10"

Phrase: "is"

Phrase: "assayed in COS-7 cells,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   862   C1257858:COS-7 Cells [Cell]
   797   C0376702:COS Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0454802:Cos [Geographic Area]
   760   C3282337:Cells [Cell]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726 E C1269647:Cell [Cell]
   726   C1510438:Assay [Laboratory Procedure]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "45% of the transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "E10"

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.87: The cis-acting regulatory elements identified are described individually below. 

Phrase: "The cis-acting regulatory elements"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   912   C0599780:cis acting element [Nucleotide Sequence]
   827   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0013879:Elements [Element, Ion, or Isotope]
   812   C0220905:regulatory [Regulation or Law]
   812   C1704735:Regulatory [Conceptual Entity]
   779 E C1705248:Element [Conceptual Entity]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "are"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "individually below."
Processing 00000000.tx.88: View larger version (36K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.89: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.90: Deletion analysis of tau E10. 

Phrase: "Deletion analysis of tau E10."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.91: A, nucleotide sequence of tau E10. 

Phrase: "A,"

Phrase: "nucleotide sequence of tau E10."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   760   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.92: Exon nucleotides are in capital letters and intron nucleotides in lowercase letters. 

Phrase: "Exon nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are in capital letters"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   816   C2827599:Capital Letter [Qualitative Concept]
   770   C0006909:Capital [Quantitative Concept]
   770   C0282413:letters [Intellectual Product]
   770   C1551058:Are [Quantitative Concept]
   737 E C1096774:Letter [Intellectual Product]
   737 E C2360551:Letter [Clinical Attribute]

Phrase: "and"

Phrase: "intron nucleotides in lowercase letters."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.93: FTDP-17 mutations are indicated by solid arrows, except for 280K which is shown with a triangle spanning the deleted nucleotides. 

Phrase: "FTDP-17 mutations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   814   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   778   C0236642:frontotemporal dementia [Disease or Syndrome]
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "are"

Phrase: "indicated by solid arrows,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205208:Solid [Qualitative Concept]
   770   C0302909:Solid [Substance]
   770   C0336721:arrows [Manufactured Object]
   770   C1378566:Solid [Biomedical or Dental Material]
   770   C1444656:Indicated [Finding]

Phrase: "except for 280K"

Phrase: "which"

Phrase: "is"

Phrase: "shown with a triangle spanning"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205119:Triangle [Conceptual Entity]
   726   C1547282:Show [Intellectual Product]
   726   C1711300:Span [Conceptual Entity]
   726   C2700613:Span [Quantitative Concept]

Phrase: "the deleted nucleotides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.94: E10 sequence differences between human and mouse are shown above the sequence (open arrows), and mouse nucleotides are in italics (differences in intronic sequences are not shown). 

Phrase: "E10 sequence differences between human"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "are"

Phrase: "shown above the sequence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "(open arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "mouse nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are in italics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1551058:Are [Quantitative Concept]

Phrase: "(differences in intronic sequences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.95: For FTDP-17 mutations and substitutions used in this study, the location of E10 nucleotide changes is indicated by the nucleotide number within the exon (the first nucleotide at the 5' end of E10 is 1). 

Phrase: "For FTDP-17 mutations"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   861   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   835   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   822   C0598172:chromosome mutations [Cell or Molecular Dysfunction]
   812   C0236642:frontotemporal dementia [Disease or Syndrome]
   793   C0008633:Chromosome [Cell Component]
   793   C0011265:dementia [Mental or Behavioral Dysfunction]
   793   C0026882:Mutations [Genetic Function]
   793   C0242422:Parkinsonism [Disease or Syndrome]
   793   C0497327:Dementia [Mental or Behavioral Dysfunction]
   793   C0521125:For [Qualitative Concept]
   787 E C0948447:chromosomal mutations [Cell or Molecular Dysfunction]
   760 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "substitutions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1555721:Substitution [Idea or Concept]
   966   C1706204:Substitution [Activity]

Phrase: "used in this study,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "the location of E10 nucleotide changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0450429:Location [Spatial Concept]
   753   C1515974:Location [Body Location or Region]

Phrase: "is"

Phrase: "indicated by the nucleotide number"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]
   760   C1444656:Indicated [Finding]

Phrase: "within the exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "("

Phrase: "the first nucleotide at the 5' end of E10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.96: The normal and the substituted nucleotide are shown in superscript. 

Phrase: "The normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "the substituted nucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "shown in superscript."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C2825228:Superscript [Intellectual Product]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.97: Thus the FTDP-17 mutation in E10 at nucleotide 15where the normal base is a T and the mutant base is a G is indicated as 15TG. 

Phrase: "Thus"

Phrase: "the FTDP-17 mutation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   800   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   770   C0236642:frontotemporal dementia [Disease or Syndrome]
   744   C0011265:dementia [Mental or Behavioral Dysfunction]
   744   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "in E10"

Phrase: "at nucleotide 15where"

Phrase: "the normal base"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0002055:base [Inorganic Chemical]
   861   C0178499:Base [Chemical Viewed Functionally]
   861   C1880279:Base [Biomedical or Dental Material]
   789 E C0205112:Basal [Spatial Concept]
   777 E C0016617:Foundation [Organization]
   777 E C1626935:Bases [Quantitative Concept]

Phrase: "is"

Phrase: "a T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0193959:a t [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the mutant base"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0002055:base [Inorganic Chemical]
   861   C0178499:Base [Chemical Viewed Functionally]
   861   C1880279:Base [Biomedical or Dental Material]
   789 E C0205112:Basal [Spatial Concept]
   777 E C0016617:Foundation [Organization]
   777 E C1626935:Bases [Quantitative Concept]

Phrase: "is"

Phrase: "a G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "is"

Phrase: "indicated as 15TG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.98: Amino acid change locations are listed with the normal amino acid shown in superscript before the codon number and the mutant amino acid shown after the codon number. 

Phrase: "Amino acid change locations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0450429:locations [Spatial Concept]
   779 E C1515974:Location [Body Location or Region]
   756   C1953353:Amino acid change [Finding]

Phrase: "are"

Phrase: "listed with the normal amino acid"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C2347086:% Normal [Quantitative Concept]
   719   C0745732:List [Conceptual Entity]
   719   C3272378:LIST [Intellectual Product]

Phrase: "shown in superscript"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C2825228:Superscript [Intellectual Product]
   756   C1547282:Show [Intellectual Product]

Phrase: "before the codon number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "the mutant amino acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "shown after the codon number."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0009221:Codon [Nucleotide Sequence]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]
   760   C1095825:Codon [Plant]
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.99: Codon numbering is based on the longest common tau isoform in brain containing E2, E3, and E10. 

Phrase: "Codon numbering"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449788:numbering [Quantitative Concept]
   827 E C0237753:*Number [Quantitative Concept]

Phrase: "is"

Phrase: "based on the longest common tau isoform"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   748   C0205214:Common [Quantitative Concept]
   748   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   748   C1522138:Common [Functional Concept]
   748   C1522425:Longest [Qualitative Concept]
   748   C1527178:Based [Functional Concept]
   748   C1705938:Based [Idea or Concept]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]
   748   C3245511:common [Intellectual Product]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C0205166:Long [Qualitative Concept]
   714 E C1706317:Long [Qualitative Concept]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "in brain containing E2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3539520:E2 [Gene or Genome]

Phrase: "E3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1537525:E3 [Gene or Genome]

Phrase: "and"

Phrase: "E10."
Processing 00000000.tx.100: The locations of I10 mutations are shown after a+symbol as the nucleotide number in I10 with the first nucleotide of the intron being 1(e.g. 

Phrase: "The locations of I10 mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0450429:locations [Spatial Concept]
   726 E C1515974:Location [Body Location or Region]

Phrase: "are"

Phrase: "shown after a+symbol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0679214:symbol [Idea or Concept]
   770   C1698987:symbol [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "as the nucleotide number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "in I10"

Phrase: "with the first nucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of the intron"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "being"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "("

Phrase: "e.g."
Processing 00000000.tx.101: E10+16ct). 

Phrase: "E10+16ct"

Phrase: ")."
Processing 00000000.tx.102: The normal and mutant nucleotides are shown in superscript. 

Phrase: "The normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "mutant nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "shown in superscript."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C2825228:Superscript [Intellectual Product]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.103: Deletions used for E10 analysis are indicated with bars directly below the sequence and are labeled E1-E17. 

Phrase: "Deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880274:Deletions [Activity]
   966 E C1442161:Deletion [Cell or Molecular Dysfunction]
   966 E C1511760:Deletion [Genetic Function]

Phrase: "used for E10 analysis"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1273517:used [Finding]
   770   C1524024:analysis [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: "indicated with bars directly"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1444656:Indicated [Finding]
   770   C1707156:BARS [Gene or Genome]
   770   C1947931:Directly [Qualitative Concept]
   770   C3274014:BARS [Intellectual Product]
   770   C3541345:BARS [Intellectual Product]

Phrase: "below the sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "E1-E17."
Processing 00000000.tx.104: The nucleotides present in a potential stem-loop are shown with a bar above the sequence with the loop region as a dotted line. 

Phrase: "The nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "present in a potential stem-loop"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0150312:Present [Quantitative Concept]
   753   C0242767:Stem [Plant]
   753   C0419518:Loop [Medical Device]
   753   C0445022:Loop [Spatial Concept]
   753   C0449450:Present [Idea or Concept]
   753   C1186763:Stem [Body Part, Organ, or Organ Component]
   753   C3245505:Potential [Qualitative Concept]

Phrase: "are"

Phrase: "shown with a bar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]

Phrase: "above the sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "with the loop region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "as a dotted line."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
Processing 00000000.tx.105: The locations of potential cis-acting regulatory regions are shown as hatched boxes below the sequence. 

Phrase: "The locations of potential cis-acting regulatory regions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0450429:locations [Spatial Concept]
   711 E C1515974:Location [Body Location or Region]

Phrase: "are"

Phrase: "shown as hatched boxes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0179400:boxes [Manufactured Object]
   770   C1638312:Boxes [Quantitative Concept]
   737   C0598016:hatch [Organism Function]
   737 E C1533124:Box [Medical Device]
   737   C1547282:Show [Intellectual Product]

Phrase: "below the sequence."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.106: B, autoradiograph of E10 splicing analyzed by RT-PCR. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "autoradiograph of E10 splicing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2986957:Autoradiograph [Manufactured Object]

Phrase: "analyzed by RT-PCR."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0035380:Reverse Transcription [Genetic Function]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0040649:Transcription [Genetic Function]
   760   C0677874:pCR [Finding]
   760   C0936012:Analyzed [Research Activity]
   760   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.107: The E10 minus (E10) fragment is 261bp and the E10+ fragment is 354bp. 

Phrase: "The E10"

Phrase: "minus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332288:Minus [Qualitative Concept]

Phrase: "(E10"

Phrase: ")"

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "is"

Phrase: "261bp"

Phrase: "and"

Phrase: "the E10+ fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "is"

Phrase: "354bp."
Processing 00000000.tx.108: A longer exposure of the last 4lanes (E14-E17) is presented below the original exposure. 

Phrase: "A longer exposure of the last 4lanes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0274281:Exposure, NOS [Injury or Poisoning]
   748   C0332157:Exposure [Clinical Attribute]

Phrase: "(E14-E17"

Phrase: ")"

Phrase: "is"

Phrase: "presented below the original exposure."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205313:Original [Idea or Concept]
   760   C0274281:Exposure, NOS [Injury or Poisoning]
   760   C0332157:Exposure [Clinical Attribute]
   760   C0449450:Presented [Idea or Concept]
   760   C2347409:Original [Occupational Activity]
   726 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.109: C, quantitation of E10 splicing. 

Phrase: "C,"

Phrase: "quantitation of E10 splicing."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantitation [Quantitative Concept]
Processing 00000000.tx.110: Radioactivity in each band was quantitated using a PhosphorImager. 

Phrase: "Radioactivity in each band"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "quantitated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a PhosphorImager."
Processing 00000000.tx.111: Each bar represents the mean of at least three separate transfection experiments and 100% is the sum of E10 and E10+. 

Phrase: "Each bar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444504:Mean [Quantitative Concept]
   790   C2347634:Mean [Quantitative Concept]
   790   C2348143:Mean [Quantitative Concept]

Phrase: "at least three separate transfection experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0681814:Experiments [Research Activity]
   771 E C1706386:Experiment [Conceptual Entity]
   721 E C1517586:Experimental [Qualitative Concept]

Phrase: "and"

Phrase: "100%"

Phrase: "is"

Phrase: "the sum of E10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515051:Sum [Quantitative Concept]

Phrase: "and"

Phrase: "E10+."
Processing 00000000.tx.112: Error bars are standard deviations. 

Phrase: "Error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "are"

Phrase: "standard deviations."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0871420:Standard deviation [Quantitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]
   827   C0012727:Deviation [Spatial Concept]
   827   C0205419:Deviation [Qualitative Concept]
   827   C1705236:Deviation [Finding]
Processing 00000000.tx.113: A corrected significance criteria of p<0.003was used, and p values for comparison of each construct to normal human E10 are indicated with the following symbols: , p<1103; 

Phrase: "A corrected significance criteria of p<0.003was"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0243161:criteria [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "and"

Phrase: "p values for comparison of each construct"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0042295:Values [Qualitative Concept]
   745   C1709380:P-Value [Quantitative Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "to normal human E10"

Phrase: "are"

Phrase: "indicated with the following symbols"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0679214:symbols [Idea or Concept]
   760   C1444656:Indicated [Finding]
   726   C0332283:follow [Temporal Concept]
   726 E C1698987:symbol [Intellectual Product]
   726   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: ","

Phrase: "p<1103"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.114: , p<1104; 

Phrase: ", p<1104"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.115: , p<1105; 

Phrase: ", p<1105"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.116: *, p<1106; 

Phrase: "*,"

Phrase: "p<1106"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.117: , p<1107; 

Phrase: ", p<1107"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.118: and +, p<1108. 

Phrase: "and"

Phrase: "+,"

Phrase: "p<1108."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.119: Purine-rich ESE Element-- Deletions E5 to E7 severely reduce E10 inclusion (Fig. 1) indicating the presence of an ESE sequence. 

Phrase: "Purine-rich ESE Element"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0014290:Enhancer Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C1705248:Element [Conceptual Entity]

Phrase: "--"

Phrase: "Deletions E5 to E7 severely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1423600:E5 [Gene or Genome]

Phrase: "reduce"

Phrase: "E10 inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "indicating"

Phrase: "the presence of an ESE sequence."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.120: This ESE is designated the polypurine enhancer (PPE) because of the high purine content of this sequence (AAGAAGCTG) and is the cis-acting element affected by FTDP-17 mutations N279K and 280K. 

Phrase: "This ESE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "designated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524084:Designated [Functional Concept]

Phrase: "the polypurine enhancer (PPE) because of the high purine content of this sequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   751   C0014290:Sequence, Enhancer [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(AAGAAGCTG"

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "the cis-acting element"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599780:cis acting element [Nucleotide Sequence]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C1705248:Element [Conceptual Entity]

Phrase: "affected by FTDP-17 mutations N279K"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   806   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   782   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   760   C0236642:frontotemporal dementia [Disease or Syndrome]
   757   C0598172:chromosome mutations [Cell or Molecular Dysfunction]
   739   C0008633:Chromosome [Cell Component]
   739   C0011265:dementia [Mental or Behavioral Dysfunction]
   739   C0026882:Mutations [Genetic Function]
   739   C0242422:Parkinsonism [Disease or Syndrome]
   739   C0392760:Affected [Functional Concept]
   739   C0497327:Dementia [Mental or Behavioral Dysfunction]
   739   C1314939:Affected [Functional Concept]
   722 E C0948447:chromosomal mutations [Cell or Molecular Dysfunction]
   706 E C0001721:Affect [Mental Process]
   706 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "280K."
Processing 00000000.tx.121: E5 and E6 are structurally equivalent and the same as FTDP-17 mutation 280K. 

Phrase: "E5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1423600:E5 [Gene or Genome]

Phrase: "and"

Phrase: "E6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1335332:E6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "structurally equivalent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205163:Equivalent [Qualitative Concept]
   861   C0439185:equivalent [Quantitative Concept]

Phrase: "and"

Phrase: "the same as FTDP-17 mutation 280K."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   797   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   775   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   756   C0236642:frontotemporal dementia [Disease or Syndrome]
   756   C1278655:SAME AS [Classification]
   754   C0598172:chromosome mutation [Cell or Molecular Dysfunction]
   738   C0008633:Chromosome [Cell Component]
   738   C0011265:dementia [Mental or Behavioral Dysfunction]
   738   C0026882:Mutation [Genetic Function]
   738   C0242422:Parkinsonism [Disease or Syndrome]
   738   C0445247:Same [Qualitative Concept]
   738   C0497327:Dementia [Mental or Behavioral Dysfunction]
   738   C1705285:Mutation [Cell or Molecular Dysfunction]
   718 E C0948447:chromosomal mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.122: This deletion results in no detectable E10+ transcript. 

Phrase: "This deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "results in no detectable E10+ transcript."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1274040:Result [Functional Concept]
   753   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]
Processing 00000000.tx.123: The downstream flanking deletion E7 reduces the splicing ratio, whereas E8 does not, thus defining the 3' limits of the PPE. 

Phrase: "The downstream flanking deletion E7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1335333:E7 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "reduces"

Phrase: "the splicing ratio,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "whereas"

Phrase: "E8"

Phrase: "does"

Phrase: "not,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "thus"

Phrase: "defining"

Phrase: "the 3' limits of the PPE."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0439801:limits [Functional Concept]
   714 E C1549649:Limit [Idea or Concept]
   714 E C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.124: The 5' end of the PPE is more difficult to define. 

Phrase: "The 5' end of the PPE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0444930:End [Spatial Concept]
   748   C2746065:End [Temporal Concept]

Phrase: "is"

Phrase: "more difficult to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205172:More [Functional Concept]
   827   C0332218:Difficult [Qualitative Concept]
   755 E C1299586:Difficulty [Finding]

Phrase: "define."
Processing 00000000.tx.125: Deletions E3 and E4 result in higher than normal E10 inclusion, suggesting that these sequences may inhibit function of the PPE. 

Phrase: "Deletions E3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1537525:E3 [Gene or Genome]

Phrase: "and"

Phrase: "E4 result in higher"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "than normal E10 inclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512693:Inclusion [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "may"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "function of the PPE."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
Processing 00000000.tx.126: The sequence requirements for PPE function were explored with single nucleotide substitutions alone or in combination with the E5 deletion (Fig. 2). 

Phrase: "The sequence requirements for PPE function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1514873:Requirement [Functional Concept]

Phrase: "were"

Phrase: "explored with single nucleotide substitutions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   726   C1555721:Substitution [Idea or Concept]
   726   C1706204:Substitution [Activity]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205195:Combination [Qualitative Concept]
   790   C1947911:Combination [Physical Object]

Phrase: "with the E5 deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.127: Mutation 15TG (FTDP-17 mutation N279K) increases E10 incorporation to 79%. 

Phrase: "Mutation 15TG"

Phrase: "(FTDP-17 mutation N279K"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   800   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   770   C0236642:frontotemporal dementia [Disease or Syndrome]
   744   C0011265:dementia [Mental or Behavioral Dysfunction]
   744   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: ")"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "E10 incorporation to 79%."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0243126:incorporation [Functional Concept]
Processing 00000000.tx.128: The 15TG change possibly acts by increasing the number of GAR sequences (R is a purine) from 1to 2when compared with the normal sequence or by increasing the number of AAG repeats from 2to 3.

Phrase: "The 15TG"

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "acts by increasing"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0079613:ACT [Therapeutic or Preventive Procedure]
   790   C0442808:Increasing [Functional Concept]
   756 E C0442805:Increase [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "the number of GAR sequences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C2348184:Sequence Number [Quantitative Concept]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "(R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "is"

Phrase: "a purine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034140:Purine [Organic Chemical]
  1000   C0220903:purine [Organic Chemical]

Phrase: ")"

Phrase: "from 1to 2when"

Phrase: "compared with the normal sequence"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1519249:Sequence [Functional Concept]
   760   C1707455:Compared [Activity]
   760   C2347086:% Normal [Quantitative Concept]

Phrase: "or by increasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0442808:Increasing [Functional Concept]
   756 E C0442805:Increase [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "the number of AAG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "repeats from 2to 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205341:Repeat [Functional Concept]
   770   C1547730:Repeat [Temporal Concept]
   770   C1705914:Repeat [Conceptual Entity]
Processing 00000000.tx.129: Both GAR and AAG repeats are known to enhance splicing in other systems (23, 24). 

Phrase: "Both GAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1150722:GAR [Molecular Function]

Phrase: "and"

Phrase: "AAG repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205341:repeats [Functional Concept]
   861   C1705914:Repeats [Conceptual Entity]
   827 E C1547730:Repeat [Temporal Concept]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "splicing in other systems"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035687:Splicing [Genetic Function]
   770   C2610186:splicing [Genetic Function]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.130: Compatible with both explanations is that E5, which eliminates E10 inclusion, deletes the lone GAR repeat and 1of the 2normal AAG repeats. 

Phrase: "Compatible with both explanations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:compatible [Idea or Concept]
   770   C1524057:Compatible [Qualitative Concept]

Phrase: "is"

Phrase: "that E5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1423600:E5 [Gene or Genome]

Phrase: "which"

Phrase: "eliminates"

Phrase: "E10 inclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]

Phrase: "deletes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Delete [Activity]

Phrase: "the lone GAR repeat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205341:Repeat [Functional Concept]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]

Phrase: "and"

Phrase: "1of"

Phrase: "the 2normal AAG repeats."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205341:repeats [Functional Concept]
   827   C1705914:Repeats [Conceptual Entity]
   793 E C1547730:Repeat [Temporal Concept]
Processing 00000000.tx.131: When an A substitution is used rather than a G (15TA), E10 inclusion is increased but to a lesser extent than with the 15TG change (61compared with 79%, respectively). 

Phrase: "When"

Phrase: "an A substitution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1555721:Substitution [Idea or Concept]
  1000   C1706204:Substitution [Activity]

Phrase: "is"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "rather than"

Phrase: "a G (15TA"

Phrase: ")"

Phrase: ","

Phrase: "E10 inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]

Phrase: "is"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "but to a lesser extent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0233535:but [Mental or Behavioral Dysfunction]
   760   C0439792:Extent [Spatial Concept]
   760   C0547044:Lesser [Qualitative Concept]

Phrase: "than"

Phrase: "with the 15TG change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "(61compared with 79%,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.132: Likewise, in double mutants when the normal function of the PPE is severely compromised by E5, the G substitution gives much higher E10 incorporation than the A substitution (71versus 16%, respectively). 

Phrase: "Likewise,"

Phrase: "in double mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "when"

Phrase: "the normal function of the PPE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "severely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205082:Severely [Qualitative Concept]

Phrase: "compromised by E5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1423600:E5 [Gene or Genome]
   756   C2945640:compromise [Finding]

Phrase: "the G substitution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1555721:Substitution [Idea or Concept]
   861   C1706204:Substitution [Activity]

Phrase: "gives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "much higher E10 incorporation than the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0243126:incorporation [Functional Concept]

Phrase: "A substitution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1555721:Substitution [Idea or Concept]
  1000   C1706204:Substitution [Activity]

Phrase: "(71versus 16%,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.133: In the context of the deletion, the G substitution, like the normal sequence, maintains 1GAR repeat and 2AAG repeats, whereas the A substitution yields only 1AAG. 

Phrase: "In the context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "of the deletion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "the G substitution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1555721:Substitution [Idea or Concept]
   861   C1706204:Substitution [Activity]

Phrase: "like the normal sequence,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "maintains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "1GAR repeat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205341:Repeat [Functional Concept]
   861   C1547730:Repeat [Temporal Concept]
   861   C1705914:Repeat [Conceptual Entity]

Phrase: "and"

Phrase: "2AAG repeats,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205341:repeats [Functional Concept]
   861   C1705914:Repeats [Conceptual Entity]
   827 E C1547730:Repeat [Temporal Concept]

Phrase: "whereas"

Phrase: "the A substitution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1555721:Substitution [Idea or Concept]
  1000   C1706204:Substitution [Activity]

Phrase: "yields"

Phrase: "only 1AAG."
Processing 00000000.tx.134: Thus, although both mutations increase the number of consecutive purines in this region by 3nucleotides, clearly the types of purine and thus the specific sequence of the element are critical. 

Phrase: "Thus,"

Phrase: "although"

Phrase: "both mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the number of consecutive purines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "in this region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "by 3nucleotides,"

Phrase: "clearly"

Phrase: "the types of purine"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0332307:Types [Qualitative Concept]
   737 E C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "the specific sequence of the element"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]

Phrase: "are"

Phrase: "critical."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511545:Critical [Qualitative Concept]
Processing 00000000.tx.135: View larger version (34K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.136: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.137: Substitution analysis of tau E10 ESE sequences. 

Phrase: "Substitution analysis of tau E10 ESE sequences."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   745   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
Processing 00000000.tx.138: A, shown are the first 45nucleotides of tau E10. 

Phrase: "A,"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "the first 45nucleotides of tau E10."
Processing 00000000.tx.139: FTDP-17 mutations N279K, 280K, and L284L are represented as 15TG, E5, and 30TC, respectively, above the exon sequence. 

Phrase: "FTDP-17 mutations N279K,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   800   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   770   C0236642:frontotemporal dementia [Disease or Syndrome]
   744   C0011265:dementia [Mental or Behavioral Dysfunction]
   744   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "280K,"

Phrase: "and"

Phrase: "L284L"

Phrase: "are"

Phrase: "represented as 15TG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1882932:Represent [Activity]

Phrase: "E5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1423600:E5 [Gene or Genome]

Phrase: "and"

Phrase: "30TC,"

Phrase: "respectively,"

Phrase: "above the exon sequence."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.140: The remaining substitutions at the indicated nucleotide positions are shown below the E10 sequence. 

Phrase: "The remaining substitutions at the indicated nucleotide positions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1555721:Substitution [Idea or Concept]
   711   C1706204:Substitution [Activity]

Phrase: "are"

Phrase: "shown below the E10 sequence."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.141: Hatched boxes show the location of the three ESE sequences. 

Phrase: "Hatched boxes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0179400:boxes [Manufactured Object]
   861   C1638312:Boxes [Quantitative Concept]
   827 E C1533124:Box [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the location of the three ESE sequences."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0450429:Location [Spatial Concept]
   742   C1515974:Location [Body Location or Region]
Processing 00000000.tx.142: B, autoradiograph showing E10 inclusion of transiently transfected constructs by RT-PCR. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "autoradiograph"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986957:Autoradiograph [Manufactured Object]
   900 E C0004400:Autoradiography [Laboratory Procedure]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "E10 inclusion of transiently transfected constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1512693:Inclusion [Qualitative Concept]

Phrase: "by RT-PCR."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   734   C0035380:Reverse Transcription [Genetic Function]
Processing 00000000.tx.143: Double mutants containing the substituted nucleotide in combination with the E5 deletion are designated with a slash. 

Phrase: "Double mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the substituted nucleotide in combination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "with the E5 deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "are"

Phrase: "designated with a slash."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1524084:Designated [Functional Concept]
Processing 00000000.tx.144: C, quantitation of E10+ transcripts was performed as in Fig. 

Phrase: "C,"

Phrase: "quantitation of E10+ transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantitation [Quantitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.145: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.146: A corrected significance criteria of p<0.004was used. 

Phrase: "A corrected significance criteria of p<0.004was"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0243161:criteria [Intellectual Product]

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.147: Significance levels for comparisons are indicated as described in Fig. 

Phrase: "Significance levels for comparisons"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   819   C0814896:levels significance [Research Activity]
   770   C0237881:Significance [Quantitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C0750502:Significance [Idea or Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.148: 1 and as follows: , p<0.003.

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: ","

Phrase: "p<0.003."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.149: Significance levels for comparison of results from each construct to normal E10 are indicated above each bar. 

Phrase: "Significance levels for comparison of results"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   783   C0814896:levels significance [Research Activity]
   753   C0237881:Significance [Quantitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C0750502:Significance [Idea or Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "from each construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "to normal E10"

Phrase: "are"

Phrase: "indicated above each bar."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.150: Significance levels for comparisons between constructs are indicated above lines connecting the bars for the constructs being compared. 

Phrase: "Significance levels for comparisons"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   819   C0814896:levels significance [Research Activity]
   770   C0237881:Significance [Quantitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C0750502:Significance [Idea or Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "between constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "are"

Phrase: "indicated above lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205132:lines [Spatial Concept]
   790   C1444656:Indicated [Finding]
   756 E C1550648:Line [Substance]
   756 E C1552960:Line [Quantitative Concept]

Phrase: "connecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2986575:Connect [Activity]

Phrase: "the bars for the constructs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1707156:BARS [Gene or Genome]
   760   C3274014:BARS [Intellectual Product]
   760   C3541345:BARS [Intellectual Product]

Phrase: "being"

Phrase: "compared."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]
Processing 00000000.tx.151: D, known ACE sequences are listed with nucleotides 27-42 shown for tau E10. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "known ACE sequences"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   840   C0014290:Enhancer Sequences [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0162326:Sequences [Nucleotide Sequence]
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "listed with nucleotides 27-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   726   C0745732:List [Conceptual Entity]
   726   C3272378:LIST [Intellectual Product]

Phrase: "shown for tau E10."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.152: ACE sequences from dsx1-4 repeats (34), the cTNT exon 16,and CT/CGRP exon 4are as described by others (34, 35). 

Phrase: "ACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "sequences from dsx1-4 repeats"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0205341:repeats [Functional Concept]
   760   C1519249:Sequence [Functional Concept]
   760   C1705914:Repeats [Conceptual Entity]
   726 E C1547730:Repeat [Temporal Concept]

Phrase: "(34"

Phrase: ")"

Phrase: ","

Phrase: "the cTNT exon 16,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C3538782:cTnT [Gene or Genome]
   827   C3538889:cTnT [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "CT/CGRP exon 4are"

Phrase: "as"

Phrase: "described by others"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1552738:described [Idea or Concept]
   790   C1955473:Others [Finding]

Phrase: "(34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.153: AC-rich ESE Element-- Deletions E9 and E10 were designed to disrupt the region of E10 affected by FTDP-17 mutation L284L (30TC). 

Phrase: "AC-rich ESE Element"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C0001246:Ac element [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   827   C0014290:Enhancer Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C1705248:Element [Conceptual Entity]

Phrase: "--"

Phrase: "Deletions E9"

Phrase: "and"

Phrase: "E10"

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "the region of E10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]

Phrase: "affected by FTDP-17 mutation L284L"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   806   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   782   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   760   C0236642:frontotemporal dementia [Disease or Syndrome]
   757   C0598172:chromosome mutation [Cell or Molecular Dysfunction]
   739   C0008633:Chromosome [Cell Component]
   739   C0011265:dementia [Mental or Behavioral Dysfunction]
   739   C0026882:Mutation [Genetic Function]
   739   C0242422:Parkinsonism [Disease or Syndrome]
   739   C0392760:Affected [Functional Concept]
   739   C0497327:Dementia [Mental or Behavioral Dysfunction]
   739   C1314939:Affected [Functional Concept]
   739   C1705285:Mutation [Cell or Molecular Dysfunction]
   722 E C0948447:chromosomal mutation [Cell or Molecular Dysfunction]
   706 E C0001721:Affect [Mental Process]

Phrase: "(30TC"

Phrase: ")."
Processing 00000000.tx.154: This mutation alters the sequence TTAG, which acts as an ESS sequence in HIV-1 tat exon 3(21). 

Phrase: "This mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the sequence TTAG,"

Phrase: "which"

Phrase: "acts as an ESS sequence"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0206630:ESS [Neoplastic Process]
   760   C1519249:Sequence [Functional Concept]
   760   C3541276:ESS [Intellectual Product]

Phrase: "in HIV-1 tat exon 3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C0858513:hiv-3 [Disease or Syndrome]
   840   C0019704:HIV-1 [Virus]
   804   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0019682:HIV [Virus]
   804   C0019699:HIV+ [Finding]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.155: These deletions were expected to increase splicing due to deletion of the putative TTAG silencer. 

Phrase: "These deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880274:Deletions [Activity]
   966 E C1442161:Deletion [Cell or Molecular Dysfunction]
   966 E C1511760:Deletion [Genetic Function]

Phrase: "were"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "splicing due to deletion of the putative TTAG silencer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035687:Splicing [Genetic Function]
   742   C2610186:splicing [Genetic Function]
Processing 00000000.tx.156: However, unlike mutation 30TC that increases E10 inclusion (87%, Fig. 2), these deletions either gave near normal splicing (E9, 51%) or substantially reduced E10 inclusion (E10, 17%; Fig. 1). 

Phrase: "However,"

Phrase: "unlike mutation 30TC"

Phrase: "that"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "E10 inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]

Phrase: "(87%,"

Phrase: "Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "these deletions either"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1880274:Deletions [Activity]
   827 E C1442161:Deletion [Cell or Molecular Dysfunction]
   827 E C1511760:Deletion [Genetic Function]

Phrase: "gave near normal splicing"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0035687:Splicing [Genetic Function]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]
   770   C2610186:splicing [Genetic Function]
   737   C1947971:Give [Functional Concept]

Phrase: "(E9,"

Phrase: "51%"

Phrase: ")"

Phrase: "or"

Phrase: "substantially reduced E10 inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1512693:Inclusion [Qualitative Concept]

Phrase: "(E10,"

Phrase: "17%"

Phrase: "; Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.157: E11 and E12, like E10, also reduce the amount of E10+ produced (6and 33%, respectively). 

Phrase: "E11"

Phrase: "and"

Phrase: "E12,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422634:E12 [Gene or Genome]

Phrase: "like E10,"

Phrase: "also"

Phrase: "reduce"

Phrase: "the amount of E10+ produced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "(6and 33%,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.158: Thus, in the tau E10 context, unlike in HIV-I tat exon 3,TTAG does not function as an ESS. 

Phrase: "Thus,"

Phrase: "in the tau E10 context,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449255:Context [Finding]
   827   C0542559:Context [Functional Concept]

Phrase: "unlike"

Phrase: "in HIV-I tat exon 3,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   897   C0858513:hiv-3 [Disease or Syndrome]
   875   C1515146:I 3 [Cell]
   840   C0019704:HIV-I [Virus]
   804   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0019682:HIV [Virus]
   804   C0019699:HIV+ [Finding]
   804   C0021966:I- [Inorganic Chemical]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "TTAG"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "function as an ESS."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0031843:function [Physiologic Function]
   770   C0206630:ESS [Neoplastic Process]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]
   770   C3541276:ESS [Intellectual Product]
Processing 00000000.tx.159: Rather, the sequence in the E9-E12 region contains an ESE that may be an AC-rich enhancer (ACE) (25), particularly when the 30TC mutation is present. 

Phrase: "Rather,"

Phrase: "the sequence in the E9-E12 region"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an ESE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "an AC-rich enhancer (ACE)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "particularly"

Phrase: "when"

Phrase: "the 30TC mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.160: This region of E10 resembles ACE elements observed in other systems (Fig. 2) (26). 

Phrase: "This region of E10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]

Phrase: "resembles"

Phrase: "ACE elements"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   886   C0001246:Ac element [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   861   C0014290:Enhancer Elements [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0013879:Elements [Element, Ion, or Isotope]
   779 E C1705248:Element [Conceptual Entity]

Phrase: "observed in other systems"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1441672:Observed [Functional Concept]
   737   C0449913:System [Functional Concept]
   737   C1553451:System [Manufactured Object]
   737   C1704459:System [Medical Device]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.161: In agreement with this hypothesis, transitions within the TTAG sequence that increase the AC content (29TC and 32GA), like 30TC, increase E10 inclusion with the TC substitutions yielding the largest increase. 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "transitions within the TTAG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0599156:Transition [Cell or Molecular Dysfunction]
   770   C2700061:Transition [Activity]

Phrase: "sequence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "that"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the AC content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "(29TC"

Phrase: "and"

Phrase: "32GA"

Phrase: ")"

Phrase: ","

Phrase: "like 30TC,"

Phrase: "increase E10 inclusion with the TC substitutions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1512693:Inclusion [Qualitative Concept]

Phrase: "yielding"

Phrase: "the largest increase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]
Processing 00000000.tx.162: However, 31AG, which decreases the AC content, also increases E10 inclusion. 

Phrase: "However,"

Phrase: "31AG,"

Phrase: "which"

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the AC content,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "also"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "E10 inclusion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.163: Thus the sequence requirements for this ESE are more complex than simply a high AC content. 

Phrase: "Thus"

Phrase: "the sequence requirements for this ESE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1514873:Requirement [Functional Concept]

Phrase: "are"

Phrase: "more complex than simply"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439855:Complex [Qualitative Concept]
   770   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "a high AC content."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.164: Additional cis-Acting Sequences in E10-- Deletions E14 and E15 markedly increase E10 inclusion (69and 90%, respectively, Fig. 1), suggesting removal of a previously unknown inhibitory element at the 3' end of the exon. 

Phrase: "Additional cis-Acting Sequences in E10"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   822   C1516561:Cis-Acting Sequence [Nucleotide Sequence]
   753   C0162326:Sequences [Nucleotide Sequence]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]

Phrase: "--"

Phrase: "Deletions E14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417775:E14 [Gene or Genome]

Phrase: "and"

Phrase: "E15 markedly"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "E10 inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]

Phrase: "(69and 90%,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: "respectively,"

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "removal of a previously unknown inhibitory element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0015252:Removal [Therapeutic or Preventive Procedure]
   748   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "at the 3' end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0444930:End [Spatial Concept]
   861   C2746065:End [Temporal Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]

Phrase: "of the exon."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.165: Flanking deletions resulted in either slightly elevated (E13) or slightly reduced (E16 and E17) E10 incorporation, indicating that the putative inhibitory element is primarily confined to the E14/E15 segment. 

Phrase: "Flanking deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1880274:Deletions [Activity]
   827 E C1442161:Deletion [Cell or Molecular Dysfunction]
   827 E C1511760:Deletion [Genetic Function]

Phrase: "resulted in either slightly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0750482:Slightly [Idea or Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "(E13"

Phrase: ")"

Phrase: "or"

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "(E16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442753:E16 [Gene or Genome]

Phrase: "and"

Phrase: "E17"

Phrase: ")"

Phrase: "E10 incorporation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243126:incorporation [Functional Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the putative inhibitory element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C1705248:Element [Conceptual Entity]

Phrase: "is"

Phrase: "primarily"

Phrase: "confined to the E14/E15 segment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441635:Segment [Spatial Concept]
   753   C1417775:E14 [Gene or Genome]
Processing 00000000.tx.166: A series of point mutations (14a, 15a, and 15b, Fig. 3) were introduced into the same region replacing the clusters of As with G, C, and T nucleotides. 

Phrase: "A series of point mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205549:Series [Quantitative Concept]
   760   C2348044:Series [Intellectual Product]

Phrase: "(14a,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553646:14a [Medical Device]

Phrase: "15a,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553647:15a [Medical Device]

Phrase: "and"

Phrase: "15b,"

Phrase: "Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "were"

Phrase: "introduced into the same region"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C0445247:Same [Qualitative Concept]
   726   C1292748:introduce [Functional Concept]

Phrase: "replacing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1299987:replacing [Functional Concept]
   966 E C1554078:Replace [Idea or Concept]

Phrase: "the clusters of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1555715:Cluster [Idea or Concept]
   756   C1704332:Cluster [Quantitative Concept]

Phrase: "As with G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439267:g% [Quantitative Concept]

Phrase: "C,"

Phrase: "and"

Phrase: "T nucleotides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.167: Each different substitution as well as combinations of substitutions increased E10 incorporation (Fig. 3). 

Phrase: "Each different substitution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1555721:Substitution [Idea or Concept]
   861   C1706204:Substitution [Activity]

Phrase: "as well as"

Phrase: "combinations of substitutions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0453882:Combinations [Manufactured Object]
   756 E C0205195:Combination [Qualitative Concept]
   756 E C1947911:Combination [Physical Object]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "E10 incorporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243126:incorporation [Functional Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.168: These point mutations show that the E14/E15 region contains a purine-rich ESS and that the effects seen with these mutations are not simply due to changes in E10 length or altering the proximity of other cis-acting elements. 

Phrase: "These point mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   861   C0026882:Mutations [Genetic Function]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the E14/E15 region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a purine-rich ESS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0206630:ESS [Neoplastic Process]
   827   C3541276:ESS [Intellectual Product]

Phrase: "and"

Phrase: "that"

Phrase: "the effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "seen with these mutations"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0026882:Mutations [Genetic Function]
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]
   737 E C1947903:See [Activity]

Phrase: "are"

Phrase: "not simply due to changes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   760   C1518422:Not [Functional Concept]
   760   C3146286:Due [Idea or Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "in E10 length"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "or"

Phrase: "altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   907   C0392747:Altered [Functional Concept]

Phrase: "the proximity of other cis-acting elements."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514583:Proximity [Spatial Concept]
Processing 00000000.tx.169: Purine-rich ESSs downstream of an ESE are also present in the human fibronectin EDA exon (27) and in HIV tat exons 2and 3(28, 29). 

Phrase: "Purine-rich ESSs downstream of an ESE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0206630:ESS [Neoplastic Process]
   742   C1538052:ESSS [Gene or Genome]
   742   C3541276:ESS [Intellectual Product]

Phrase: "are"

Phrase: "also"

Phrase: "present in the human fibronectin EDA exon"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0016055:Fibronectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0086418:Human [Human]
   748   C0150312:Present [Quantitative Concept]
   748   C0162359:EDA [Congenital Abnormality,Disease or Syndrome]
   748   C0406702:EDA [Congenital Abnormality,Disease or Syndrome]
   748   C0449450:Present [Idea or Concept]
   748   C1539327:EDA [Gene or Genome]
   748   C3539920:EDA [Disease or Syndrome]

Phrase: "(27"

Phrase: ")"

Phrase: "and in HIV tat exons 2and 3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0858513:hiv-3 [Disease or Syndrome]
   748   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0019682:HIV [Virus]
   748   C0019699:HIV+ [Finding]
   748   C1515981:And [Idea or Concept]

Phrase: "(28,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.170: View larger version (27K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.171: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.172: Substitution analysis within the E10 ESS sequences. 

Phrase: "Substitution analysis within the E10 ESS sequences."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
Processing 00000000.tx.173: A, E10 ESS sequence from nucleotides 55-72 with the E14 and E15 deletions and additional substitutions. 

Phrase: "A,"

Phrase: "E10 ESS sequence from nucleotides 55-72"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]

Phrase: "with the E14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417775:E14 [Gene or Genome]

Phrase: "and"

Phrase: "E15 deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1880274:Deletions [Activity]
   827 E C1442161:Deletion [Cell or Molecular Dysfunction]
   827 E C1511760:Deletion [Genetic Function]

Phrase: "and"

Phrase: "additional substitutions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1555721:Substitution [Idea or Concept]
   827   C1706204:Substitution [Activity]
Processing 00000000.tx.174: Filled arrows above the exon sequence show contiguous A residues that were substituted in constructs 14a, 15a, and 15b. 

Phrase: "Filled arrows above the exon sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0336721:arrows [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "contiguous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205283:Contiguous [Spatial Concept]

Phrase: "A residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "substituted in constructs 14a,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1553646:14a [Medical Device]
   737   C2827421:Construct [Classification]

Phrase: "15a,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553647:15a [Medical Device]

Phrase: "and"

Phrase: "15b."
Processing 00000000.tx.175: Mutant 15ab contains substitutions from both 15a and 15b, and mutant 14a+15ab contains substitutions from both 14a and 15ab. 

Phrase: "Mutant 15ab"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "substitutions from both 15a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1555721:Substitution [Idea or Concept]
   737   C1706204:Substitution [Activity]

Phrase: "and"

Phrase: "15b,"

Phrase: "and"

Phrase: "mutant 14a+15ab"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "substitutions from both 14a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1555721:Substitution [Idea or Concept]
   737   C1706204:Substitution [Activity]

Phrase: "and"

Phrase: "15ab."
Processing 00000000.tx.176: For the single nucleotide difference in this region between human and mouse, the mouse nucleotide is shown with an open arrow. 

Phrase: "For the single nucleotide difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   755 E C0443199:Differential [Qualitative Concept]

Phrase: "in this region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "between human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "the mouse nucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "shown with an open arrow."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0175566:Open [Spatial Concept]
   760   C0336721:Arrow [Manufactured Object]
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.177: B, autoradiograph of RT-PCR showing E10 inclusion for substitution mutants. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "autoradiograph of RT-PCR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2986957:Autoradiograph [Manufactured Object]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "E10 inclusion for substitution mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.178: Assays were performed as described in Fig. 

Phrase: "Assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.179: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.180: C, quantitation of E10 inclusion. 

Phrase: "C,"

Phrase: "quantitation of E10 inclusion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantitation [Quantitative Concept]
Processing 00000000.tx.181: A corrected significance criteria of p<0.007was used. 

Phrase: "A corrected significance criteria of p<0.007was"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0243161:criteria [Intellectual Product]

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.182: Significance levels for each mutant were compared with normal human E10 are indicated with symbols used in Fig. 

Phrase: "Significance levels for each mutant"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   797   C0814896:levels significance [Research Activity]
   760   C0237881:Significance [Quantitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C0750502:Significance [Idea or Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "compared with normal human E10"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0086418:Human [Human]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1707455:Compared [Activity]
   760   C2347086:% Normal [Quantitative Concept]

Phrase: "are"

Phrase: "indicated with symbols"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0679214:symbols [Idea or Concept]
   790   C1444656:Indicated [Finding]
   756 E C1698987:symbol [Intellectual Product]

Phrase: "used in Fig."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1273517:used [Finding]
   790   C1337208:FIG [Food]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.183: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.184: Another potential regulatory region is at the 5' end of E10. 

Phrase: "Another potential regulatory region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0034987:Regulatory Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "is at the 5' end of E10."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0444930:End [Spatial Concept]
   748   C2746065:End [Temporal Concept]
Processing 00000000.tx.185: E1 dramatically reduces E10 inclusion to 12% (Fig. 1). 

Phrase: "E1 dramatically"

Phrase: "reduces"

Phrase: "E10 inclusion to 12%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1512693:Inclusion [Qualitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.186: This deletion alters the sequence TGCAGAT that resembles the degenerate binding consensus TGCNGYY for the SR protein SC35 (30). 

Phrase: "This deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the sequence TGCAGAT"

Phrase: "that"

Phrase: "resembles"

Phrase: "the degenerate binding consensus TGCNGYY for the SR protein SC35"

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.187: Deletion of the AT-rich sequences in E3 and E4 results in increased E10 inclusion suggesting that either an inhibitory sequence has been removed or that a reduction in the distance between the SC35-like and the purine-rich ESE sequences is important for both to function. 

Phrase: "Deletion of the AT-rich sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0162773:Sequence Deletion [Cell or Molecular Dysfunction]
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "in E3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1537525:E3 [Gene or Genome]

Phrase: "and"

Phrase: "E4"

Phrase: "results in increased E10 inclusion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1274040:Result [Functional Concept]
   760   C1512693:Inclusion [Qualitative Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that either"

Phrase: "an inhibitory sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "or"

Phrase: "that"

Phrase: "a reduction in the distance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "between the SC35-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419992:SC35 [Gene or Genome]
  1000   C3538863:SC35 [Gene or Genome]

Phrase: "like"

Phrase: "and"

Phrase: "the purine-rich ESE sequences"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0014290:Enhancer Sequences [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0162326:Sequences [Nucleotide Sequence]
   766 E C0004793:Sequence [Nucleotide Sequence]
   766 E C0162327:Sequence [Nucleotide Sequence]
   766 E C1519249:Sequence [Functional Concept]
   716 E C1548958:Sequential [Idea or Concept]
   716 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "important for both to"

Phrase: "function."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
Processing 00000000.tx.188: Role of the 5' Splice Site in E10 Inclusion-- The E10 5' splice site is predicted to be weak because the sequence (GTgtgagt) differs from the optimal consensus sequence (AGgt(a/g)agt) for U1/U6 snRNP binding (31). 

Phrase: "Role of the 5' Splice Site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C2347795:Site Role [Idea or Concept]
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in E10 Inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The E10 5' splice site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "weak"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004093:Weak [Sign or Symptom]
  1000   C1762617:Weak [Qualitative Concept]

Phrase: "because"

Phrase: "the sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "(GTgtgagt"

Phrase: ")"

Phrase: "differs from the optimal consensus sequence"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0079160:Consensus Sequence [Nucleotide Sequence]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0376298:Consensus [Social Behavior]
   753   C1519249:Sequence [Functional Concept]
   753   C2698651:Optimal [Qualitative Concept]

Phrase: "(AGgt"

Phrase: "(a/g)agt) for U1/U6 snRNP binding"

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.189: The role of the 5' splice site and immediately adjacent exon sequences was investigated using single nucleotide substitutions in the 5' splice site and by replacing tau E10 sequences with the 3' end of human -globin E2. 

Phrase: "The role of the 5' splice site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C2347795:Site Role [Idea or Concept]
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "immediately adjacent exon sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0162326:Sequences [Nucleotide Sequence]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "single nucleotide substitutions in the 5' splice site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1555721:Substitution [Idea or Concept]
   711   C1706204:Substitution [Activity]

Phrase: "and by replacing tau E10"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C1299987:replacing [Functional Concept]
   760   C1515981:And [Idea or Concept]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]
   726 E C1554078:Replace [Idea or Concept]

Phrase: "sequences with the 3' end of human -globin E2."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   762   C0677773:E2.3 [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0004793:Sequence [Nucleotide Sequence]
   742   C0017645:Globin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0086418:Human [Human]
   742   C0162326:Sequence [Nucleotide Sequence]
   742   C0162327:Sequence [Nucleotide Sequence]
   742   C0444930:End [Spatial Concept]
   742   C1149093:globin [Molecular Function]
   742   C1519249:Sequence [Functional Concept]
   742   C2746065:End [Temporal Concept]
   742   C3539520:E2 [Gene or Genome]
Processing 00000000.tx.190: The -globin E2 sequences used were the last 10nucleotides of the exon and the first 6nucleotides of the intron (the entire 5' splice site). 

Phrase: "The -globin E2 sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "the last 10nucleotides of the exon"

Phrase: "and"

Phrase: "the first 6nucleotides of the intron"

Phrase: "("

Phrase: "the entire 5' splice site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.191: This constitutively spliced middle exon was chosen because its 5' splice site can easily be converted to that of tau E10 by altering the 1 position. 

Phrase: "This constitutively"

Phrase: "spliced"

Phrase: "middle exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: "because"

Phrase: "its 5' splice site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0887917:5' Splice Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "can"

Phrase: "easily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332219:Easily [Qualitative Concept]

Phrase: "be"

Phrase: "converted to that of tau E10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "by altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   907   C0392747:Altered [Functional Concept]

Phrase: "the 1 position."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]
Processing 00000000.tx.192: Predictably, the hybrid construct spliced to completion as it contains a strong 5' splice site GGgtgagt (Fig. 4). 

Phrase: "Predictably,"

Phrase: "the hybrid construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "spliced to completion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205197:Completion [Qualitative Concept]
   790   C1554962:completion [Qualitative Concept]

Phrase: "as"

Phrase: "it"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a strong 5' splice site GGgtgagt"

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.193: However, when a single nucleotide substitution changes the 1 from the -globin to the tau nucleotide (Glo 1), E10 inclusion returns to levels seen with normal tau (39%). 

Phrase: "However,"

Phrase: "when"

Phrase: "a single nucleotide substitution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1555721:Substitution [Idea or Concept]
   827   C1706204:Substitution [Activity]

Phrase: "changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "the 1 from the -globin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017645:Globin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1149093:globin [Molecular Function]

Phrase: "to the tau nucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Glo 1"

Phrase: ")"

Phrase: ","

Phrase: "E10 inclusion returns to levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332156:Return to [Qualitative Concept]
           Return

Phrase: "seen with normal tau"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0205307:Normal [Qualitative Concept]
   770   C0205397:Seen [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
   770   C2347086:% Normal [Quantitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "(39%"

Phrase: ")."
Processing 00000000.tx.194: Likewise, changing the last nucleotide of tau E10 to a G (93TG) as in globin E2 strengthened the 5' splice site, and constitutive E10 splicing was observed. 

Phrase: "Likewise,"

Phrase: "changing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changing [Functional Concept]
  1000   C0443172:changing [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "the last nucleotide of tau E10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "to a G (93TG"

Phrase: ")"

Phrase: "as in globin E2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017645:Globin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1149093:globin [Molecular Function]
   770   C3539520:E2 [Gene or Genome]

Phrase: "strengthened"

Phrase: "the 5' splice site,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0887917:5' Splice Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "constitutive E10 splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035687:Splicing [Genetic Function]
   827   C2610186:splicing [Genetic Function]

Phrase: "was"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.195: The same results are seen when the penultimate E10 nucleotide is changed to strengthen the splice site sequence (FTDP-17 mutation 92GA, Fig. 5). 

Phrase: "The same results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "are"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "when"

Phrase: "the penultimate E10 nucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "strengthen"

Phrase: "the splice site sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "(FTDP-17 mutation 92GA,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   800   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   770   C0236642:frontotemporal dementia [Disease or Syndrome]
   744   C0011265:dementia [Mental or Behavioral Dysfunction]
   744   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.196: Thus a strong 5' splice site sequence overrides other inhibitory elements in E10 and the intron splicing silencer (ISS, see below) in I10. 

Phrase: "Thus"

Phrase: "a strong 5' splice site sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   804   C0004793:Sequence [Nucleotide Sequence]
   804   C0162326:Sequence [Nucleotide Sequence]
   804   C0162327:Sequence [Nucleotide Sequence]
   804   C1519249:Sequence [Functional Concept]
   733 E C1548958:Sequential [Idea or Concept]
   733 E C1705294:Sequential [Qualitative Concept]

Phrase: "overrides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547671:Override [Activity]

Phrase: "other inhibitory elements in E10"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C2924497:Other elements [Laboratory Procedure]
   760   C0013879:Elements [Element, Ion, or Isotope]
   726 E C1705248:Element [Conceptual Entity]

Phrase: "and"

Phrase: "the intron splicing silencer"

Phrase: "(ISS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1845118:ISS [Congenital Abnormality,Disease or Syndrome]

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")"

Phrase: "in I10."
Processing 00000000.tx.197: View larger version (68K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(68K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.198: 4.  

Phrase: "4."
Processing 00000000.tx.199: Role of 5' splice site and adjacent E10 sequences. 

Phrase: "Role of 5' splice site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C2347795:Site Role [Idea or Concept]
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "adjacent E10 sequences."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.200: A, autoradiograph of RT-PCR products for E10 inclusion assays. 

Phrase: "A,"

Phrase: "autoradiograph of RT-PCR products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2986957:Autoradiograph [Manufactured Object]

Phrase: "for E10 inclusion assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.201: B, quantitation of E10 inclusion for alterations in the 5'splice site of E10. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "quantitation of E10 inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantitation [Quantitative Concept]

Phrase: "for alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515926:Alteration [Idea or Concept]

Phrase: "in the 5'splice site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0887917:5' Splice Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "of E10."
Processing 00000000.tx.202: The human tau sequence shown is the last 16nucleotides of E10 in capital letters and the first 6nucleotides of I10 in lowercase letters. 

Phrase: "The human tau sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "is"

Phrase: "the last 16nucleotides of E10"

Phrase: "in capital letters"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   983   C2827599:Capital Letter [Qualitative Concept]
   861   C0282413:letters [Intellectual Product]
   827 E C1096774:Letter [Intellectual Product]
   827 E C2360551:Letter [Clinical Attribute]
   789 E C0079691:Levothyroxine Sodium [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   768 E C0728762:Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "the first 6nucleotides of I10"

Phrase: "in lowercase letters."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0282413:letters [Intellectual Product]
   827 E C1096774:Letter [Intellectual Product]
   827 E C2360551:Letter [Clinical Attribute]
   789 E C0079691:Levothyroxine Sodium [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   768 E C0728762:Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.203: Human -globin sequences are in italics. 

Phrase: "Human -globin sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "are in italics."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1551058:Are [Quantitative Concept]
Processing 00000000.tx.204: Non--globin substitutions are in bold. 

Phrase: "Non--globin substitutions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1555721:Substitution [Idea or Concept]
   793   C1706204:Substitution [Activity]

Phrase: "are in bold."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1551058:Are [Quantitative Concept]
Processing 00000000.tx.205: A corrected significance criteria of p<0.007was used. 

Phrase: "A corrected significance criteria of p<0.007was"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0243161:criteria [Intellectual Product]

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.206: Significance levels are for comparison of each construct to the normal human construct (hN). 

Phrase: "Significance levels"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   966   C0814896:Significance Level [Research Activity]
   861   C0237881:Significance [Quantitative Concept]
   861   C0441889:Levels [Qualitative Concept]
   861   C0750502:Significance [Idea or Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "are for comparison of each construct"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1551058:Are [Quantitative Concept]
   753   C1707455:Comparison [Activity]
   753   C2827421:Construct [Classification]

Phrase: "to the normal human construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "(hN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: ")."
Processing 00000000.tx.207: For WTGlo and 93TG no E10- transcript was observed. 

Phrase: "For WTGlo"

Phrase: "and"

Phrase: "93TG"

Phrase: "no E10- transcript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.208: View larger version (49K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(49K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.209: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.210: Interactions between exon and intron splicing elements. 

Phrase: "Interactions between exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "intron splicing elements."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013879:Elements [Element, Ion, or Isotope]
   793 E C1705248:Element [Conceptual Entity]
Processing 00000000.tx.211: The effects of 5' splice site (92GA) and intronic (E10+12, E10+13, E10+14, and E10+16) FTDP-17 mutations on E10 splicing were analyzed in the absence of a functional ESE sequence. 

Phrase: "The effects of 5' splice site"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "(92GA"

Phrase: ")"

Phrase: "and"

Phrase: "intronic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(E10+12,"

Phrase: "E10+13,"

Phrase: "E10+14,"

Phrase: "and"

Phrase: "E10+16"

Phrase: ")"

Phrase: "FTDP-17 mutations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   814   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   778   C0236642:frontotemporal dementia [Disease or Syndrome]
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "on E10 splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]

Phrase: "were"

Phrase: "analyzed in the absence of a functional ESE sequence."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   756   C0014290:Sequence, Enhancer [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0004793:Sequence [Nucleotide Sequence]
   738   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0035687:Splicing [Genetic Function]
   738   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0162326:Sequence [Nucleotide Sequence]
   738   C0162327:Sequence [Nucleotide Sequence]
   738   C0205245:Functional [Functional Concept]
   738   C0332197:absence [Quantitative Concept]
   738   C0542341:Functional [Functional Concept]
   738   C0936012:Analyzed [Research Activity]
   738   C1519249:Sequence [Functional Concept]
   738   C1689985:Absence [Anatomical Abnormality]
   738   C2610186:splicing [Genetic Function]
   738   C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.212: ESE function was disrupted using the E5 mutation. 

Phrase: "ESE function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1705273:Function [Intellectual Product]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: "was"

Phrase: "disrupted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:Disrupted [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the E5 mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.213: A, autoradiograph showing results for E10 splicing assays for normal and mutant constructs. 

Phrase: "A,"

Phrase: "autoradiograph showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1547282:Show [Intellectual Product]

Phrase: "results for E10 splicing assays"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0035687:Splicing [Genetic Function]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2610186:splicing [Genetic Function]
   760   C2825142:Result [Finding]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "for normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "mutant constructs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]
Processing 00000000.tx.214: B, quantitation of E10 inclusion. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "quantitation of E10 inclusion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantitation [Quantitative Concept]
Processing 00000000.tx.215: A corrected significance criteria of p<0.002was used. 

Phrase: "A corrected significance criteria of p<0.002was"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0243161:criteria [Intellectual Product]

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.216: Assays were performed as in Fig. 

Phrase: "Assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.217: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.218: Significance levels for comparison of each mutant to normal human E10 are indicated by symbols above bars as described in Fig. 

Phrase: "Significance levels for comparison of each mutant"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   774   C0814896:levels significance [Research Activity]
   748   C0237881:Significance [Quantitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C0750502:Significance [Idea or Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "to normal human E10"

Phrase: "are"

Phrase: "indicated by symbols"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0679214:symbols [Idea or Concept]
   790   C1444656:Indicated [Finding]
   756 E C1698987:symbol [Intellectual Product]

Phrase: "above bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.219: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.220: Comparisons between mutant constructs are shown with lines connecting the constructs compared and significance levels shown above the line. 

Phrase: "Comparisons between mutant constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1707455:Comparison [Activity]

Phrase: "are"

Phrase: "shown with lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205132:lines [Spatial Concept]
   756   C1547282:Show [Intellectual Product]
   756 E C1550648:Line [Substance]
   756 E C1552960:Line [Quantitative Concept]

Phrase: "connecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2986575:Connect [Activity]

Phrase: "the constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "significance levels"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   966   C0814896:Significance Level [Research Activity]
   861   C0237881:Significance [Quantitative Concept]
   861   C0441889:Levels [Qualitative Concept]
   861   C0750502:Significance [Idea or Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "shown above the line."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205132:Line [Spatial Concept]
   770   C1550648:Line [Substance]
   770   C1552960:Line [Quantitative Concept]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.221: The 5' Splice Site-ISS Interaction-- Intronic FTDP-17 mutations (E10+3ga, E10+12ct, E10+13ag, E10+14ct, and E10+16ct; Fig. 1) immediately adjacent to the 5' splice site dramatically increase E10 inclusion, demonstrating that this region is an ISS element. 

Phrase: "The 5' Splice Site-ISS Interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1704675:Interaction [Functional Concept]
   717   C0887917:5' Splice Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "--"

Phrase: "Intronic FTDP-17 mutations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   800   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   770   C0236642:frontotemporal dementia [Disease or Syndrome]
   744   C0011265:dementia [Mental or Behavioral Dysfunction]
   744   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "(E10+3ga,"

Phrase: "E10+12ct,"

Phrase: "E10+13ag,"

Phrase: "E10+14ct,"

Phrase: "and"

Phrase: "E10+16ct"

Phrase: "; Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "immediately adjacent to the 5' splice site dramatically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205117:Adjacent to [Spatial Concept]
           Adjacent

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "E10 inclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]

Phrase: "demonstrating"

Phrase: "that"

Phrase: "this region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "is"

Phrase: "an ISS element."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]
Processing 00000000.tx.222: One proposed mechanism for how this ISS functions is that the normal sequence results in a stem-loop spanning the E10/I10 junction; 

Phrase: "One proposed mechanism for how"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "this ISS functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "that"

Phrase: "the normal sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "results in a stem-loop"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0242767:Stem [Plant]
   760   C0419518:Loop [Medical Device]
   760   C0445022:Loop [Spatial Concept]
   760   C1186763:Stem [Body Part, Organ, or Organ Component]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "the E10/I10 junction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205144:Junction [Spatial Concept]
   827   C1706311:Junction [Medical Device]

Phrase: ";"
Processing 00000000.tx.223: this structure sequesters the 5' splice site, inhibiting binding to U1 snRNP (32) and subsequent splicing (33). 

Phrase: "this structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "sequesters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333312:sequester [Functional Concept]

Phrase: "the 5' splice site,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0887917:5' Splice Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "binding to U1 snRNP (32"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C2754093:snRNP binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: "and"

Phrase: "subsequent splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.224: In this model, the FTDP-17 intronic mutations and the E10 mutation 92GA enhance E10 inclusion by disrupting base pairing in this stem-loop. 

Phrase: "In this model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "the FTDP-17 intronic mutations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   790   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   764   C0236642:frontotemporal dementia [Disease or Syndrome]
   742   C0011265:dementia [Mental or Behavioral Dysfunction]
   742   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "the E10 mutation 92GA"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "E10 inclusion by disrupting base pairing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1512693:Inclusion [Qualitative Concept]

Phrase: "in this stem-loop."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0242767:Stem [Plant]
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]
Processing 00000000.tx.225: Three different stem-loops have been proposed, each containing different lengths of E10 sequences (Fig. 6). 

Phrase: "Three different stem-loops"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0181687:loops [Medical Device]
   812   C0242767:Stem [Plant]
   812   C1186763:Stem [Body Part, Organ, or Organ Component]
   779 E C0419518:Loop [Medical Device]
   779 E C0445022:Loop [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: ","

Phrase: "each"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "different lengths of E10 sequences"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1444754:Lengths [Quantitative Concept]
   726 E C1706316:LENGTH [Research Activity]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.226: The longer versions extend into E10 raising the possibility that the inhibitory element includes both exon and intron sequences. 

Phrase: "The longer versions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0333052:versions [Functional Concept]
   827 E C2607870:Version [Spatial Concept]

Phrase: "extend into E10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0231448:Extend [Functional Concept]
   790   C0439792:extend [Spatial Concept]

Phrase: "raising"

Phrase: "the possibility"

Phrase: "that"

Phrase: "the inhibitory element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "both exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "intron sequences."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.227: However, E17 reduces E10 inclusion to 26% (Fig. 1), a result that is inconsistent with these exon sequences being part of an inhibitory element. 

Phrase: "However,"

Phrase: "E17"

Phrase: "reduces"

Phrase: "E10 inclusion to 26%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1512693:Inclusion [Qualitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "that"

Phrase: "is"

Phrase: "inconsistent with these exon sequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442809:Inconsistent [Qualitative Concept]

Phrase: "being"

Phrase: "part of an inhibitory element."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1292711:Part of [Spatial Concept]
   760   C0449719:Part [Spatial Concept]
   760   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.228: Also, substitutions 49 and 59 (Fig. 4) introduced into the E10 sequences immediately adjacent to the 5' splice either did not alter E10 inclusion (49) or only slightly increased E10 inclusion to 58%. 

Phrase: "Also,"

Phrase: "substitutions 49"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1555721:Substitution [Idea or Concept]
   827   C1706204:Substitution [Activity]

Phrase: "and"

Phrase: "59"

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "introduced into the E10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1292748:introduce [Functional Concept]

Phrase: "sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "immediately adjacent to the 5' splice either"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0205117:Adjacent to [Spatial Concept]
           Adjacent

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "E10 inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]

Phrase: "(49"

Phrase: ")"

Phrase: "or"

Phrase: "only slightly increased E10 inclusion to 58%."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.229: The substituted nucleotides were mostly transitions, chosen so as not to base pair with their corresponding partners in I10. 

Phrase: "The substituted nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "mostly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750554:mostly [Idea or Concept]

Phrase: "transitions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0599156:Transition [Cell or Molecular Dysfunction]
  1000   C2700061:Transition [Activity]

Phrase: ","

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "as"

Phrase: "not to base pair"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0600436:Base Pair [Molecular Function]
   770   C0002055:base [Inorganic Chemical]
   770   C0178499:Base [Chemical Viewed Functionally]
   770   C1518422:Not [Functional Concept]
   770   C1709450:Pair [Qualitative Concept]
   770   C1880279:Base [Biomedical or Dental Material]

Phrase: "with their corresponding partners"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0682323:partners [Family Group]

Phrase: "in I10."
Processing 00000000.tx.230: These substitutions and the E17 deletion would be expected to disrupt the lower portions of the 25-and 30-nucleotide stem-loop structures (Fig. 6A) without disrupting the 18-nucleotide structure at the top. 

Phrase: "These substitutions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1555721:Substitution [Idea or Concept]
   966   C1706204:Substitution [Activity]

Phrase: "and"

Phrase: "the E17 deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "would"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "the lower portions of the 25-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0449719:Portion [Spatial Concept]

Phrase: "and"

Phrase: "30-nucleotide stem-loop structures"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0242767:Stem [Plant]
   804   C0419518:Loop [Medical Device]
   804   C0445022:Loop [Spatial Concept]
   804   C0678594:structures [Spatial Concept]
   804   C1186763:Stem [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")"

Phrase: "without disrupting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupting [Qualitative Concept]

Phrase: "the 18-nucleotide structure at the top."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.231: These results show that either secondary structure is not important for the inhibitory activity of the ISS or that only the shortest stem-loop is important for regulation. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that either secondary structure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0162807:Secondary Structure [Spatial Concept]
   827   C0027627:secondary [Neoplastic Process]
   827   C0175668:Secondary [Temporal Concept]
   827   C0205436:Secondary [Quantitative Concept]
   827   C0678594:Structure [Spatial Concept]

Phrase: "is"

Phrase: "not important for the inhibitory activity of the ISS"

Phrase: "or"

Phrase: "that only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the shortest stem-loop"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0242767:Stem [Plant]
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "important for regulation."
Processing 00000000.tx.232: View larger version (18K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.233: 6.  

Phrase: "6."
Processing 00000000.tx.234: Predicted stem-loop structures for the region surrounding the E10 5' splice site of human and mouse. 

Phrase: "Predicted stem-loop structures for the region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0242767:Stem [Plant]
   748   C0419518:Loop [Medical Device]
   748   C0445022:Loop [Spatial Concept]
   748   C0678594:structures [Spatial Concept]
   748   C1186763:Stem [Body Part, Organ, or Organ Component]

Phrase: "surrounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounding [Spatial Concept]

Phrase: "the E10 5' splice site of human"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C2945843:Site of [Qualitative Concept]
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]
Processing 00000000.tx.235: The 49-nucleotide structures begin at E10 nucleotide 78and extend to I10 nucleotide 34.

Phrase: "The 49-nucleotide structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]

Phrase: "begin at E10 nucleotide 78and"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0439659:Begin [Temporal Concept]

Phrase: "extend to I10 nucleotide 34."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0231448:Extend [Functional Concept]
   760   C0439792:extend [Spatial Concept]
Processing 00000000.tx.236: The 18-,25-,and 30-nucleotide structures were proposed by Hutton et al. 

Phrase: "The 18-,"

Phrase: "25-,"

Phrase: "and"

Phrase: "30-nucleotide structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]

Phrase: "were"

Phrase: "proposed by Hutton et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1441414:PROPOSED [Idea or Concept]
   760   C1553874:Proposed [Qualitative Concept]
   760   C1578820:Proposed [Idea or Concept]
Processing 00000000.tx.237: (6), Spillantini et al. 

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "Spillantini et al."
Processing 00000000.tx.238: (7), and D'Souza et al. 

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "D'"

Phrase: "Souza et al."
Processing 00000000.tx.239: (15), respectively. 

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.240: The 30-nucleotide structure shown in A was predicted by the MFOLD program. 

Phrase: "The 30-nucleotide structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:Structure [Spatial Concept]

Phrase: "shown in A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "was"

Phrase: "predicted by the MFOLD program."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0681842:Predicted [Idea or Concept]
   760   C1709697:Program [Conceptual Entity]
   760   C1882327:%{Predicted} [Quantitative Concept]
   760   C2728259:Program [Pharmacologic Substance]
   760   C3484370:Program [Functional Concept]
Processing 00000000.tx.241: NMR analysis of the 25-nucleotide structure indicates that the bottom 2base pairs do not form or are too unstable to be observed and that the top base pair shown in A is not observed (32) resulting in a 6-bp loop at the top. 

Phrase: "NMR analysis of the 25-nucleotide structure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0024485:NMR [Diagnostic Procedure]
   748   C0028580:NMR [Natural Phenomenon or Process]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   738   C0204514:Structural analysis [Therapeutic or Preventive Procedure]

Phrase: "indicates"

Phrase: "that"

Phrase: "the bottom 2base pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709450:Pair [Qualitative Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "or"

Phrase: "are"

Phrase: "too unstable to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443343:Unstable [Finding]
   827   C1883468:UNSTABLE [Phenomenon or Process]

Phrase: "be"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "that"

Phrase: "the top base pair"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0600436:Base Pair [Molecular Function]
   827   C0002055:base [Inorganic Chemical]
   827   C0178499:Base [Chemical Viewed Functionally]
   827   C1709450:Pair [Qualitative Concept]
   827   C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]
   743 E C0016617:Foundation [Organization]
   743 E C1626935:Bases [Quantitative Concept]

Phrase: "shown in A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(32"

Phrase: ")"

Phrase: "resulting in a 6-bp loop"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C0332294:Resulting in [Functional Concept]
   778   C0600436:Base Pair [Molecular Function]
   748   C0002055:base [Inorganic Chemical]
   748   C0178499:Base [Chemical Viewed Functionally]
   748   C0419518:Loop [Medical Device]
   748   C0445022:Loop [Spatial Concept]
   748   C0678226:resulting [Functional Concept]
   748   C1709450:Pair [Qualitative Concept]
   748   C1880279:Base [Biomedical or Dental Material]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "at the top."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.242: Structures in B and C were predicted by MFOLD, and no other structures with similar stability were predicted. 

Phrase: "Structures in B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0678594:structures [Spatial Concept]

Phrase: "and"

Phrase: "C"

Phrase: "were"

Phrase: "predicted by MFOLD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0681842:Predicted [Idea or Concept]
   790   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "and"

Phrase: "no other structures with similar stability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:structures [Spatial Concept]

Phrase: "were"

Phrase: "predicted."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]
Processing 00000000.tx.243: Interactions between cis-Acting Elements-- The interactions between different regulatory sequences were examined by comparing E10 splicing in constructs with mutations in single elements to constructs with mutations in two different elements. 

Phrase: "Interactions between cis-Acting Elements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "-"

Phrase: "-"

Phrase: "The interactions between different regulatory sequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1704675:Interaction [Functional Concept]

Phrase: "were"

Phrase: "examined by comparing E10 splicing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0035687:Splicing [Genetic Function]
   760   C0332128:Examined [Finding]
   760   C2610186:splicing [Genetic Function]
   726   C1707455:Compare [Activity]

Phrase: "in constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "with mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in single elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013879:Elements [Element, Ion, or Isotope]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "to constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "with mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in two different elements."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013879:Elements [Element, Ion, or Isotope]
   793 E C1705248:Element [Conceptual Entity]
Processing 00000000.tx.244: The E5 mutation was used to abolish function of the PPE. 

Phrase: "The E5 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "abolish"

Phrase: "function of the PPE."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
Processing 00000000.tx.245: FTDP-17 mutation 92GA or E10+3ga was used to strengthen the 5' splice site. 

Phrase: "FTDP-17 mutation 92GA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   800   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   770   C0236642:frontotemporal dementia [Disease or Syndrome]
   744   C0011265:dementia [Mental or Behavioral Dysfunction]
   744   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "or"

Phrase: "E10+3ga"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "strengthen"

Phrase: "the 5' splice site."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0887917:5' Splice Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
Processing 00000000.tx.246: Double mutants 92GA/E5 and E10+3ga/E5 yielded high levels of E10 inclusion (80and 87%, respectively) demonstrating that in the presence of a strong 5' splice site, the PPE is not required for efficient E10 splicing (Fig. 5). 

Phrase: "Double mutants 92GA/E5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1423600:E5 [Gene or Genome]

Phrase: "and"

Phrase: "E10+3ga/E5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1423600:E5 [Gene or Genome]

Phrase: "yielded"

Phrase: "high levels of E10 inclusion"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(80and 87%,"

Phrase: "respectively"

Phrase: ")"

Phrase: "demonstrating"

Phrase: "that in the presence of a strong 5' splice site,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C2945843:Site of [Qualitative Concept]
   739   C0205145:Site [Spatial Concept]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C0442821:Strong [Qualitative Concept]
   739   C1515974:Site [Body Location or Region]
   739   C2825164:Site [Spatial Concept]

Phrase: "the PPE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "required for efficient E10 splicing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0035687:Splicing [Genetic Function]
   760   C0442799:Efficient [Qualitative Concept]
   760   C1514873:Required [Functional Concept]
   760   C2610186:splicing [Genetic Function]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.247: When the FTDP-17 ISS mutations E10+12ct, E10+13ag, E10+14ct, and E10+16ct were combined with E5, E10 inclusion was reduced compared with the results when only the ISS mutations were present. 

Phrase: "When"

Phrase: "the FTDP-17 ISS mutations E10+12ct,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   775   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   756   C0236642:frontotemporal dementia [Disease or Syndrome]
   738   C0011265:dementia [Mental or Behavioral Dysfunction]
   738   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "E10+13ag,"

Phrase: "E10+14ct,"

Phrase: "and"

Phrase: "E10+16ct"

Phrase: "were"

Phrase: "combined with E5,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205195:Combined [Qualitative Concept]
   790   C1423600:E5 [Gene or Genome]
   756 E C0336789:Combine [Manufactured Object]

Phrase: "E10 inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "compared with the results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1707455:Compared [Activity]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "when"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the ISS mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.248: Thus the ISS and the PPE must collaborate to regulate E10 inclusion. 

Phrase: "Thus"

Phrase: "the ISS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1845118:ISS [Congenital Abnormality,Disease or Syndrome]

Phrase: "and"

Phrase: "the PPE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "must"

Phrase: "collaborate"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "E10 inclusion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.249: Removal of the PPE with the E5 mutation had varied effects when combined with the different ISS mutations. 

Phrase: "Removal of the PPE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015252:Removal [Therapeutic or Preventive Procedure]
   760   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "with the E5 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "had"

Phrase: "varied effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "when"

Phrase: "combined with the different ISS mutations."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0026882:Mutations [Genetic Function]
   753   C0205195:Combined [Qualitative Concept]
   753   C1705242:Different [Qualitative Concept]
   753   C1845118:ISS [Congenital Abnormality,Disease or Syndrome]
   719 E C0336789:Combine [Manufactured Object]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.250: The E5 mutation with E10+12ct or E10+14ct only modestly reduced E10 inclusion compared with results for only the single E10+12ct or E10+14ct mutations; 

Phrase: "The E5 mutation with E10+12ct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "E10+14ct only modestly reduced E10 inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1512693:Inclusion [Qualitative Concept]

Phrase: "compared with results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1707455:Compared [Activity]
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]

Phrase: "for only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the single E10+12ct"

Phrase: "or"

Phrase: "E10+14ct mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: ";"
Processing 00000000.tx.251: E10 inclusion was still greater (59and 65%, respectively) than seen with the normal E10 sequence. 

Phrase: "E10 inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]

Phrase: "was"

Phrase: "still greater"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0443228:greater [Quantitative Concept]
   861   C1704243:Greater [Quantitative Concept]
   827 E C0549177:Great [Quantitative Concept]

Phrase: "(59and 65%,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450385:65 [Intellectual Product]

Phrase: "respectively"

Phrase: ")"

Phrase: "than"

Phrase: "seen with the normal E10 sequence."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0205307:Normal [Qualitative Concept]
   753   C0205397:Seen [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C1519249:Sequence [Functional Concept]
   753   C2347086:% Normal [Quantitative Concept]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]
Processing 00000000.tx.252: In contrast, for double mutants containing E10+13ag and E10+16ct, E10 inclusion was dramatically reduced (28and 26%, respectively) to levels below those seen with the normal sequence. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "for double mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "E10+13ag"

Phrase: "and"

Phrase: "E10+16ct,"

Phrase: "E10 inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]

Phrase: "was"

Phrase: "dramatically"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "(28and 26%,"

Phrase: "respectively"

Phrase: ")"

Phrase: "to levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "below those"

Phrase: "seen with the normal sequence."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0205307:Normal [Qualitative Concept]
   760   C0205397:Seen [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1519249:Sequence [Functional Concept]
   760   C2347086:% Normal [Quantitative Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]
Processing 00000000.tx.253: These results imply that not all nucleotides within the ISS are equivalent. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "imply"

Phrase: "that"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all nucleotides within the ISS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "equivalent."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205163:Equivalent [Qualitative Concept]
  1000   C0439185:equivalent [Quantitative Concept]
Processing 00000000.tx.254: The PPE also interacts with the ACE element. 

Phrase: "The PPE also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "interacts with the ACE element."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0014290:Enhancer Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   774   C0001246:Ac element [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0013879:Element [Element, Ion, or Isotope]
   748   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0699759:Rich [Qualitative Concept]
   748   C1412573:AC [Gene or Genome]
   748   C1705248:Element [Conceptual Entity]
   748   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   748   C3539770:AC [Gene or Genome]
Processing 00000000.tx.255: The effect of the FTDP-17 mutation 30TC that strengthens the AC-rich ESE and enhances E10 inclusion is modulated when the PPE is abolished in the double mutant 30TC/E5 (Fig. 2). 

Phrase: "The effect of the FTDP-17 mutation 30TC"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   790   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   770   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   753   C0236642:frontotemporal dementia [Disease or Syndrome]
   751   C0598172:chromosome mutation [Cell or Molecular Dysfunction]
   736   C0008633:Chromosome [Cell Component]
   736   C0011265:dementia [Mental or Behavioral Dysfunction]
   736   C0026882:Mutation [Genetic Function]
   736   C0242422:Parkinsonism [Disease or Syndrome]
   736   C0497327:Dementia [Mental or Behavioral Dysfunction]
   736   C1280500:Effect [Qualitative Concept]
   736   C1705285:Mutation [Cell or Molecular Dysfunction]
   736   C2348382:Effect [Qualitative Concept]
   715 E C0948447:chromosomal mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "strengthens"

Phrase: "the AC-rich ESE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "E10 inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]

Phrase: "is"

Phrase: "modulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulated [Spatial Concept]

Phrase: "when"

Phrase: "the PPE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "abolished in the double mutant 30TC/E5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205173:Double [Functional Concept]
   748   C0596988:Mutant [Cell or Molecular Dysfunction]
   748   C1423600:E5 [Gene or Genome]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.256: Comparison of Human and Mouse E10 Splicing-- Mice and humans regulate E10 splicing differently. 

Phrase: "Comparison of Human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "Mouse E10 Splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035687:Splicing [Genetic Function]
   827   C2610186:splicing [Genetic Function]

Phrase: "--"

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "regulate"

Phrase: "E10"

Phrase: "splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]

Phrase: "differently."
Processing 00000000.tx.257: In fetal brain in both organisms, E10 is not incorporated into tau transcripts. 

Phrase: "In fetal brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0440731:Fetal brain [Embryonic Structure]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "in both organisms,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029235:Organisms [Organism]

Phrase: "E10"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "incorporated into tau transcripts."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
Processing 00000000.tx.258: In adult mouse brain, all tau transcripts have E10, and only 4R tau protein is produced. 

Phrase: "In adult mouse brain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1521713:Mouse Brain [Tissue]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "all tau transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "have"

Phrase: "E10,"

Phrase: "and"

Phrase: "only 4R tau protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "produced."
Processing 00000000.tx.259: In contrast, in adult human brain, both E10+ and E10 tau transcripts and 3R and 4R tau protein are found in roughly equal proportions (14). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "in adult human brain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0001675:Human, Adult [Age Group]

Phrase: "both E10+"

Phrase: "and"

Phrase: "E10 tau transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "3R"

Phrase: "and"

Phrase: "4R tau protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "are"

Phrase: "found in roughly equal proportions"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0150312:Found [Quantitative Concept]
   760   C0205163:Equal [Qualitative Concept]
   760   C1549782:Equal [Idea or Concept]
   726 E C0243095:Find [Finding]
   726   C1709707:Proportion [Quantitative Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.260: E10 is highly conserved between these two species with only 3nucleotides being different (Fig. 1A), and the 5' and 3' splice sites are identical. 

Phrase: "E10"

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "conserved between these two species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205448:Two [Quantitative Concept]
   760   C1705920:Species [Conceptual Entity]

Phrase: "with only 3nucleotides"

Phrase: "being"

Phrase: "different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the 5'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "3' splice sites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0887918:Splice Sites, 3' [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "identical."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.261: However, the adjacent intronic regions are more divergent (Fig. 7). 

Phrase: "However,"

Phrase: "the adjacent intronic regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "are"

Phrase: "more divergent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0443204:Divergence [Spatial Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.262: To assess the role of these divergent sequences on E10 regulation, a wild-type mouse splicing template (mWT) was generated that is analogous to the human sequences used here and is comprised of mouse E10 (EM) flanked by 30and 51nucleotides from mouse I9 (I9M) and I10 (I10M), respectively. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the role of these divergent sequences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "on E10 regulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1327622:Regulation [Biologic Function]

Phrase: "a wild-type mouse splicing template"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0728990:TEMPLATE [Medical Device]
   804   C1514575:Template [Conceptual Entity]
   804   C1705542:Template [Idea or Concept]
   717   C1520150:Wild Type Mouse [Mammal]

Phrase: "(mWT)"

Phrase: "was"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "that"

Phrase: "is"

Phrase: "analogous to the human sequences"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "here"

Phrase: "and"

Phrase: "is"

Phrase: "comprised of mouse E10"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   737   C2700400:Comprise [Activity]

Phrase: "(EM)"

Phrase: "flanked by 30and 51nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0230171:Flank [Body Location or Region]

Phrase: "from mouse I9"

Phrase: "(I9M"

Phrase: ")"

Phrase: "and"

Phrase: "I10"

Phrase: "(I10M"

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.263: In COS-7 cells, the efficiency of E10 inclusion (34%) was somewhat less than the human equivalent. 

Phrase: "In COS-7 cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1257858:COS-7 Cells [Cell]
   913   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "the efficiency of E10 inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0013682:Efficiency [Quantitative Concept]

Phrase: "(34%"

Phrase: ")"

Phrase: "was"

Phrase: "somewhat less than the human equivalent."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0086418:Human [Human]
   753   C0205163:Equivalent [Qualitative Concept]
   753   C0439185:equivalent [Quantitative Concept]
   753   C2984079:Somewhat [Intellectual Product]
Processing 00000000.tx.264: View larger version (40K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(40K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.265: 7.  

Phrase: "7."
Processing 00000000.tx.266: Comparison of human and mouse E10 splicing. 

Phrase: "Comparison of human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "mouse E10 splicing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035687:Splicing [Genetic Function]
   827   C2610186:splicing [Genetic Function]
Processing 00000000.tx.267: A, human and mouse I9 and I10 sequences shown are those present in the normal human (hN) and wild-type mouse (mWT) constructs. 

Phrase: "A,"

Phrase: "human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "mouse I9"

Phrase: "and"

Phrase: "I10 sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "those present in the normal human (hN)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "wild-type mouse"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(mWT) constructs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]
Processing 00000000.tx.268: B, autoradiograph showing results for E10 splicing assays. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "autoradiograph showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1547282:Show [Intellectual Product]

Phrase: "results for E10 splicing assays."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0035687:Splicing [Genetic Function]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2610186:splicing [Genetic Function]
   760   C2825142:Result [Finding]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.269: C, quantitation of splicing assay results of hN, mWT, and mouse-human hybrid constructs. 

Phrase: "C,"

Phrase: "quantitation of splicing assay results of hN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709793:Quantitation [Quantitative Concept]

Phrase: "mWT,"

Phrase: "and"

Phrase: "mouse-human hybrid constructs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C2827421:Construct [Classification]
Processing 00000000.tx.270: Human E10, I9, and I10 sequences (EH, I9H, and I10H, respectively) are represented by open boxes. 

Phrase: "Human E10,"

Phrase: "I9,"

Phrase: "and"

Phrase: "I10 sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "(EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1520135:EH [Geographic Area]

Phrase: "I9H,"

Phrase: "and"

Phrase: "I10H,"

Phrase: "respectively"

Phrase: ")"

Phrase: "are"

Phrase: "represented by open boxes."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0175566:Open [Spatial Concept]
   770   C0179400:boxes [Manufactured Object]
   770   C1638312:Boxes [Quantitative Concept]
   737 E C1533124:Box [Medical Device]
   737   C1882932:Represent [Activity]
Processing 00000000.tx.271: Mouse E10 (EM) and intron sequences (I9M and I10M) are represented by a hatched box and bold solid lines, respectively. 

Phrase: "Mouse E10"

Phrase: "(EM)"

Phrase: "and"

Phrase: "intron sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "(I9M"

Phrase: "and"

Phrase: "I10M"

Phrase: ")"

Phrase: "are"

Phrase: "represented by a hatched box"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0179400:Box [Manufactured Object]
   760   C1533124:Box [Medical Device]
   726   C0598016:hatch [Organism Function]
   726   C1882932:Represent [Activity]

Phrase: "and"

Phrase: "bold solid lines,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "respectively."
Processing 00000000.tx.272: Nucleotides divergent between mouse and human at E10 nucleotides 57,84,and 87(Fig. 

Phrase: "Nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "divergent between mouse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0443204:Divergence [Spatial Concept]

Phrase: "and"

Phrase: "human at E10 nucleotides 57,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086418:Human [Human]

Phrase: "84,"

Phrase: "and"

Phrase: "87"

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.273: 1A) are indicated as a superscript above E10 with E10AAC being the human sequence and E10GTA being the mouse sequence. 

Phrase: "1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: "are"

Phrase: "indicated as a superscript"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1444656:Indicated [Finding]
   770   C2825228:Superscript [Intellectual Product]

Phrase: "above E10"

Phrase: "with E10AAC"

Phrase: "being"

Phrase: "the human sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "E10GTA"

Phrase: "being"

Phrase: "the mouse sequence."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.274: SD is standard deviation. 

Phrase: "SD"

Phrase: "is"

Phrase: "standard deviation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0871420:Standard deviation [Quantitative Concept]
   861   C0012727:Deviation [Spatial Concept]
   861   C0205419:Deviation [Qualitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C1705236:Deviation [Finding]
   861   C2828392:Standard [Intellectual Product]
Processing 00000000.tx.275: A corrected significance criteria of p<0.003was used. 

Phrase: "A corrected significance criteria of p<0.003was"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0243161:criteria [Intellectual Product]

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.276: Significance levels are given for comparisons for each construct to results for both hN and mWT constructs. 

Phrase: "Significance levels"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   966   C0814896:Significance Level [Research Activity]
   861   C0237881:Significance [Quantitative Concept]
   861   C0441889:Levels [Qualitative Concept]
   861   C0750502:Significance [Idea or Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "are"

Phrase: "given for comparisons"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1442162:GIVEN [Conceptual Entity]
   790   C1550718:given [Idea or Concept]
   790   C3244317:given [Intellectual Product]
   756   C1707455:Comparison [Activity]
   756 E C1947971:Give [Functional Concept]

Phrase: "for each construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "to results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "for both hN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "mWT constructs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]
Processing 00000000.tx.277: To evaluate the effects of mouse and human intronic sequence differences on splicing, constructs were generated with different combinations of human and mouse sequences (Fig. 7). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the effects of mouse"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "human intronic sequence differences on splicing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "generated with different combinations of human"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0086418:Human [Human]
   753   C0453882:Combinations [Manufactured Object]
   753   C1705242:Different [Qualitative Concept]
   753   C3146294:Generated [Activity]
   719 E C0205195:Combination [Qualitative Concept]
   719 E C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "mouse sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.278: These combinations permitted evaluation of the role of I10 and E10 sequence differences separately. 

Phrase: "These combinations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0453882:Combinations [Manufactured Object]
   966 E C0205195:Combination [Qualitative Concept]
   966 E C1947911:Combination [Physical Object]

Phrase: "permitted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0329040:permitted [Fish]
   966 E C0023636:Permit [Regulation or Law]

Phrase: "evaluation of the role of I10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0220825:Evaluation [Functional Concept]
   753   C1261322:Evaluation [Health Care Activity]

Phrase: "and"

Phrase: "E10 sequence differences separately."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1705241:*Difference [Quantitative Concept]
   779   C1705242:Difference [Qualitative Concept]
   729 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.279: Mouse I10 sequences (I10M) are substantially more inhibitory than I10H sequences; 

Phrase: "Mouse I10 sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "(I10M"

Phrase: ")"

Phrase: "are"

Phrase: "substantially more inhibitory than I10H sequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3463820:Inhibitory [Activity]

Phrase: ";"
Processing 00000000.tx.280: when human I9 and E10 (I9HEH) are coupled to I10M, splicing is reduced (compare hN to I9HEHI10M; 45and 5%, respectively). 

Phrase: "when"

Phrase: "human I9"

Phrase: "and"

Phrase: "E10"

Phrase: "(I9HEH"

Phrase: ")"

Phrase: "are"

Phrase: "coupled to I10M,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1948027:Coupled [Functional Concept]
   756 E C0010222:couple [Family Group]

Phrase: "splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]

Phrase: "is"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "hN to I9HEHI10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0086418:Human [Human]

Phrase: "; 45and 5%,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.281: Conversely, when mouse I9 and E10 sequences are coupled to I10H, E10 incorporation is increased (compare mWT to I9MEMI10H; 34and 61%, respectively). 

Phrase: "Conversely,"

Phrase: "when"

Phrase: "mouse I9"

Phrase: "and"

Phrase: "E10 sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "coupled to I10H,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1948027:Coupled [Functional Concept]
   756 E C0010222:couple [Family Group]

Phrase: "E10 incorporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243126:incorporation [Functional Concept]

Phrase: "is"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "mWT to I9MEMI10H"

Phrase: "; 34and 61%,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.282: The same strong inhibition by I10M is also seen when mouse and human divergent nucleotides (TA and AC, respectively) at positions 84and 87in E10 are exchanged (compare results from I9MEGACI10M and I9MEGACI10H). 

Phrase: "The same strong inhibition by I10M"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "is"

Phrase: "also"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "when"

Phrase: "mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "human divergent nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(TA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1506978:Ta [Immunologic Factor]
  1000   C1705538:TA [Idea or Concept]

Phrase: "and"

Phrase: "AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412573:AC [Gene or Genome]
  1000   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539770:AC [Gene or Genome]

Phrase: "respectively"

Phrase: ")"

Phrase: "at positions 84and 87in E10"

Phrase: "are"

Phrase: "exchanged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0678640:exchange [Social Behavior]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "results from I9MEGACI10M"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]

Phrase: "and"

Phrase: "I9MEGACI10H"

Phrase: ")."
Processing 00000000.tx.283: Exon sequence differences between human and mouse tau also affect splicing. 

Phrase: "Exon sequence differences between human"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "mouse tau also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "splicing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]
Processing 00000000.tx.284: When in hN, E10 nucleotide 57is changed from A found in humans to G found in mouse (I9HEGACI10H), and E10 inclusion is increased from 45to 89%. 

Phrase: "When in hN,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086418:Human [Human]
   790   C1720477:When [Qualitative Concept]
   790   C1948054:When [Temporal Concept]

Phrase: "E10 nucleotide 57is"

Phrase: "changed from A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392747:Changed [Functional Concept]
   790   C0443172:Changed [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "found in humans"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0086418:Humans [Human]
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "to G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "found in mouse"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0025914:Mouse [Mammal]
   790   C0025929:mouse [Mammal]
   790   C0026809:Mouse [Mammal]
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "(I9HEGACI10H"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "E10 inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]

Phrase: "is"

Phrase: "increased from 45to 89%."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
Processing 00000000.tx.285: This result is consistent with an ESS element in the E14/E15 region of E10 (Fig. 3). 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "is"

Phrase: "consistent with an ESS element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in the E14/E15 region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "of E10"

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.286: When mouse E10 nucleotides at positions 84and 87were inserted into hN, splicing was reduced to 14% (compare hN to I9HEATAI10H; Fig. 7). 

Phrase: "When"

Phrase: "mouse E10 nucleotides at positions 84and 87were"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "inserted into hN,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0086418:Human [Human]
   790   C0441587:Inserted [Health Care Activity]
   756 E C1743766:Insert [Medical Device]
   756 E C1883719:Insert [Functional Concept]

Phrase: "splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]

Phrase: "was"

Phrase: "reduced to 14%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "hN to I9HEATAI10H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0086418:Human [Human]

Phrase: "; Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.287: Human nucleotides at positions 84and 87were also replaced individually to determine which is responsible for the decrease in splicing. 

Phrase: "Human nucleotides at positions 84and 87were also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "replaced"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0559956:Replaced [Functional Concept]
  1000   C1299987:replaced [Functional Concept]
   966 E C1554078:Replace [Idea or Concept]

Phrase: "individually to"

Phrase: "determine"

Phrase: "which"

Phrase: "is"

Phrase: "responsible for the decrease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "in splicing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]
Processing 00000000.tx.288: At position 87,when the human C nucleotide was replaced with the mouse A, little change in splicing was observed (compare hN to I9HEAAAI10H, 45versus 50%, respectively, Fig. 7). 

Phrase: "At position 87,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "when"

Phrase: "the human C nucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "replaced with the mouse A,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0559956:Replaced [Functional Concept]
   760   C1299987:replaced [Functional Concept]
   726 E C1554078:Replace [Idea or Concept]

Phrase: "little change in splicing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "hN to I9HEAAAI10H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0086418:Human [Human]

Phrase: "45versus 50%,"

Phrase: "respectively,"

Phrase: "Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.289: In contrast, the single nucleotide replacement of the human A at position 84with either the mouse T or another pyrimidine (C) resulted in a dramatic reduction in splicing to 11and 5%, respectively (compare hN to I9HEATAI10H and I9HEACAI10H; Fig. 7). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the single nucleotide replacement of the human A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0035139:Replacement [Therapeutic or Preventive Procedure]
   744   C0559956:Replacement [Functional Concept]
   744   C1555302:Replacement [Idea or Concept]

Phrase: "at position 84with either"

Phrase: "the mouse T"

Phrase: "or"

Phrase: "another pyrimidine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034284:Pyrimidine [Organic Chemical]
  1000   C0034289:Pyrimidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "resulted in a dramatic reduction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]

Phrase: "to 11and 5%,"

Phrase: "respectively"

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "hN to I9HEATAI10H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0086418:Human [Human]

Phrase: "and"

Phrase: "I9HEACAI10H"

Phrase: "; Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.290: Thus, nucleotide 84is critical, and the reduction in splicing observed when this nucleotide is changed is consistent with results seen with E16 and E17 (Fig. 1) and suggests that a stimulatory element is present immediately upstream of the end of E10. 

Phrase: "Thus,"

Phrase: "nucleotide 84is"

Phrase: "critical,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511545:Critical [Qualitative Concept]

Phrase: "and"

Phrase: "the reduction in splicing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "this nucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "is"

Phrase: "consistent with results"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "seen with E16"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205397:Seen [Qualitative Concept]
   790   C1442753:E16 [Gene or Genome]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "and"

Phrase: "E17"

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a stimulatory element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "is"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "immediately upstream of the end of E10."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205548:Immediately [Temporal Concept]
   748   C0444930:End [Spatial Concept]
   748   C0522505:Upstream [Spatial Concept]
   748   C2746065:End [Temporal Concept]
Processing 00000000.tx.291: However, presently we cannot exclude the possibility that deletions E16 and E17 affect splicing by bringing the E10 ESS closer to the 5' splice site. 

Phrase: "However,"

Phrase: "presently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750528:presently [Idea or Concept]

Phrase: "we"

Phrase: "cannot"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that deletions E16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442753:E16 [Gene or Genome]

Phrase: "and"

Phrase: "E17"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "splicing by bringing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035687:Splicing [Genetic Function]
   790   C2610186:splicing [Genetic Function]

Phrase: "the E10 ESS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0206630:ESS [Neoplastic Process]
   861   C3541276:ESS [Intellectual Product]

Phrase: "closer to the 5' splice site."
Processing 00000000.tx.292: When human nucleotides were inserted into mWT at positions 84and 87,E10 inclusion was reduced (compare mWT to I9MEGACI10M, 34versus 20%, respectively). 

Phrase: "When"

Phrase: "human nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "inserted into mWT"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0441587:Inserted [Health Care Activity]
   756 E C1743766:Insert [Medical Device]
   756 E C1883719:Insert [Functional Concept]

Phrase: "at positions 84and 87,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0733755:positions [Spatial Concept]
   743 E C0240795:POSITIONAL [Finding]

Phrase: "E10 inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "mWT to I9MEGACI10M,"

Phrase: "34versus 20%,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.293: However, the inhibitory effects of the substituted nucleotides were overridden when the downstream intron was human (compare I9MEGAC I10M to I9MEGACI10H; 20and 93%, respectively). 

Phrase: "However,"

Phrase: "the inhibitory effects of the substituted nucleotides"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "overridden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547671:Override [Activity]

Phrase: "when"

Phrase: "the downstream intron"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "I9MEGAC I10M to I9MEGACI10H"

Phrase: "; 20and 93%,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.294: In contrast, no change in splicing occurred on replacing the mouse G at nucleotide 57for the human A at this position (compare mWT to I9MEATAI10M; 34and 35%, respectively). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "no change in splicing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0442739:No change [Finding]
   833   C1548568:No change [Intellectual Product]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "occurred on replacing"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1299987:replacing [Functional Concept]
   790   C1709305:Occurred [Activity]
   756 E C1554078:Replace [Idea or Concept]
   756 E C2745955:OCCUR [Temporal Concept]

Phrase: "the mouse G at nucleotide 57for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439267:g% [Quantitative Concept]

Phrase: "the human A at this position"

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "mWT to I9MEATAI10M"

Phrase: "; 34and 35%,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.295: Presumably the strong inhibitory effect of mouse I10 overrides other elements (e.g. the ESS) in mouse E10. 

Phrase: "Presumably"

Phrase: "the strong inhibitory effect of mouse I10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "overrides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547671:Override [Activity]

Phrase: "other elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013879:Elements [Element, Ion, or Isotope]
   966 E C1705248:Element [Conceptual Entity]

Phrase: "("

Phrase: "e.g."

Phrase: "the ESS) in mouse E10."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0206630:ESS [Neoplastic Process]
   760   C3541276:ESS [Intellectual Product]
Processing 00000000.tx.296: The mouse and human I9 sequences used here also differentially affect E10 splicing. 

Phrase: "The mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "human I9 sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "here also differentially"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "E10 splicing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]
Processing 00000000.tx.297: The mouse I9 sequence is more permissive for E10 inclusion when compared with the human I9 sequence (compare I9MEATAI10M to I9HEATAI10M; 35and 3%, respectively).  

Phrase: "The mouse I9 sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "more permissive for E10 inclusion"

Phrase: "when"

Phrase: "compared with the human I9 sequence"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0086418:Human [Human]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]
   753   C1707455:Compared [Activity]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "I9MEATAI10M to I9HEATAI10M"

Phrase: "; 35and 3%,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.298: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The ratio of tau E10+ to E10 transcripts is regulated by a complex combination of intronic and exonic sequences. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The ratio of tau E10+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "to E10 transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "regulated by a complex combination of intronic"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205195:Combination [Qualitative Concept]
   748   C0439855:Complex [Qualitative Concept]
   748   C0851285:Regulated [Governmental or Regulatory Activity]
   748   C1704241:Complex [Chemical Viewed Structurally]
   748   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "exonic sequences."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.299: Nearly the entire exon is involved in controlling the inclusion of E10 in tau transcripts. 

Phrase: "Nearly"

Phrase: "the entire exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "involved in controlling"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0332298:controlling [Functional Concept]
   790   C1314939:Involved [Functional Concept]
   790   C2587213:Controlling [Functional Concept]
   756 E C0243148:control [Qualitative Concept]
   756 E C1550141:Control [Substance]
   756 E C1882979:Control [Conceptual Entity]
   756 E C3274648:Control [Qualitative Concept]

Phrase: "the inclusion of E10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1512693:Inclusion [Qualitative Concept]

Phrase: "in tau transcripts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.300: The in vivo importance of this complex regulation is revealed by FTDP-17 mutations that disrupt critical cis-acting elements within or closely flanking E10. 

Phrase: "The in vivo importance of this complex regulation"

Phrase: "is"

Phrase: "revealed by FTDP-17 mutations"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   818   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   790   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   764   C0236642:frontotemporal dementia [Disease or Syndrome]
   762   C0598172:chromosome mutations [Cell or Molecular Dysfunction]
   742   C0008633:Chromosome [Cell Component]
   742   C0011265:dementia [Mental or Behavioral Dysfunction]
   742   C0026882:Mutations [Genetic Function]
   742   C0242422:Parkinsonism [Disease or Syndrome]
   742   C0443289:Revealed [Qualitative Concept]
   742   C0497327:Dementia [Mental or Behavioral Dysfunction]
   726 E C0948447:chromosomal mutations [Cell or Molecular Dysfunction]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "critical cis-acting elements within"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   851   C0599780:cis acting element [Nucleotide Sequence]
   760   C0013879:Elements [Element, Ion, or Isotope]
   726 E C1705248:Element [Conceptual Entity]

Phrase: "or"

Phrase: "closely"

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "E10."
Processing 00000000.tx.301: In the adult under normal conditions, the E10+/E10 ratio is close to 1(14). 

Phrase: "In the adult"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001675:Adult [Age Group]
  1000   C1706450:Adult [Human]

Phrase: "under normal conditions,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   983   C0231162:Normal condition [Finding]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "the E10+/E10 ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "is"

Phrase: "close to 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0587267:Close [Functional Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.302: Autosomal dominant FTDP-17 splicing mutations that only affect 1copy of the tau gene, elevate this ratio to 2:1 (e.g. N279K mutation) (14, 19) or 3:1 (I10 mutations) (6, 7) or decrease this ratio to 1:3 (280K mutation) (15, 17). 

Phrase: "Autosomal dominant FTDP-17 splicing mutations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   782   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   760   C0236642:frontotemporal dementia [Disease or Syndrome]
   739   C0011265:dementia [Mental or Behavioral Dysfunction]
   739   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "that only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "1copy of the tau gene,"

Phrase: "elevate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "this ratio to 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "("

Phrase: "e.g. N279K mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "(14,"

Phrase: "19"

Phrase: ")"

Phrase: "or"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(I10 mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "(6,"

Phrase: "7"

Phrase: ")"

Phrase: "or"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "this ratio to 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]

Phrase: ":"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(280K mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "(15,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.303: The consequence of these relatively subtle changes is onset of severe neurodegenerative disease in mid-life. 

Phrase: "The consequence of these relatively subtle changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "is"

Phrase: "onset of severe neurodegenerative disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0277793:disease onset [Temporal Concept]
   760   C0332162:Onset [Qualitative Concept]

Phrase: "in mid-life."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0026062:mid-life [Temporal Concept]
   861   C0376558:Life [Idea or Concept]
   861   C0444598:Mid [Spatial Concept]
   777 E C0595998:lives [Finding]
Processing 00000000.tx.304: The work described here demonstrates that the regulation of E10 splicing is complex involving both ESE and ESS elements within the exon. 

Phrase: "The work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "here"

Phrase: "demonstrates"

Phrase: "that"

Phrase: "the regulation of E10 splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "is"

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "both ESE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "ESS elements within the exon."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0013879:Elements [Element, Ion, or Isotope]
   726 E C1705248:Element [Conceptual Entity]
Processing 00000000.tx.305: In addition, intronic sequences immediately adjacent to the 3' end of E10 inhibit splicing. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "intronic sequences"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   861   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "immediately adjacent to the 3' end of E10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205117:Adjacent to [Spatial Concept]
           Adjacent

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "splicing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]
Processing 00000000.tx.306: Other more distant intronic sequences not studied here also affect E10 splicing. 

Phrase: "Other more distant intronic sequences"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   812   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0162326:Sequences [Nucleotide Sequence]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "here also"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "E10 splicing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]
Processing 00000000.tx.307: The deletion and substitution analysis described above demonstrates that tau E10 splicing is regulated by a multipartite ESE composed of at least three functional motifs as follows: a potential 5' SC35-like binding element, a central purine-rich enhancer (PPE), and a 3' ACE-like element. 

Phrase: "The deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "and"

Phrase: "substitution analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "demonstrates"

Phrase: "that tau E10 splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035687:Splicing [Genetic Function]
   827   C2610186:splicing [Genetic Function]

Phrase: "is"

Phrase: "regulated by a multipartite ESE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0035687:Splicing [Genetic Function]
   748   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0851285:Regulated [Governmental or Regulatory Activity]
   748   C2610186:splicing [Genetic Function]

Phrase: "composed of"

Phrase: "at least three functional motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1514562:Motif [Amino Acid Sequence]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "a potential 5' SC35-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1419992:SC35 [Gene or Genome]
   827   C3538863:SC35 [Gene or Genome]

Phrase: "like binding element,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "a central purine-rich enhancer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(PPE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a 3' ACE-like element."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   876   C0001246:Ac element [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   839   C0014290:Enhancer Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C1705248:Element [Conceptual Entity]
Processing 00000000.tx.308: In addition, results from deletions E3 and E4 show that the sequence between the SC35-like element and the PPE element is critical for splicing regulation and is a potential inhibitory element. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "results from deletions E3"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C1274040:Result [Functional Concept]
   770   C1537525:E3 [Gene or Genome]
   770   C1546471:Result [Idea or Concept]
   770   C1880274:Deletions [Activity]
   770   C2825142:Result [Finding]
   737 E C1442161:Deletion [Cell or Molecular Dysfunction]
   737 E C1511760:Deletion [Genetic Function]

Phrase: "and"

Phrase: "E4"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the sequence between the SC35-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "like element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013879:Element [Element, Ion, or Isotope]
  1000   C1705248:Element [Conceptual Entity]

Phrase: "and"

Phrase: "the PPE element"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0014290:Enhancer Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C1705248:Element [Conceptual Entity]

Phrase: "is"

Phrase: "critical for splicing regulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511545:Critical [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "a potential inhibitory element."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C1705248:Element [Conceptual Entity]
Processing 00000000.tx.309: Deletions in each ESE motif reduce E10 inclusion indicating that all three ESE motifs are required for the level of E10 inclusion observed for normal tau. 

Phrase: "Deletions in each ESE motif"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C1880274:Deletions [Activity]
   714 E C1442161:Deletion [Cell or Molecular Dysfunction]
   714 E C1511760:Deletion [Genetic Function]

Phrase: "reduce"

Phrase: "E10 inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "all three ESE motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1514562:Motif [Amino Acid Sequence]

Phrase: "are"

Phrase: "required for the level of E10 inclusion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1512693:Inclusion [Qualitative Concept]
   748   C1514873:Required [Functional Concept]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "observed for normal tau."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
   770   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.310: Thus, these individual ESE components are not functionally redundant. 

Phrase: "Thus,"

Phrase: "these individual ESE components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0449432:Components [Manufactured Object]
   771 E C1705248:Component [Conceptual Entity]

Phrase: "are"

Phrase: "not functionally redundant."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0425087:Redundant [Finding]
   827   C1313915:Redundant [Functional Concept]
Processing 00000000.tx.311: Whereas only the PPE element appears to be absolutely required for E10 splicing as shown by results from the E5/E6 deletion, correct regulation of E10 splicing requires that all elements be present for exon definition. 

Phrase: "Whereas"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the PPE element"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0014290:Enhancer Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C1705248:Element [Conceptual Entity]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "absolutely"

Phrase: "required for E10 splicing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035687:Splicing [Genetic Function]
   770   C1514873:Required [Functional Concept]
   770   C2610186:splicing [Genetic Function]

Phrase: "as"

Phrase: "shown by results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C1547282:Show [Intellectual Product]
   756   C2825142:Result [Finding]

Phrase: "from the E5/E6 deletion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1442161:Deletion [Cell or Molecular Dysfunction]
   827   C1511760:Deletion [Genetic Function]
   827   C1880274:Deletion [Activity]

Phrase: "correct regulation of E10 splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "requires"

Phrase: "that"

Phrase: "all elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013879:Elements [Element, Ion, or Isotope]
   966 E C1705248:Element [Conceptual Entity]

Phrase: "be"

Phrase: "present for exon definition."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
Processing 00000000.tx.312: Double mutation experiments show that when the PPE is silenced by the E5 deletion, either other enhancer sequences must be strengthened or inhibitory sequences weakened before E10 can be recognized. 

Phrase: "Double mutation experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "when"

Phrase: "the PPE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "silenced by the E5 deletion,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1423600:E5 [Gene or Genome]
   760   C1442161:Deletion [Cell or Molecular Dysfunction]
   760   C1511760:Deletion [Genetic Function]
   760   C1880274:Deletion [Activity]
   726   C0858952:silence [Mental or Behavioral Dysfunction]

Phrase: "either"

Phrase: "other enhancer sequences"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0014290:Enhancer Sequences [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "must"

Phrase: "be"

Phrase: "strengthened"

Phrase: "or"

Phrase: "inhibitory sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "weakened before E10"

Phrase: "can"

Phrase: "be"

Phrase: "recognized."
Processing 00000000.tx.313: Although in the present work, the function of ESE was defined in COS-7 cells, this ESE clearly functions in vivo because the N279K mutation in this ESE results in an increase of 4R tau (19). 

Phrase: "Although in the present work,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0043227:Work [Occupational Activity]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "the function of ESE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "was"

Phrase: "defined in COS-7 cells,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   862   C1257858:COS-7 Cells [Cell]
   797   C0376702:COS Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0454802:Cos [Geographic Area]
   760   C1704788:Defined [Conceptual Entity]
   760   C3282337:Cells [Cell]
   760   C3539106:Defined [Intellectual Product]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "this ESE clearly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "functions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "because"

Phrase: "the N279K mutation in this ESE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0026882:Mutation [Genetic Function]
   744   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "results in an increase of 4R tau"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0442805:Increase [Functional Concept]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]
   748   C2825142:Result [Finding]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.314: This increase in the 4R/3R ratio at the protein level is consistent with this mutation causing increased E10 inclusion and resulting FTDP-17. 

Phrase: "This increase in the 4R/3R ratio"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "at the protein level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0428479:Protein level [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "consistent with this mutation causing increased E10 inclusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "and"

Phrase: "resulting FTDP-17."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   814   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   778   C0236642:frontotemporal dementia [Disease or Syndrome]
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.315: Also, two other mutations in the ESE (280K and L284L) cause FTDP-17. 

Phrase: "Also,"

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other mutations in the ESE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(280K"

Phrase: "and"

Phrase: "L284L"

Phrase: ")"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "FTDP-17."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   833   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   790   C0236642:frontotemporal dementia [Disease or Syndrome]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.316: The PPE element has a core requirement for GAR or possibly AAG repeats. 

Phrase: "The PPE element"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0014290:Enhancer Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C1705248:Element [Conceptual Entity]

Phrase: "has"

Phrase: "a core requirement for GAR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514873:Requirement [Functional Concept]

Phrase: "or"

Phrase: "possibly AAG repeats."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205341:repeats [Functional Concept]
   827   C1705914:Repeats [Conceptual Entity]
   793 E C1547730:Repeat [Temporal Concept]
Processing 00000000.tx.317: The mechanism by which the FTDP-17 mutation N279K (15TG) causes increased E10 inclusion is somewhat difficult to define because this mutation is at the border between the PPE and a potential inhibitory element defined by deletions E3 and E4. 

Phrase: "The mechanism by which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "the FTDP-17 mutation N279K"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   790   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   764   C0236642:frontotemporal dementia [Disease or Syndrome]
   742   C0011265:dementia [Mental or Behavioral Dysfunction]
   742   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "(15TG"

Phrase: ")"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "increased E10 inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512693:Inclusion [Qualitative Concept]

Phrase: "is"

Phrase: "somewhat difficult to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332218:Difficult [Qualitative Concept]
   827   C2984079:Somewhat [Intellectual Product]
   755 E C1299586:Difficulty [Finding]

Phrase: "define"

Phrase: "because"

Phrase: "this mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is at the border"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205284:Border [Spatial Concept]
   770   C1522411:Border [Body Location or Region]
   770   C2828371:Border [Classification]

Phrase: "between the PPE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "a potential inhibitory element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C1705248:Element [Conceptual Entity]

Phrase: "defined by deletions E3"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C1537525:E3 [Gene or Genome]
   770   C1704788:Defined [Conceptual Entity]
   770   C1880274:Deletions [Activity]
   770   C3539106:Defined [Intellectual Product]
   737 E C1442161:Deletion [Cell or Molecular Dysfunction]
   737 E C1511760:Deletion [Genetic Function]

Phrase: "and"

Phrase: "E4."
Processing 00000000.tx.318: This mutation appears to act by extending the purine tract of the PRE as either an A or G at position 15increases E10 inclusion. 

Phrase: "This mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act by extending"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0079613:ACT [Therapeutic or Preventive Procedure]
   790   C0439792:Extending [Spatial Concept]
   756 E C0231448:Extend [Functional Concept]

Phrase: "the purine tract of the PRE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1185740:Tract [Body Part, Organ, or Organ Component]

Phrase: "as either"

Phrase: "an A"

Phrase: "or"

Phrase: "G at position 15increases E10 inclusion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.319: The G at position 15is clearly more effective than an A as seen when either are assayed alone or in combination with the E5 deletion (Fig. 2). 

Phrase: "The G at position 15is clearly more effective"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439267:g% [Quantitative Concept]

Phrase: "than an A"

Phrase: "as"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "when"

Phrase: "either"

Phrase: "are"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205195:Combination [Qualitative Concept]
   790   C1947911:Combination [Physical Object]

Phrase: "with the E5 deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.320: The normal T at position 15may negatively modulate the activity of PPE. 

Phrase: "The normal T at position 15may negatively"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the activity of PPE."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.321: Others (23) have shown that a T within a purine-rich enhancer sequence can be inhibitory. 

Phrase: "Others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that a T within a purine-rich enhancer sequence"

Phrase: "can"

Phrase: "be"

Phrase: "inhibitory."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3463820:Inhibitory [Activity]
Processing 00000000.tx.322: The splicing enhancing effects of the FTDP-17 mutation L284L were originally hypothesized to be due to disruption of an ISS with the core sequence of TTAG (15). 

Phrase: "The splicing enhancing effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "of the FTDP-17 mutation L284L"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   840   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   821   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   813   C0598172:chromosome mutation [Cell or Molecular Dysfunction]
   804   C0236642:frontotemporal dementia [Disease or Syndrome]
   790   C0008633:Chromosome [Cell Component]
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0026882:Mutation [Genetic Function]
   790   C0242422:Parkinsonism [Disease or Syndrome]
   790   C0332285:Of [Spatial Concept]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]
   790   C1705285:Mutation [Cell or Molecular Dysfunction]
   777 E C0948447:chromosomal mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "originally"

Phrase: "hypothesized"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be due to disruption of an ISS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0332453:Disruption [Functional Concept]
   748   C1845118:ISS [Congenital Abnormality,Disease or Syndrome]
   748   C2987476:Be [Conceptual Entity]
   748   C3146286:Due [Idea or Concept]

Phrase: "with the core sequence"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C0444669:Core [Spatial Concept]
   861   C1167518:core [Cell Component]
   861   C1519249:Sequence [Functional Concept]
   861   C1706352:Core [Medical Device]
   861   C1882467:Core [Manufactured Object]
   861   C3274653:Core [Body Substance]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "of TTAG"

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.323: This prediction was based on previous work (21) showing that this core sequence inhibits splicing of HIV tat exon 3.

Phrase: "This prediction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681842:Prediction [Idea or Concept]

Phrase: "was"

Phrase: "based on previous work"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0043227:Work [Occupational Activity]
   770   C0205156:Previous [Temporal Concept]
   770   C1527178:Based [Functional Concept]
   770   C1552607:previous [Temporal Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(21"

Phrase: ")"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "this core sequence"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C0444669:Core [Spatial Concept]
   861   C1167518:core [Cell Component]
   861   C1519249:Sequence [Functional Concept]
   861   C1706352:Core [Medical Device]
   861   C1882467:Core [Manufactured Object]
   861   C3274653:Core [Body Substance]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "splicing of HIV tat exon 3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035687:Splicing [Genetic Function]
   753   C2610186:splicing [Genetic Function]
Processing 00000000.tx.324: However, deletions E9 and E10 that span the TTAG sequence, rather than increasing E10 inclusion, do not alter or actually reduce E10 inclusion, respectively (Fig. 1). 

Phrase: "However,"

Phrase: "deletions E9"

Phrase: "and"

Phrase: "E10"

Phrase: "that"

Phrase: "span"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1711300:Span [Conceptual Entity]
  1000   C2700613:Span [Quantitative Concept]

Phrase: "the TTAG sequence,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "rather than"

Phrase: "increasing E10 inclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512693:Inclusion [Qualitative Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "or"

Phrase: "actually"

Phrase: "reduce"

Phrase: "E10 inclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]

Phrase: "respectively"

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.325: Deletions E10 and E11 reduce splicing, demonstrating that this region contains an enhancer element. 

Phrase: "Deletions E10"

Phrase: "and"

Phrase: "E11"

Phrase: "reduce"

Phrase: "splicing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]

Phrase: "demonstrating"

Phrase: "that"

Phrase: "this region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an enhancer element."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014290:Enhancer Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]
Processing 00000000.tx.326: Mutations introduced to alter each nucleotide of TTAG all increase E10 inclusion (Fig. 2). 

Phrase: "Mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "introduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "each nucleotide of TTAG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "all"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "E10 inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.327: These results suggest that the TTAG inhibitory sequence is directly adjacent to an enhancer region (ACE, Fig. 1). 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the TTAG inhibitory sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "directly adjacent to an enhancer region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205117:Adjacent to [Spatial Concept]
           Adjacent

Phrase: "(ACE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.328: The FTDP-17 mutation L284L (E30TC) that increases splicing may act by disrupting the inhibitory TTAG sequence and by extending the ACE element to include an additional CA repeat. 

Phrase: "The FTDP-17 mutation L284L"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   790   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   764   C0236642:frontotemporal dementia [Disease or Syndrome]
   742   C0011265:dementia [Mental or Behavioral Dysfunction]
   742   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "(E30TC"

Phrase: ")"

Phrase: "that"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]

Phrase: "may"

Phrase: "act by disrupting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0079613:ACT [Therapeutic or Preventive Procedure]
   790   C0332454:disrupting [Qualitative Concept]

Phrase: "the inhibitory TTAG sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "and by extending"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0439792:Extending [Spatial Concept]
   790   C1515981:And [Idea or Concept]
   756 E C0231448:Extend [Functional Concept]

Phrase: "the ACE element to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0001246:Ac element [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   840   C0014290:Enhancer Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C1705248:Element [Conceptual Entity]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "an additional CA repeat."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1707076:CA Repeat [Gene or Genome]
   827   C0205341:Repeat [Functional Concept]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]
Processing 00000000.tx.329: Thus, both FTDP-17 mutations L284L and N279K are at critical nucleotides between closely adjacent elements that regulate E10 splicing. 

Phrase: "Thus,"

Phrase: "both FTDP-17 mutations L284L"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   790   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   764   C0236642:frontotemporal dementia [Disease or Syndrome]
   742   C0011265:dementia [Mental or Behavioral Dysfunction]
   742   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "N279K"

Phrase: "are at critical nucleotides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1511545:Critical [Qualitative Concept]
   770   C1551058:Are [Quantitative Concept]

Phrase: "between closely adjacent elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013879:Elements [Element, Ion, or Isotope]
   793 E C1705248:Element [Conceptual Entity]

Phrase: "that"

Phrase: "regulate"

Phrase: "E10 splicing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]
Processing 00000000.tx.330: An alternative explanation is that the TTAG sequence, within the context of tau E10, does not strongly influence splicing, as shown by the fact that E9 that deletes the first two nucleotides of this sequence only slightly increases splicing (Fig. 1). 

Phrase: "An alternative explanation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "that"

Phrase: "the TTAG sequence,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "within the context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "of tau E10,"

Phrase: "does"

Phrase: "not strongly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "splicing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]

Phrase: "as"

Phrase: "shown by the fact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]

Phrase: "that E9"

Phrase: "that"

Phrase: "deletes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Delete [Activity]

Phrase: "the first two nucleotides of this sequence only slightly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C0004793:Nucleotide Sequence [Nucleotide Sequence]
   742   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.331: The multipartite ESE and the inhibitory sequences within E10 act in the context of a weak 5' splice site. 

Phrase: "The multipartite ESE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the inhibitory sequences within E10"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0162326:Sequences [Nucleotide Sequence]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "act in the context of a weak 5' splice site."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   757   C2945843:Site of [Qualitative Concept]
   739   C0004093:Weak [Sign or Symptom]
   739   C0079613:ACT [Therapeutic or Preventive Procedure]
   739   C0205145:Site [Spatial Concept]
   739   C0449255:Context [Finding]
   739   C0542559:Context [Functional Concept]
   739   C1515974:Site [Body Location or Region]
   739   C1762617:Weak [Qualitative Concept]
   739   C2825164:Site [Spatial Concept]
Processing 00000000.tx.332: When the 5' splice is strengthened either by mutations that bring the sequence closer to the U1/U6 snRNP hybridization consensus sequence (e.g. FTDP-17 mutations 92GA) or when the splice site is replaced by a -globin splice site known to give constitutive splicing (e.g. WTGlo), E10 inclusion is nearly complete. 

Phrase: "When"

Phrase: "the 5' splice"

Phrase: "is"

Phrase: "strengthened"

Phrase: "either by mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0026882:Mutations [Genetic Function]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "bring"

Phrase: "the sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "closer to the U1/U6 snRNP hybridization consensus sequence"

Phrase: "("

Phrase: "e.g. FTDP-17 mutations 92GA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   782   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   760   C0236642:frontotemporal dementia [Disease or Syndrome]
   739   C0011265:dementia [Mental or Behavioral Dysfunction]
   739   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: ")"

Phrase: "or"

Phrase: "when"

Phrase: "the splice site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "replaced by a -globin splice site"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C1299987:Replaced by [Functional Concept]
           replaced
   753   C0017645:Globin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205145:Site [Spatial Concept]
   753   C0559956:Replaced [Functional Concept]
   753   C1149093:globin [Molecular Function]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]
   719 E C1554078:Replace [Idea or Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "constitutive splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]

Phrase: "("

Phrase: "e.g. WTGlo"

Phrase: ")"

Phrase: ","

Phrase: "E10 inclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512693:Inclusion [Qualitative Concept]

Phrase: "is"

Phrase: "nearly"

Phrase: "complete."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]
Processing 00000000.tx.333: When a strong splice site is present, destruction of the ESE function by E5 only slightly decreases E10 splicing (Fig. 5), showing that a strong splice site is dominant over other regulatory elements. 

Phrase: "When"

Phrase: "a strong splice site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "present, destruction of the ESE function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1261381:Destruction [Therapeutic or Preventive Procedure]
   744   C1948029:Destruction [Activity]

Phrase: "by E5 only slightly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205171:Only [Quantitative Concept]
   827   C0750482:Slightly [Idea or Concept]
   827   C1423600:E5 [Gene or Genome]
   827   C1720467:Only [Intellectual Product]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "E10 splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "a strong splice site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "dominant over other regulatory elements."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1527180:Dominant [Functional Concept]
Processing 00000000.tx.334: The downstream I10 sequence immediately adjacent to the 5' splice site is clearly inhibitory. 

Phrase: "The downstream I10"

Phrase: "sequence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "immediately adjacent to the 5' splice site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0205117:Adjacent to [Spatial Concept]
           Adjacent

Phrase: "is"

Phrase: "clearly inhibitory."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3463820:Inhibitory [Activity]
Processing 00000000.tx.335: One hypothesis on how this sequence acts is that a stem-loop forms that spans the splice site, blocks hybridization of U1/U6 snRNP, and inhibits initiation of splicing. 

Phrase: "One hypothesis on how"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1512571:Hypothesis [Idea or Concept]

Phrase: "this sequence acts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "that"

Phrase: "a stem-loop"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0242767:Stem [Plant]
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "that spans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "the splice site,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "hybridization of U1/U6 snRNP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020202:Hybridisation [Genetic Function]
   760   C1300517:Hybridization [Laboratory Procedure]

Phrase: "and"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "initiation of splicing."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0589507:Initiation [Mental Process]
   790   C1158830:Initiation [Genetic Function]
   790   C1704686:Initiation [Functional Concept]
Processing 00000000.tx.336: A second hypothesis is that a stem-loop is the binding substrate for a trans-acting factor. 

Phrase: "A second hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "that"

Phrase: "a stem-loop"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0242767:Stem [Plant]
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "the binding substrate for a trans-acting factor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.337: One ambiguity of these hypotheses is that the stem-loop structure and stability is dependent on how many nucleotides from E10/I10 are included (Fig. 6 and Table I). 

Phrase: "One ambiguity of these hypotheses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346729:Ambiguity [Qualitative Concept]

Phrase: "is"

Phrase: "that"

Phrase: "the stem-loop structure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0242767:Stem [Plant]
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]
   827   C0678594:Structure [Spatial Concept]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "stability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205360:Stability [Qualitative Concept]
  1000   C2347098:Stability [Qualitative Concept]
   928 E C1547311:Stable [Intellectual Product]

Phrase: "is"

Phrase: "dependent on how"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0851827:Dependent [Qualitative Concept]
   790   C1701901:Dependent [Qualitative Concept]
   790   C3244310:dependent [Functional Concept]

Phrase: "many nucleotides from E10/I10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.338: Even more extensive structures are predicted when additional flanking nucleotides are included (not shown). 

Phrase: "Even more extensive structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0678594:structures [Spatial Concept]

Phrase: "are"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "when"

Phrase: "additional flanking nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.339: Although at least some of these stem-loops do form in vitro (32, 33), it is not clear if any of these structures form in vivo where multiple splicing regulatory proteins (e.g. SR proteins) coat the pre-mRNA, potentially altering or abolishing predicted secondary structure. 

Phrase: "Although at least"

Phrase: "some of these stem-loops"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0181687:loops [Medical Device]
   760   C0205392:Some [Quantitative Concept]
   760   C0242767:Stem [Plant]
   760   C1186763:Stem [Body Part, Organ, or Organ Component]
   760   C3540770:Some [Intellectual Product]
   726 E C0419518:Loop [Medical Device]
   726 E C0445022:Loop [Spatial Concept]

Phrase: "do"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(32,"

Phrase: "33"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "if"

Phrase: "any of these structures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0678594:structures [Spatial Concept]
   770   C1552551:Any [Qualitative Concept]
   770   C3272371:ANY [Intellectual Product]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "in vivo where multiple splicing regulatory proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C0815047:regulatory proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0220905:regulatory [Regulation or Law]
   795   C1704735:Regulatory [Conceptual Entity]

Phrase: "("

Phrase: "e.g. SR proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "coat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0453946:Coat [Manufactured Object]
  1000   C1522408:Coat [Qualitative Concept]
  1000   C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "the pre-mRNA,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0026661:Pre-mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0035695:Pre-mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0332152:Pre [Temporal Concept]
   861   C0740175:Pre [Qualitative Concept]
   861   C2257086:PRE [Genetic Function]

Phrase: "potentially altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   768   C0392747:Altered [Functional Concept]

Phrase: "or"

Phrase: "abolishing predicted secondary structure."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0162807:Secondary Structure [Spatial Concept]
   812   C0027627:secondary [Neoplastic Process]
   812   C0175668:Secondary [Temporal Concept]
   812   C0205436:Secondary [Quantitative Concept]
   812   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.340: An alternative hypothesis is that the I10 linear sequence is the critical functional inhibitory unit that acts as a single-stranded sequence and binds a trans-acting splicing factor(s).  

Phrase: "An alternative hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1512571:Hypothesis [Idea or Concept]
   861   C1523987:Alternative [Conceptual Entity]

Phrase: "is"

Phrase: "that"

Phrase: "the I10 linear sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "the critical functional inhibitory unit"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0439148:Unit [Quantitative Concept]
   812   C1519795:Unit [Quantitative Concept]
   812   C1704753:Unit [Manufactured Object]
   812   C1880519:Unit [Quantitative Concept]

Phrase: "that acts as a single-stranded sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "a trans-acting splicing factor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0040627:Trans-Acting Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C0600448:Trans-Splicing [Molecular Function]
   812   C0035687:Splicing [Genetic Function]
   812   C1521761:Factor [Functional Concept]
   812   C2610186:splicing [Genetic Function]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "("

Phrase: "s)."
Processing 00000000.tx.341: View this table: [in this window] [in a new window]  Table I Stability of RNA secondary structures Nucleotides (nt) used for free energy predictions are as follows: E10 nt 78to I10 nt 35for the 49-nucleotide sequence; 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I Stability of RNA secondary structures Nucleotides (nt)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0752249:RNA Stability [Qualitative Concept]
   744   C0205360:Stability [Qualitative Concept]
   744   C2347098:Stability [Qualitative Concept]

Phrase: "used for free energy predictions"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C0678591:Free Energy [Natural Phenomenon or Process]
   760   C0332296:free [Functional Concept]
   760   C0424589:Energy [Finding]
   760   C0542479:Energy [Natural Phenomenon or Process]
   760   C0681842:predictions [Idea or Concept]
   760   C1273517:used [Finding]
   760   C1442080:Energy [Quantitative Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "E10 nt 78to I10 nt 35for"

Phrase: "the 49-nucleotide sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.342: E10 nt 85to I10 nt 21for the 30-nucleotide sequence; 

Phrase: "E10 nt 85to I10 nt 21for"

Phrase: "the 30-nucleotide sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.343: E10 nt 88to I10 nt 19for the 25-nucleotide sequence; 

Phrase: "E10 nt 88to I10 nt 19for"

Phrase: "the 25-nucleotide sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.344: and from E10 nt 92to I10 nt 16for the 18-nucleotide sequence. 

Phrase: "and from E10 nt 92to I10 nt 16for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C1515981:And [Idea or Concept]

Phrase: "the 18-nucleotide sequence."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.345: Evidence for the stem-loop hypothesis is that FTDP-17 mutations predicted to disrupt the stem-loop increase E10 inclusion. 

Phrase: "Evidence for the stem-loop hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332120:Evidence [Functional Concept]

Phrase: "is"

Phrase: "that FTDP-17 mutations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   800   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   770   C0236642:frontotemporal dementia [Disease or Syndrome]
   744   C0011265:dementia [Mental or Behavioral Dysfunction]
   744   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "the stem-loop increase E10 inclusion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.346: Thus, mutations within the splice site (92GA and E10+3) and those 3' to the splice site (E10+12, E10+13, E10+14, and E10+16) destabilize the stem-loop and increase splicing from the normal 45to 88-97%. 

Phrase: "Thus,"

Phrase: "mutations within the splice site"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1519478:Splice-Site Mutation [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(92GA"

Phrase: "and"

Phrase: "E10+3"

Phrase: ")"

Phrase: "and"

Phrase: "those 3'"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "to the splice site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "(E10+12,"

Phrase: "E10+13,"

Phrase: "E10+14,"

Phrase: "and"

Phrase: "E10+16"

Phrase: ")"

Phrase: "destabilize"

Phrase: "the stem-loop"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0242767:Stem [Plant]
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "increase splicing from the normal 45to 88-97%."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035687:Splicing [Genetic Function]
   744   C2610186:splicing [Genetic Function]
Processing 00000000.tx.347: Interpretation of the results for 92GA and E10+3 is complicated because these mutations may act by directly strengthening the 5' splice site interaction with U1/U6 snRNP rather than by disrupting an inhibitory element or structure. 

Phrase: "Interpretation of the results"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0459471:Interpretation [Intellectual Product]
   770   C3173575:Interpretation [Clinical Attribute]

Phrase: "for 92GA"

Phrase: "and"

Phrase: "E10+3"

Phrase: "is"

Phrase: "complicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231242:Complicated [Functional Concept]

Phrase: "because"

Phrase: "these mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "act by directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0079613:ACT [Therapeutic or Preventive Procedure]
   790   C1947931:Directly [Qualitative Concept]

Phrase: "strengthening"

Phrase: "the 5' splice site interaction with U1/U6 snRNP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1704675:Interaction [Functional Concept]

Phrase: "rather than by disrupting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332454:disrupting [Qualitative Concept]

Phrase: "an inhibitory element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "or"

Phrase: "structure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.348: Another line of evidence supporting the stem-loop hypothesis is that substitutions in nucleotides within the loop do not alter splicing (33). 

Phrase: "Another line of evidence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205132:Line [Spatial Concept]
   770   C1550648:Line [Substance]
   770   C1552960:Line [Quantitative Concept]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the stem-loop hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "that substitutions in nucleotides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1555721:Substitution [Idea or Concept]
   737   C1706204:Substitution [Activity]

Phrase: "within the loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0419518:Loop [Medical Device]
  1000   C0445022:Loop [Spatial Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.349: Also, lengthening the stem portion of the structure by introducing complementary nucleotides at I10 positions 17and 18(GTTG) reduces splicing. 

Phrase: "Also,"

Phrase: "lengthening"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441592:Lengthening [Therapeutic or Preventive Procedure]
   966 E C0392744:lengthen [Functional Concept]

Phrase: "the stem portion of the structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449719:Portion [Spatial Concept]

Phrase: "by introducing complementary nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "at I10"

Phrase: "positions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]

Phrase: "17and 18"

Phrase: "(GTTG"

Phrase: ")"

Phrase: "reduces"

Phrase: "splicing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]
Processing 00000000.tx.350: The stem-loop hypothesis can also be tested by generating double mutants that restore the secondary structure disrupted by mutations in the stem. 

Phrase: "The stem-loop hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]

Phrase: "can"

Phrase: "also"

Phrase: "be"

Phrase: "tested by generating double mutants"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   781   C0554818:Double test [Laboratory Procedure]
   760   C0205173:Double [Functional Concept]
   760   C0392366:tested [Intellectual Product]
   760   C0596988:mutants [Cell or Molecular Dysfunction]
   760   C1705764:Double [Activity]
   760   C1705765:Double [Qualitative Concept]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "that"

Phrase: "restore"

Phrase: "the secondary structure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162807:Secondary Structure [Spatial Concept]
   861   C0027627:secondary [Neoplastic Process]
   861   C0175668:Secondary [Temporal Concept]
   861   C0205436:Secondary [Quantitative Concept]
   861   C0678594:Structure [Spatial Concept]

Phrase: "disrupted by mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0026882:Mutations [Genetic Function]
   790   C0332454:Disrupted [Qualitative Concept]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the stem."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242767:Stem [Plant]
  1000   C1186763:Stem [Body Part, Organ, or Organ Component]
Processing 00000000.tx.351: Double mutants 92GA/E10+16 and E10+3/E10+12 do not restore normal splicing as expected, even though these changes stabilize the stem-loop, as shown both empirically in melting experiments (32) and as predicted by free energy calculations (22). 

Phrase: "Double mutants 92GA/E10+16"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205173:Double [Functional Concept]
   804   C0596988:mutants [Cell or Molecular Dysfunction]
   804   C1705764:Double [Activity]
   804   C1705765:Double [Qualitative Concept]

Phrase: "and"

Phrase: "E10+3/E10+12"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "restore"

Phrase: "normal splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]

Phrase: "as"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "even"

Phrase: "though"

Phrase: "these changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "stabilize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "the stem-loop,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0242767:Stem [Plant]
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]

Phrase: "as"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "both empirically in melting experiments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0238767:Both [Spatial Concept]
   760   C0599882:Melting [Natural Phenomenon or Process]
   760   C0681814:Experiments [Research Activity]
   760   C1706086:Both [Qualitative Concept]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "(32"

Phrase: ")"

Phrase: "and"

Phrase: "as"

Phrase: "predicted by free energy calculations"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0678591:Free Energy [Natural Phenomenon or Process]
   760   C0332296:free [Functional Concept]
   760   C0424589:Energy [Finding]
   760   C0542479:Energy [Natural Phenomenon or Process]
   760   C0681842:Predicted [Idea or Concept]
   760   C1442080:Energy [Quantitative Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1882327:%{Predicted} [Quantitative Concept]
   760   C1996904:Free [Qualitative Concept]
   726   C1441506:Calculation [Activity]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.352: This result appears to argue against the stem-loop hypothesis although another interpretation is that E10+3 and 92GA result in a strong splice site that over-rides the silencing effects of the stem-loop. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "argue against the stem-loop hypothesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0242767:Stem [Plant]
   753   C0419518:Loop [Medical Device]
   753   C0445022:Loop [Spatial Concept]
   753   C1186763:Stem [Body Part, Organ, or Organ Component]
   753   C1512571:Hypothesis [Idea or Concept]

Phrase: "although"

Phrase: "another interpretation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0459471:Interpretation [Intellectual Product]
  1000   C3173575:Interpretation [Clinical Attribute]

Phrase: "is"

Phrase: "that E10+3"

Phrase: "and"

Phrase: "92GA result in a strong splice site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "that"

Phrase: "over-rides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1547671:Over-ride [Activity]
   861   C0205136:Over [Spatial Concept]

Phrase: "the silencing effects of the stem-loop."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.353: As shown here, a strong 5' splice site is dominant over other cis-acting elements that control E10 splicing. 

Phrase: "As"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here,"

Phrase: "a strong 5' splice site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "dominant over other cis-acting elements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1527180:Dominant [Functional Concept]

Phrase: "that"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "E10 splicing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]
Processing 00000000.tx.354: E10 mutations that disrupt the longer possible stem-loop structures (49, 59, E17, and the -globin sequences used in Glo-1) do not significantly alter splicing. 

Phrase: "E10 mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "the longer possible stem-loop structures"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0242767:Stem [Plant]
   804   C0419518:Loop [Medical Device]
   804   C0445022:Loop [Spatial Concept]
   804   C0678594:structures [Spatial Concept]
   804   C1186763:Stem [Body Part, Organ, or Organ Component]

Phrase: "(49,"

Phrase: "59,"

Phrase: "E17,"

Phrase: "and"

Phrase: "the -globin sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "used in Glo-1"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: ")"

Phrase: "do"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "splicing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]
Processing 00000000.tx.355: Thus the sequences immediately 5' to the end of the exon do not participate in regulation, and the longer stem-loop structures are probably not involved in E10 regulation. 

Phrase: "Thus"

Phrase: "the sequences immediately 5'"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0162326:Sequences [Nucleotide Sequence]
   827   C0205548:Immediately [Temporal Concept]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "to the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "participate in regulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0851285:Regulation [Governmental or Regulatory Activity]
   790   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "the longer stem-loop structures"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0242767:Stem [Plant]
   812   C0419518:Loop [Medical Device]
   812   C0445022:Loop [Spatial Concept]
   812   C0678594:structures [Spatial Concept]
   812   C1186763:Stem [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involved in E10 regulation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1314939:Involved [Functional Concept]
   770   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.356: Evidence against the short 18-nucleotide stem-loop being a regulatory structure comes from splicing experiments with FTDP-17 mutations E10+12ct, E10+13ag, E10+14ct, and E10+16ct in combination with the E5 mutation. 

Phrase: "Evidence against the short 18-nucleotide stem-loop"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332120:Evidence [Functional Concept]

Phrase: "being"

Phrase: "a regulatory structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "comes from splicing experiments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0035687:Splicing [Genetic Function]
   770   C0681814:Experiments [Research Activity]
   770   C2610186:splicing [Genetic Function]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "with FTDP-17 mutations E10+12ct,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   813   C0598172:chromosome mutations [Cell or Molecular Dysfunction]
   804   C0236642:frontotemporal dementia [Disease or Syndrome]
   804   C0338451:Frontotemporal dementia [Disease or Syndrome]
   790   C0008633:Chromosome [Cell Component]
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0026882:Mutations [Genetic Function]
   790   C0242422:Parkinsonism [Disease or Syndrome]
   790   C0332287:With [Qualitative Concept]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]
   790   C1705690:With [Intellectual Product]
   777 E C0948447:chromosomal mutations [Cell or Molecular Dysfunction]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "E10+13ag,"

Phrase: "E10+14ct,"

Phrase: "and"

Phrase: "E10+16ct in combination"

Phrase: "with the E5 mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.357: Singly, these mutations increase splicing so that E10 is nearly constitutively included, which correlates with the expected destabilization of the stem-loop. 

Phrase: "Singly,"

Phrase: "these mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that E10"

Phrase: "is"

Phrase: "nearly constitutively"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: ","

Phrase: "which"

Phrase: "correlates with the expected destabilization of the stem-loop."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0242767:Stem [Plant]
   742   C0419518:Loop [Medical Device]
   742   C0445022:Loop [Spatial Concept]
   742   C1186763:Stem [Body Part, Organ, or Organ Component]
   742   C1517001:Expected [Idea or Concept]
Processing 00000000.tx.358: However, when E5 is present, splicing is dramatically variable, ranging from 65% for E5/E10+14ct to 26% for E5/E10+16ct, even though these I10 mutants would produce stem-loops with similar free energies (Table I). 

Phrase: "However,"

Phrase: "when"

Phrase: "E5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1423600:E5 [Gene or Genome]

Phrase: "is"

Phrase: "present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]

Phrase: "is"

Phrase: "dramatically variable,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:Variable [Qualitative Concept]

Phrase: "ranging from 65%"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0450385:65 [Intellectual Product]
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "for E5/E10+14ct"

Phrase: "to 26%"

Phrase: "for E5/E10+16ct,"

Phrase: "even"

Phrase: "though"

Phrase: "these I10 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "would"

Phrase: "produce"

Phrase: "stem-loops with similar free energies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0181687:loops [Medical Device]
   753   C0242767:Stem [Plant]
   753   C1186763:Stem [Body Part, Organ, or Organ Component]
   719 E C0419518:Loop [Medical Device]
   719 E C0445022:Loop [Spatial Concept]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.359: Thus, for these double mutants, splicing does not correlate with stem-loop stability for any of the structures described in Fig. 

Phrase: "Thus,"

Phrase: "for these double mutants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "correlate with stem-loop stability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205360:Stability [Qualitative Concept]
   760   C0242767:Stem [Plant]
   760   C0419518:Loop [Medical Device]
   760   C0445022:Loop [Spatial Concept]
   760   C1186763:Stem [Body Part, Organ, or Organ Component]
   760   C2347098:Stability [Qualitative Concept]

Phrase: "for any"

Phrase: "of the structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.360: 6 and Table I. 

Phrase: "6"

Phrase: "and"

Phrase: "Table I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.361: Other less-direct evidence against the stem-loop hypothesis is that when mouse sequences are used either alone or in hybrid constructs with human sequences, splicing and predicted stem-loop free energies also do not correlate with E10 splicing levels (Fig. 6 and Table I). 

Phrase: "Other less-direct evidence against the stem-loop hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0332120:Evidence [Functional Concept]

Phrase: "is"

Phrase: "that"

Phrase: "when"

Phrase: "mouse sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "either alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]

Phrase: "or in hybrid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020205:Hybrid [Organism]

Phrase: "constructs with human sequences,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0086418:Human [Human]
   770   C0162326:Sequences [Nucleotide Sequence]
   770   C2827421:Construct [Classification]
   737 E C0004793:Sequence [Nucleotide Sequence]
   737 E C0162327:Sequence [Nucleotide Sequence]
   737 E C1519249:Sequence [Functional Concept]

Phrase: "splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035687:Splicing [Genetic Function]
  1000   C2610186:splicing [Genetic Function]

Phrase: "and"

Phrase: "predicted stem-loop free energies also"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   810   C0678591:Free Energy [Natural Phenomenon or Process]
   799   C0542479:energies [Natural Phenomenon or Process]
   766 E C0424589:Energy [Finding]
   766 E C1442080:Energy [Quantitative Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "correlate with E10 splicing levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0035687:Splicing [Genetic Function]
   760   C0441889:Levels [Qualitative Concept]
   760   C2610186:splicing [Genetic Function]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.362: The conclusion from our work is consistent with an alternative possibility for E10 splicing regulation, where the linear sequence starting at I10 position 12and extending at least to nucleotide 18and perhaps farther is an ISS. 

Phrase: "The conclusion from our work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707478:Conclusion [Idea or Concept]

Phrase: "is"

Phrase: "consistent with an alternative possibility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "for E10 splicing regulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]

Phrase: "where"

Phrase: "the linear sequence starting at I10 position 12and"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0439659:Start [Temporal Concept]

Phrase: "extending at least"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0439792:Extending [Spatial Concept]
   756 E C0231448:Extend [Functional Concept]

Phrase: "to nucleotide 18and perhaps farther"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   779   C0205108:far [Spatial Concept]

Phrase: "is"

Phrase: "an ISS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1845118:ISS [Congenital Abnormality,Disease or Syndrome]
Processing 00000000.tx.363: E10 splicing is regulated differently in mice and humans. 

Phrase: "E10 splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]

Phrase: "is"

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "differently in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.364: Whereas no E10+ is produced in fetal brain of either species, in adult mouse brain only E10+ mRNA is generated, whereas in adult human brain approximately equal amounts of E10+ and E10 transcripts are made. 

Phrase: "Whereas"

Phrase: "no E10+"

Phrase: "is"

Phrase: "produced in fetal brain of either species,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0440731:Fetal brain [Embryonic Structure]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0015965:Fetal [Embryonic Structure]
   748   C0521457:Fetal [Functional Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1705920:Species [Conceptual Entity]

Phrase: "in adult mouse brain only E10+ mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: ","

Phrase: "whereas in adult human brain approximately equal amounts of E10+"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0001675:Human, Adult [Age Group]
           Adult
   739   C0006104:Brain [Body Part, Organ, or Organ Component]
   739   C0086418:Human [Human]
   739   C0205163:Equal [Qualitative Concept]
   739   C0332232:Approximately [Qualitative Concept]
   739   C1265611:amounts [Quantitative Concept]
   739   C1269537:Brain [Body Part, Organ, or Organ Component]
   739   C1549782:Equal [Idea or Concept]
   739   C1706450:Adult [Human]

Phrase: "and"

Phrase: "E10 transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "made."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]
Processing 00000000.tx.365: The factors controlling the switching from fetal to adult pattern of regulation is unknown, as is the reason for the difference in regulation between mouse and human in adult brain. 

Phrase: "The factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "the"

Phrase: "switching from fetal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0015965:Fetal [Embryonic Structure]
   790   C0521457:Fetal [Functional Concept]
   756   C1707719:Switch [Manufactured Object]

Phrase: "to adult pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Pattern [Spatial Concept]

Phrase: "of regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "is"

Phrase: "unknown, as is"

Phrase: "the reason for the difference"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392360:Reason [Idea or Concept]

Phrase: "in regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "between mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "human in adult brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0001675:Human, Adult [Age Group]
   770   C0086418:Human [Human]
Processing 00000000.tx.366: Hutton and co-workers (33) suggested that the difference in regulation between these two species is due to the fact that a stem-loop forms at the E10/I10 junction in human but not mouse pre-mRNA. 

Phrase: "Hutton"

Phrase: "and"

Phrase: "co-workers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024752:workers [Functional Concept]
   861   C1306056:workers [Occupation or Discipline]
   861   C1527116:Workers [Population Group]

Phrase: "(33"

Phrase: ")"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the difference in regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "between these two species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "is due to the fact"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0678226:Due to [Functional Concept]
           due
   760   C3146286:Due [Idea or Concept]

Phrase: "that"

Phrase: "a stem-loop"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0242767:Stem [Plant]
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]

Phrase: "forms at the E10/I10 junction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205144:Junction [Spatial Concept]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]
   753   C1706311:Junction [Medical Device]

Phrase: "in human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "but"

Phrase: "not mouse pre-mRNA."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0026661:Pre-mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0035695:Pre-mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0332152:Pre [Temporal Concept]
   812   C0740175:Pre [Qualitative Concept]
   812   C2257086:PRE [Genetic Function]
Processing 00000000.tx.367: The lack of a stem-loop in mouse would result in constitutive E10 inclusion in mouse brain. 

Phrase: "The lack of a stem-loop"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332268:lack [Qualitative Concept]

Phrase: "in mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "would"

Phrase: "result in constitutive E10 inclusion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1274040:Result [Functional Concept]
   760   C1512693:Inclusion [Qualitative Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "in mouse brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1521713:Mouse Brain [Tissue]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.368: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.369: 6, the mouse sequence can form an E10/I10 junction stem-loop that is different from the human structure and is less stable (G=4.3 and 6.5 kcal, respectively, for the shortest structures). 

Phrase: "6,"

Phrase: "the mouse sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "can"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "an E10/I10 junction stem-loop"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0242767:Stem [Plant]
   804   C0419518:Loop [Medical Device]
   804   C0445022:Loop [Spatial Concept]
   804   C1186763:Stem [Body Part, Organ, or Organ Component]

Phrase: "that"

Phrase: "is"

Phrase: "different from the human structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "less stable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205360:Stable [Qualitative Concept]
   861   C1547311:Stable [Intellectual Product]

Phrase: "(G=4.3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "6.5 kcal,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439259:kcal [Quantitative Concept]
   827   C1556156:kcal [Quantitative Concept]
   734   C0442749:6/5 [Finding]

Phrase: "respectively,"

Phrase: "for the shortest structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.370: The lower stability of the mouse stem-loop would be consistent with more E10 inclusion in the adult mouse. 

Phrase: "The lower stability of the mouse stem-loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205360:Stability [Qualitative Concept]
   744   C2347098:Stability [Qualitative Concept]

Phrase: "would"

Phrase: "be"

Phrase: "consistent with more E10 inclusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in the adult mouse."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]
Processing 00000000.tx.371: However, when hN and mWT are compared in COS-7 cells, the mouse construct actually results in slightly lower levels of E10 inclusion (Fig. 7). 

Phrase: "However,"

Phrase: "when"

Phrase: "hN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "mWT"

Phrase: "are"

Phrase: "compared in COS-7 cells,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   862   C1257858:COS-7 Cells [Cell]
   797   C0376702:COS Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0454802:Cos [Geographic Area]
   760   C1707455:Compared [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "the mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "actually"

Phrase: "results in slightly lower levels of E10 inclusion"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   744   C0441889:Levels [Qualitative Concept]
   744   C0441994:Lower [Spatial Concept]
   744   C0750482:Slightly [Idea or Concept]
   744   C1274040:Result [Functional Concept]
   744   C1512693:Inclusion [Qualitative Concept]
   744   C1546471:Result [Idea or Concept]
   744   C1548802:Lower [Body Location or Region]
   744   C2003888:Lower [Activity]
   744   C2825142:Result [Finding]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.372: Also, mouse I10 ISS sequences are more inhibitory than the human ISS sequence. 

Phrase: "Also,"

Phrase: "mouse I10 ISS sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0162326:Sequences [Nucleotide Sequence]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "more inhibitory than the human ISS sequence."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3463820:Inhibitory [Activity]
Processing 00000000.tx.373: This observation is not consistent with the E10/I10 junction being the mechanistic difference between mouse and human splicing regulation. 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "is"

Phrase: "not consistent with the E10/I10 junction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "being"

Phrase: "the mechanistic difference between mouse"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "human splicing regulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.374: However, the possibility remains that this ISS may act differently in adult neurons, compared with COS-7 cells. 

Phrase: "However,"

Phrase: "the possibility"

Phrase: "remains"

Phrase: "that"

Phrase: "this ISS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1845118:ISS [Congenital Abnormality,Disease or Syndrome]

Phrase: "may"

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "differently in adult neurons,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001675:Adult [Age Group]
   770   C0027882:Neurons [Cell]
   770   C1706450:Adult [Human]

Phrase: "compared with COS-7 cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   862   C1257858:COS-7 Cells [Cell]
   797   C0376702:COS Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0454802:Cos [Geographic Area]
   760   C1707455:Compared [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.375: A more likely explanation is that the constructs used here lack a regulatory element(s) that controls the switch between fetal and adult patterns and the element(s) that controls E10+/E10 ratios in the adult brain. 

Phrase: "A more likely explanation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "that"

Phrase: "the constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "here"

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "a regulatory element"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]
   861   C1705248:Element [Conceptual Entity]

Phrase: "("

Phrase: "s)"

Phrase: "that"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the switch between fetal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707719:Switch [Manufactured Object]

Phrase: "and"

Phrase: "adult patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Patterns [Spatial Concept]

Phrase: "and"

Phrase: "the element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013879:Element [Element, Ion, or Isotope]
  1000   C1705248:Element [Conceptual Entity]

Phrase: "("

Phrase: "s)"

Phrase: "that"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "E10+/E10 ratios in the adult brain."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0456603:Ratios [Quantitative Concept]
   748   C1610540:*Ratios [Quantitative Concept]
   714 E C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.376: This interpretation is supported by the fact that when the human and mouse E10 constructs used here are assayed in rat fetal neuron cultures, approximately equal amounts of E10+ and E10 transcripts are made. 

Phrase: "This interpretation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0459471:Interpretation [Intellectual Product]
  1000   C3173575:Interpretation [Clinical Attribute]

Phrase: "is"

Phrase: "supported by the fact"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "that"

Phrase: "when"

Phrase: "the human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "mouse E10 constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "here"

Phrase: "are"

Phrase: "assayed in rat fetal neuron cultures,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   753   C0010453:Cultures [Idea or Concept]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0027882:Neuron [Cell]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0521457:Fetal [Functional Concept]
   719   C0005507:Assay [Laboratory Procedure]
   719 E C0220814:culture [Functional Concept]
   719   C0243073:assay [Qualitative Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719   C1510438:Assay [Laboratory Procedure]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "approximately equal amounts of E10+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "and"

Phrase: "E10 transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "made."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]
Processing 00000000.tx.377: In contrast, the endogenous rat tau gene almost exclusively produces E10 transcripts in the same cultured cells,2 suggesting that additional regulatory elements have been deleted in the abbreviated hN and mWT constructs. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the endogenous rat tau gene almost exclusively"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0017337:Gene [Gene or Genome]
   799   C0034693:Rat, NOS [Mammal]
   799   C0034721:Rat [Mammal]
   799   C0205227:Endogenous [Functional Concept]
   799   C1720655:Tau [Intellectual Product]
   799   C1947974:Tau [Research Activity]

Phrase: "produces"

Phrase: "E10 transcripts in the same cultured cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that additional regulatory elements"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   867   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Elements [Element, Ion, or Isotope]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   793 E C1705248:Element [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "deleted in the abbreviated hN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086418:Human [Human]
   760   C1880274:Deleted [Activity]

Phrase: "and"

Phrase: "mWT constructs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]
Processing 00000000.tx.378: The work described here shows that there are at least five different regulatory elements within tau E10 and an inhibitory element in the intronic sequences immediately downstream of this exon. 

Phrase: "The work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "here"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that there"

Phrase: "are at least five different regulatory elements"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0013879:Elements [Element, Ion, or Isotope]
   748   C0205451:Five [Quantitative Concept]
   748   C0220905:regulatory [Regulation or Law]
   748   C1551058:Are [Quantitative Concept]
   748   C1704735:Regulatory [Conceptual Entity]
   748   C1705242:Different [Qualitative Concept]
   745   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   714 E C1705248:Element [Conceptual Entity]

Phrase: "within tau E10"

Phrase: "and"

Phrase: "an inhibitory element in the intronic sequences immediately"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0013879:Element [Element, Ion, or Isotope]
   744   C1705248:Element [Conceptual Entity]

Phrase: "downstream of this exon."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.379: Other work2 indicates that other intronic sequences also control E10 splicing. 

Phrase: "Other work2"

Phrase: "indicates"

Phrase: "that"

Phrase: "other intronic sequences also"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "E10 splicing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]
Processing 00000000.tx.380: FTDP-17 mutations alter function of three of these elements (the PPE, ACE, and the I10 ISS), demonstrating that these regulatory sequences function in vivo by a mechanism similar to that observed in the model system used here. 

Phrase: "FTDP-17 mutations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   814   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   778   C0236642:frontotemporal dementia [Disease or Syndrome]
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "function of three of these elements"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "("

Phrase: "the PPE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "ACE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the I10 ISS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1845118:ISS [Congenital Abnormality,Disease or Syndrome]

Phrase: ")"

Phrase: ","

Phrase: "demonstrating"

Phrase: "that"

Phrase: "these regulatory sequences"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   966   C0314642:Regulatory sequence [Nucleotide Sequence]
   861   C0162326:Sequences [Nucleotide Sequence]
   861   C0220905:regulatory [Regulation or Law]
   861   C1704735:Regulatory [Conceptual Entity]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "in vivo by a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "observed in the model system"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0026339:Model System [Intellectual Product,Research Device]
   806   C3161035:Model System [Intellectual Product]
           Model
   760   C0449913:System [Functional Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "here."
Processing 00000000.tx.381: To our knowledge N279K and L284L are the first examples of disease mutations that actually enhance splicing by strengthening an existing ESE. 

Phrase: "To our knowledge N279K"

Phrase: "and"

Phrase: "L284L"

Phrase: "are"

Phrase: "the first examples of disease mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1707959:Example [Conceptual Entity]

Phrase: "that actually"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "splicing by strengthening"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035687:Splicing [Genetic Function]
   790   C2610186:splicing [Genetic Function]

Phrase: "an existing ESE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.382: Complete definition of each enhancer and silencer element in their normal and mutant contexts may require testing in heterologous splicing constructs. 

Phrase: "Complete definition of each enhancer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1550452:definition [Idea or Concept]
   760   C1704788:Definition [Conceptual Entity]
   760   C3539107:Definition [Intellectual Product]

Phrase: "and"

Phrase: "silencer element in their normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1136185:Silencer Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0013879:Element [Element, Ion, or Isotope]
   760   C1705248:Element [Conceptual Entity]

Phrase: "and"

Phrase: "mutant contexts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449255:contexts [Finding]
   861   C0542559:contexts [Functional Concept]

Phrase: "may"

Phrase: "require"

Phrase: "testing in heterologous splicing constructs."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0035687:Splicing [Genetic Function]
   760   C0039593:Testing [Functional Concept]
   760   C0392366:testing [Intellectual Product]
   760   C0439860:Heterologous [Qualitative Concept]
   760   C2610186:splicing [Genetic Function]
   726 E C0022885:Test [Laboratory Procedure]
   726   C2827421:Construct [Classification]
Processing 00000000.tx.383: Additional work is needed to determine what splicing factors bind specifically to these regulatory elements and whether these factors are active in neurons and glial cells in the adult brain.  

Phrase: "Additional work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "is"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "what splicing factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "specifically to these regulatory elements"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   773   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0013879:Elements [Element, Ion, or Isotope]
   760   C0220905:regulatory [Regulation or Law]
   760   C1704735:Regulatory [Conceptual Entity]
   726 E C1705248:Element [Conceptual Entity]

Phrase: "and"

Phrase: "whether"

Phrase: "these factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "active in neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205177:Active [Functional Concept]

Phrase: "and"

Phrase: "glial cells in the adult brain."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0027836:Glial Cells [Cell]
           Glial
   783   C0596208:brain cells [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.384: ACKNOWLEDGEMENTS We thank Elaine Loomis and Leojean Anderson for technical help and Thomas Cooper for helpful discussions. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Elaine Loomis"

Phrase: "and"

Phrase: "Leojean Anderson for technical"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "and"

Phrase: "Thomas Cooper for helpful discussions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0335912:Cooper [Professional or Occupational Group]
Processing 00000000.tx.385: We also thank Parvoneh Poorkaj for the mouse sequence for I10, for helpful suggestions, and critical reading of the manuscript.  

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Parvoneh Poorkaj for the mouse sequence"

Phrase: "for I10,"

Phrase: "for helpful suggestions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038659:Suggestions [Idea or Concept]
   827 E C1705535:suggestion [Idea or Concept]

Phrase: "and"

Phrase: "critical reading of the manuscript."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0034754:Reading [Daily or Recreational Activity]
   760   C1705179:Reading [Finding]
Processing 00000000.tx.386: FOOTNOTES * This work was supported by NIA Grant RO1 AG11762 from the National Institutes of Health and by a Veterans Affairs Administration Merit award.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by NIA Grant RO1 AG11762"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0018173:Grant [Quantitative Concept]
   753   C1074110:Nia [Fungus]
   753   C1521721:Supported [Conceptual Entity]
   753   C1548284:Grant [Idea or Concept]
   753   C1955974:NIA [Health Care Related Organization]
   719 E C0183683:Support [Medical Device]

Phrase: "from the National Institutes of Health"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "and by a Veterans Affairs Administration Merit award."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C1549054:Veterans Affairs [Organization]
   767   C0041735:Veterans Administration [Organization]
   744   C0001554:Administration [Occupational Activity]
   744   C0004446:Award [Manufactured Object]
   744   C0042610:Veterans [Population Group]
   744   C1515981:And [Idea or Concept]
   744   C1533734:Administration [Therapeutic or Preventive Procedure]
   711 E C3245459:veteran [Intellectual Product]
Processing 00000000.tx.387: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.388: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.389: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.390: To whom correspondence should be addressed. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.391: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.392: 206-764-2701; 

Phrase: "206-764-2701"

Phrase: ";"
Processing 00000000.tx.393: E-mail: Zachdad@U.

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "Zachdad@U."
Processing 00000000.tx.394: Washington.edu. 

Phrase: "Washington.edu."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.395: Published, JBC Papers in Press, March 29,2000,DOI 10.1074/jbc.M909470199 2 I. 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "March 29,"

Phrase: "2000,"

Phrase: "DOI 10.1074/jbc.M909470199 2 I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0021966:I- [Inorganic Chemical]
   795   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.396: D'Souza and G.D.

Phrase: "D'"

Phrase: "Souza"

Phrase: "and"

Phrase: "G.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439417:g d [Quantitative Concept]
Processing 00000000.tx.397: Schellenberg, unpublished data.  

Phrase: "Schellenberg,"

Phrase: "unpublished data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.398: ABBREVIATIONS The abbreviations used are: E10, exon 10; 

Phrase: "ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "E10,"

Phrase: "exon 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.399: 3R, 3-repeat tau; 

Phrase: "3R,"

Phrase: "3-repeat tau"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0205341:Repeat [Functional Concept]
   827   C0439086:<3 [Quantitative Concept]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: ";"
Processing 00000000.tx.400: 4R, 4-repeat tau; 

Phrase: "4R,"

Phrase: "4-repeat tau"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205341:Repeat [Functional Concept]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: ";"
Processing 00000000.tx.401: ACE, A/C-rich enhancer; 

Phrase: "ACE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "A/C-rich enhancer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.402: AD, Alzheimer's disease; 

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.403: ESE, exon splicing enhancer; 

Phrase: "ESE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "exon splicing enhancer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.404: ESS, exon splicing silencer; 

Phrase: "ESS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206630:ESS [Neoplastic Process]
  1000   C3541276:ESS [Intellectual Product]

Phrase: "exon splicing silencer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0035687:Splicing [Genetic Function]
   827   C2610186:splicing [Genetic Function]

Phrase: ";"
Processing 00000000.tx.405: FTDP-17, frontotemporal dementia with Parkinsonism-chromosome 17type; 

Phrase: "FTDP-17,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   833   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   790   C0236642:frontotemporal dementia [Disease or Syndrome]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "frontotemporal dementia with Parkinsonism-chromosome 17type"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C0338451:Frontotemporal Dementia with Parkinsonism [Disease or Syndrome]
           Frontotemporal dementia
   833   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   790   C0236642:frontotemporal dementia [Disease or Syndrome]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: ";"
Processing 00000000.tx.406: I9, intron 9; 

Phrase: "I9,"

Phrase: "intron 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.407: I10, intron 10; 

Phrase: "I10,"

Phrase: "intron 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.408: ISS, intron splicing silencer; 

Phrase: "ISS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1845118:ISS [Congenital Abnormality,Disease or Syndrome]

Phrase: "intron splicing silencer"

Phrase: ";"
Processing 00000000.tx.409: MCS, multiple cloning site; 

Phrase: "MCS,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "multiple cloning site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1705686:Cloning Site [Nucleotide Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.410: PPE, polypurine enhancer; 

Phrase: "PPE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "polypurine enhancer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.411: SR, Arg/Ser-rich splicing factors; 

Phrase: "SR,"

Phrase: "Arg/Ser-rich splicing factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0035687:Splicing [Genetic Function]
   804   C2610186:splicing [Genetic Function]
   771   C1521761:Factor [Functional Concept]
   771   C2827422:Factor [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.412: PCR, polymerase chain reaction; 

Phrase: "PCR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "polymerase chain reaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.413: RT-PCR, reverse transcription-PCR; 

Phrase: "RT-PCR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   734   C0035380:Reverse Transcription [Genetic Function]

Phrase: "reverse transcription-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   734   C0035380:Reverse Transcription [Genetic Function]

Phrase: ";"
Processing 00000000.tx.414: bp, base pair; 

Phrase: "bp,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0600436:Base Pair [Molecular Function]
   861   C0002055:base [Inorganic Chemical]
   861   C0178499:Base [Chemical Viewed Functionally]
   861   C1709450:Pair [Qualitative Concept]
   861   C1880279:Base [Biomedical or Dental Material]
   789 E C0205112:Basal [Spatial Concept]
   777 E C0016617:Foundation [Organization]
   777 E C1626935:Bases [Quantitative Concept]

Phrase: "base pair"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0600436:Base Pair [Molecular Function]
   861   C0002055:base [Inorganic Chemical]
   861   C0178499:Base [Chemical Viewed Functionally]
   861   C1709450:Pair [Qualitative Concept]
   861   C1880279:Base [Biomedical or Dental Material]
   789 E C0205112:Basal [Spatial Concept]
   777 E C0016617:Foundation [Organization]
   777 E C1626935:Bases [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.415: HIV, human immunodeficiency virus; 

Phrase: "HIV,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019682:HIV [Virus]
  1000   C0019699:HIV+ [Finding]

Phrase: "human immunodeficiency virus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0019682:Virus, Human Immunodeficiency [Virus]
   913   C0318356:Human virus [Virus]
   901   C0682458:immunodeficiency virus [Virus]
   827   C0021051:IMMUNO-DEFICIENCY [Disease or Syndrome]
   827   C0042776:Virus [Virus]
   827   C0086418:Human [Human]
   827   C0319157:virus [Virus]

Phrase: ";"
Processing 00000000.tx.416: snRNP, small nuclear ribonucleoprotein.  

Phrase: "snRNP,"

Phrase: "small nuclear ribonucleoprotein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0142661:Small Nuclear Ribonucleoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167162:small nuclear ribonucleoprotein [Cell Component]
   827   C0035544:Ribonucleoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0521447:Nuclear [Spatial Concept]
   827   C0700321:Small [Quantitative Concept]
   827   C1167298:ribonucleoprotein [Cell Component]
Processing 00000000.tx.417: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.418: Schoenfeld, T. 

Phrase: "Schoenfeld,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.419: A., and Obar, R. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Obar,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.420: A. 

Phrase: "A."
Processing 00000000.tx.421: (1994) Int. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.422: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.423: Cytol. 

Phrase: "Cytol."
Processing 00000000.tx.424: 151, 67-137[Medline] [OrderarticleviaInfotrieve] 2. 

Phrase: "151,"

Phrase: "67-137"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.425: Mandelkow, E., and Mandelkow, E. 

Phrase: "Mandelkow,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Mandelkow,"

Phrase: "E."
Processing 00000000.tx.426: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.427: (1995) Curr. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.428: Opin. 

Phrase: "Opin."
Processing 00000000.tx.429: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.430: 7, 72-81[CrossRef][Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "7,"

Phrase: "72-81"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.431: Goedert, M., Spillantini, M. 

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.432: G., and Crowther, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.433: A. 

Phrase: "A."
Processing 00000000.tx.434: (1992) Proc. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.435: Natl. 

Phrase: "Natl."
Processing 00000000.tx.436: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.437: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.438: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.439: 89, 1983-1987[Abstract] 4. 

Phrase: "89,"

Phrase: "1983-1987"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 4."
Processing 00000000.tx.440: Goedert, M., Spillantini, M. 

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.441: G., Hasegawa, M., Jakes, R., Crowther, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.442: A., and Klug, A. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Klug,"

Phrase: "A."
Processing 00000000.tx.443: (1996) Cold Spring Harbor Symp. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Cold Spring Harbor Symp."
Processing 00000000.tx.444: Quant. 

Phrase: "Quant."
Processing 00000000.tx.445: Biol. 

Phrase: "Biol."
Processing 00000000.tx.446: 61, 565-573[Medline] [OrderarticleviaInfotrieve] 5. 

Phrase: "61,"

Phrase: "565-573"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.447: Poorkaj, P., Bird, T. 

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.448: D., Wijsman, E., Nemens, E., Garruto, R. 

Phrase: "D."

Phrase: ","

Phrase: "Wijsman,"

Phrase: "E.,"

Phrase: "Nemens,"

Phrase: "E.,"

Phrase: "Garruto,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.449: M., Anderson, L., Andreadis, A., Wiederholt, W. 

Phrase: "M."

Phrase: ","

Phrase: "Anderson,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Andreadis,"

Phrase: "A.,"

Phrase: "Wiederholt,"

Phrase: "W."
Processing 00000000.tx.450: C., Raskind, M., and Schellenberg, G. 

Phrase: "C., Raskind,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Schellenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.451: D. 

Phrase: "D."
Processing 00000000.tx.452: (1998) Ann. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.453: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.454: 43, 815-825[Medline] [OrderarticleviaInfotrieve] 6. 

Phrase: "43,"

Phrase: "815-825"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 6."
Processing 00000000.tx.455: Hutton, M., Lendon, C. 

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Lendon,"

Phrase: "C."
Processing 00000000.tx.456: L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickeringbrown, S., Chakraverty, S., Isaacs, A., Grover, A., Hackett, J., Adamson, J., Lincoln, S., Dickson, D., Davies, P., Petersen, R. 

Phrase: "L., Rizzu,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Froelich,"

Phrase: "S."

Phrase: ","

Phrase: "Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Pickeringbrown,"

Phrase: "S."

Phrase: ","

Phrase: "Chakraverty,"

Phrase: "S."

Phrase: ","

Phrase: "Isaacs,"

Phrase: "A.,"

Phrase: "Grover,"

Phrase: "A.,"

Phrase: "Hackett,"

Phrase: "J.,"

Phrase: "Adamson,"

Phrase: "J.,"

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Dickson,"

Phrase: "D."

Phrase: ","

Phrase: "Davies,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Petersen,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.457: C., Stevens, M., Degraaff, E., Wauters, E., Vanbaren, J., Hillebrand, M., Joosse, M., Kwon, J. 

Phrase: "C., Stevens,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1551756:Stevens [Population Group]

Phrase: "M."

Phrase: ","

Phrase: "Degraaff,"

Phrase: "E.,"

Phrase: "Wauters,"

Phrase: "E.,"

Phrase: "Vanbaren,"

Phrase: "J.,"

Phrase: "Hillebrand,"

Phrase: "M."

Phrase: ","

Phrase: "Joosse,"

Phrase: "M."

Phrase: ","

Phrase: "Kwon,"

Phrase: "J."
Processing 00000000.tx.458: M., Nowotny, P., Che, L. 

Phrase: "M."

Phrase: ","

Phrase: "Nowotny,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Che,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:CHE [Geographic Area]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.459: K., Norton, J., Morris, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Norton,"

Phrase: "J.,"

Phrase: "Morris,"

Phrase: "J."
Processing 00000000.tx.460: C., Reed, L. 

Phrase: "C., Reed,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.461: A., Trojanowski, J., Basun, H., Lannfelt, L., Neystat, M., Fahn, S., Dark, F., Tannenberg, T., Dodd, P. 

Phrase: "A.,"

Phrase: "Trojanowski,"

Phrase: "J.,"

Phrase: "Basun,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Neystat,"

Phrase: "M."

Phrase: ","

Phrase: "Fahn,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1823105:FAHN [Gene or Genome]

Phrase: "S."

Phrase: ","

Phrase: "Dark,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332582:Dark [Qualitative Concept]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Tannenberg,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Dodd,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.462: R., Hayward, N., Kwok, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hayward,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kwok,"

Phrase: "J."
Processing 00000000.tx.463: B.J., Schofield, P. 

Phrase: "B.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Schofield,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.464: R., Andreadis, A., Snowden, J., Craufurd, D., Neary, D., Owen, F., Oostra, B. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Andreadis,"

Phrase: "A.,"

Phrase: "Snowden,"

Phrase: "J.,"

Phrase: "Craufurd,"

Phrase: "D."

Phrase: ","

Phrase: "Neary,"

Phrase: "D."

Phrase: ","

Phrase: "Owen,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Oostra,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.465: A., Hardy, J., Goate, A., van Swieten, J., Mann, D., Lynch, T., and Heutink, P. 

Phrase: "A.,"

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Goate,"

Phrase: "A.,"

Phrase: "van Swieten,"

Phrase: "J.,"

Phrase: "Mann,"

Phrase: "D."

Phrase: ","

Phrase: "Lynch,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Heutink,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.466: (1998) Nature 393, 702-705[CrossRef][Medline] [OrderarticleviaInfotrieve] 7. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nature 393,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "702-705"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 7."
Processing 00000000.tx.467: Spillantini, M. 

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.468: G., Murrell, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Murrell,"

Phrase: "J."
Processing 00000000.tx.469: R., Goedert, M., Farlow, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Farlow,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.470: R., Klug, A., and Ghetti, B. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Klug,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Ghetti,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.471: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.472: Natl. 

Phrase: "Natl."
Processing 00000000.tx.473: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.474: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.475: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.476: 95, 7737-7741[Abstract/Free FullText] 8. 

Phrase: "95,"

Phrase: "7737-7741"

Phrase: "[Abstract/Free FullText"

Phrase: "] 8."
Processing 00000000.tx.477: Spillantini, M. 

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.478: G., Goedert, M., Crowther, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.479: A., Murrell, J. 

Phrase: "A.,"

Phrase: "Murrell,"

Phrase: "J."
Processing 00000000.tx.480: R., Farlow, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Farlow,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.481: R., and Ghetti, B. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Ghetti,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.482: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.483: Natl. 

Phrase: "Natl."
Processing 00000000.tx.484: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.485: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.486: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.487: 94, 4113-4118[Abstract/Free FullText] 9. 

Phrase: "94,"

Phrase: "4113-4118"

Phrase: "[Abstract/Free FullText"

Phrase: "] 9."
Processing 00000000.tx.488: Sumi, S. 

Phrase: "Sumi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.489: M., Bird, T. 

Phrase: "M."

Phrase: ","

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.490: D., Nochlin, D., and Raskind, M. 

Phrase: "D."

Phrase: ","

Phrase: "Nochlin,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Raskind,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.491: A. 

Phrase: "A."
Processing 00000000.tx.492: (1992) Neurology 42, 120-127[Abstract] 10. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Neurology 42,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "120-127"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 10."
Processing 00000000.tx.493: Spillantini, M. 

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.494: G., Crowther, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.495: A., and Goedert, M. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.496: (1996) Acta Neuropathol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Acta Neuropathol."
Processing 00000000.tx.497: 92, 42-48[CrossRef][Medline] [OrderarticleviaInfotrieve] 11. 

Phrase: "92,"

Phrase: "42-48"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 11."
Processing 00000000.tx.498: Bugiani, O., Murrell, J. 

Phrase: "Bugiani,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Murrell,"

Phrase: "J."
Processing 00000000.tx.499: R., Giaccone, G., Hasegawa, M., Ghigo, G., Tabaton, M., Morbin, M., Primavera, A., Carella, F., Solaro, C., Grisoli, M., Savoiardo, M., Spillantini, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Giaccone,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "Ghigo,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tabaton,"

Phrase: "M."

Phrase: ","

Phrase: "Morbin,"

Phrase: "M."

Phrase: ","

Phrase: "Primavera,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1036374:primavera [Plant]

Phrase: "A.,"

Phrase: "Carella,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Solaro,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Grisoli,"

Phrase: "M."

Phrase: ","

Phrase: "Savoiardo,"

Phrase: "M."

Phrase: ","

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.500: G., Tagliavini, F., Goedert, M., and Ghetti, B. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tagliavini,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ghetti,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.501: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.502: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.503: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.504: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.505: 58, 667-677[Medline] [OrderarticleviaInfotrieve] 12. 

Phrase: "58,"

Phrase: "667-677"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 12."
Processing 00000000.tx.506: Spillantini, M. 

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.507: G., Crowther, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.508: A., Kamphorst, W., Heutink, P., and Van Swieten, J. 

Phrase: "A.,"

Phrase: "Kamphorst,"

Phrase: "W.,"

Phrase: "Heutink,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Van Swieten,"

Phrase: "J."
Processing 00000000.tx.509: C. 

Phrase: "C."
Processing 00000000.tx.510: (1998) Am. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.511: J.Pathol. 

Phrase: "J.Pathol."
Processing 00000000.tx.512: 153, 1359-1363[Abstract/Free FullText] 13. 

Phrase: "153,"

Phrase: "1359-1363"

Phrase: "[Abstract/Free FullText"

Phrase: "] 13."
Processing 00000000.tx.513: Murrell, J. 

Phrase: "Murrell,"

Phrase: "J."
Processing 00000000.tx.514: R., Koller, D., Foroud, T., Goedert, M., Spillantini, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Koller,"

Phrase: "D."

Phrase: ","

Phrase: "Foroud,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.515: G., Edenberg, H. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Edenberg,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.516: J., Farlow, M. 

Phrase: "J.,"

Phrase: "Farlow,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.517: R., and Ghetti, B. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Ghetti,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.518: (1997) Am. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.519: J.Hum. 

Phrase: "J.Hum."
Processing 00000000.tx.520: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.521: 61, 1131-1138[CrossRef][Medline] [OrderarticleviaInfotrieve] 14. 

Phrase: "61,"

Phrase: "1131-1138"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 14."
Processing 00000000.tx.522: Hong, M., Zhukareva, V., Vogelsberg-Ragaglia, V., Wszolek, Z., Reed, L., Miller, B. 

Phrase: "Hong,"

Phrase: "M."

Phrase: ","

Phrase: "Zhukareva,"

Phrase: "V.,"

Phrase: "Vogelsberg-Ragaglia,"

Phrase: "V.,"

Phrase: "Wszolek,"

Phrase: "Z.,"

Phrase: "Reed,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.523: I., Geschwind, D. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Geschwind,"

Phrase: "D."
Processing 00000000.tx.524: H., Bird, T. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.525: D., Mckeel, D., Goate, A., Morris, J. 

Phrase: "D."

Phrase: ","

Phrase: "Mckeel,"

Phrase: "D."

Phrase: ","

Phrase: "Goate,"

Phrase: "A.,"

Phrase: "Morris,"

Phrase: "J."
Processing 00000000.tx.526: C., Wilhelmsen, K. 

Phrase: "C., Wilhelmsen,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.527: C., Schellenberg, G. 

Phrase: "C., Schellenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.528: D., Trojanowski, J. 

Phrase: "D."

Phrase: ","

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.529: Q., and Lee, V. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.530: M.Y. 

Phrase: "M."

Phrase: "Y."
Processing 00000000.tx.531: (1998) Science 282, 1914-1917[Abstract/Free FullText] 15. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Science 282,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1914-1917"

Phrase: "[Abstract/Free FullText"

Phrase: "] 15."
Processing 00000000.tx.532: D'Souza, I., Poorkaj, P., Hong, M., Nochlin, D., Lee, V. 

Phrase: "D'"

Phrase: "Souza,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hong,"

Phrase: "M."

Phrase: ","

Phrase: "Nochlin,"

Phrase: "D."

Phrase: ","

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.533: M.Y., Bird, T. 

Phrase: "M."

Phrase: "Y.,"

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.534: D., and Schellenberg, G. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Schellenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.535: D. 

Phrase: "D."
Processing 00000000.tx.536: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.537: Natl. 

Phrase: "Natl."
Processing 00000000.tx.538: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.539: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.540: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.541: 96, 5598-5603[Abstract/Free FullText] 16. 

Phrase: "96,"

Phrase: "5598-5603"

Phrase: "[Abstract/Free FullText"

Phrase: "] 16."
Processing 00000000.tx.542: Hasegawa, M., Smith, M. 

Phrase: "Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.543: J., and Goedert, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.544: (1998) FEBS Lett. 

Phrase: "(1998"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.545: 437, 207-210[CrossRef][Medline] [OrderarticleviaInfotrieve] 17. 

Phrase: "437,"

Phrase: "207-210"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 17."
Processing 00000000.tx.546: Rizzu, P., van Swieten, J. 

Phrase: "Rizzu,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "van Swieten,"

Phrase: "J."
Processing 00000000.tx.547: C., Joosse, M., Hasegawa, M., Stevens, M., Tibben, A., Niermeijer, M. 

Phrase: "C., Joosse,"

Phrase: "M."

Phrase: ","

Phrase: "Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "Stevens,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551756:Stevens [Population Group]

Phrase: "M."

Phrase: ","

Phrase: "Tibben,"

Phrase: "A.,"

Phrase: "Niermeijer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.548: F., Hillebrand, M., Ravid, R., Oostra, B. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Hillebrand,"

Phrase: "M."

Phrase: ","

Phrase: "Ravid,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Oostra,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.549: A., Goedert, M., van Duijn, C. 

Phrase: "A.,"

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "van Duijn,"

Phrase: "C."
Processing 00000000.tx.550: M., and Heutink, P. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Heutink,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.551: (1999) Am. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.552: J.Hum. 

Phrase: "J.Hum."
Processing 00000000.tx.553: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.554: 64, 414-421[CrossRef][Medline] [OrderarticleviaInfotrieve] 18. 

Phrase: "64,"

Phrase: "414-421"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 18."
Processing 00000000.tx.555: Hasegawa, M., Smith, M. 

Phrase: "Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.556: J., Iijima, M., Tabira, T., and Goedert, M. 

Phrase: "J.,"

Phrase: "Iijima,"

Phrase: "M."

Phrase: ","

Phrase: "Tabira,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.557: (1999) FEBS Lett. 

Phrase: "(1999"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.558: 443, 93-96[CrossRef][Medline] [OrderarticleviaInfotrieve] 19. 

Phrase: "443,"

Phrase: "93-96"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 19."
Processing 00000000.tx.559: Clark, L. 

Phrase: "Clark,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.560: N., Poorkaj, P., Wszolek, Z., Geschwind, D. 

Phrase: "N., Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wszolek,"

Phrase: "Z.,"

Phrase: "Geschwind,"

Phrase: "D."
Processing 00000000.tx.561: H., Nasreddine, Z. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nasreddine,"

Phrase: "Z."
Processing 00000000.tx.562: S., Miller, B., Li, D., Payami, H., Awert, F., Markopoulou, K., Andreadis, A., D'Souza, I., Lee, V. 

Phrase: "S."

Phrase: ","

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "D."

Phrase: ","

Phrase: "Payami,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Awert,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Markopoulou,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Andreadis,"

Phrase: "A.,"

Phrase: "D'"

Phrase: "Souza,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.563: M.Y., Reed, L., Trojanowski, J. 

Phrase: "M."

Phrase: "Y.,"

Phrase: "Reed,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.564: Q., Zhukareva, V., Bird, T., Schellenberg, G. 

Phrase: "Q., Zhukareva,"

Phrase: "V.,"

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Schellenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.565: D., and Wilhelmsen, K. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Wilhelmsen,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.566: C. 

Phrase: "C."
Processing 00000000.tx.567: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.568: Natl. 

Phrase: "Natl."
Processing 00000000.tx.569: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.570: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.571: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.572: 95, 13103-13107[Abstract/Free FullText] 20. 

Phrase: "95,"

Phrase: "13103-13107"

Phrase: "[Abstract/Free FullText"

Phrase: "] 20."
Processing 00000000.tx.573: Burn, T. 

Phrase: "Burn,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006434:Burn [Injury or Poisoning]
  1000   C1550619:Burn [Substance]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.574: C., Connors, T. 

Phrase: "C., Connors,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.575: D., Klinger, K. 

Phrase: "D."

Phrase: ","

Phrase: "Klinger,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.576: W., and Landes, G. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Landes,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.577: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.578: (1995) Gene (Amst.) 

Phrase: "(1995"

Phrase: ")"

Phrase: "Gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "(Amst."

Phrase: ")"
Processing 00000000.tx.579: 161, 183-187[CrossRef][Medline] [OrderarticleviaInfotrieve] 21. 

Phrase: "161,"

Phrase: "183-187"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 21."
Processing 00000000.tx.580: Si, Z.-H., Rauch, D., and Stoltzfus, M. 

Phrase: "Si,"

Phrase: "Z.-H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Rauch,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Stoltzfus,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.581: (1998) Mol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.582: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.583: 18, 5404-5413[Abstract/Free FullText] 22. 

Phrase: "18,"

Phrase: "5404-5413"

Phrase: "[Abstract/Free FullText"

Phrase: "] 22."
Processing 00000000.tx.584: Zuker, M. 

Phrase: "Zuker,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.585: (1989) Science 244, 48-52[Medline] [OrderarticleviaInfotrieve] 23. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Science 244,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "48-52"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.586: Tanaka, K., Watakabe, A., and Shimura, Y. 

Phrase: "Tanaka,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Watakabe,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Shimura,"

Phrase: "Y."
Processing 00000000.tx.587: (1994) Mol. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.588: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.589: Biol. 

Phrase: "Biol."
Processing 00000000.tx.590: 14, 1347-1354[Abstract] 24. 

Phrase: "14,"

Phrase: "1347-1354"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 24."
Processing 00000000.tx.591: Xu, R., Teng, J., and Cooper, T. 

Phrase: "Xu,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Teng,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.592: A. 

Phrase: "A."
Processing 00000000.tx.593: (1993) Mol. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.594: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.595: Biol. 

Phrase: "Biol."
Processing 00000000.tx.596: 13, 3660-3674[Abstract] 25. 

Phrase: "13,"

Phrase: "3660-3674"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 25."
Processing 00000000.tx.597: Coulter, L. 

Phrase: "Coulter,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.598: R., Landree, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Landree,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.599: A., and Cooper, T. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.600: A. 

Phrase: "A."
Processing 00000000.tx.601: (1997) Mol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.602: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.603: Biol. 

Phrase: "Biol."
Processing 00000000.tx.604: 17, 2143-2150[Abstract] 26. 

Phrase: "17,"

Phrase: "2143-2150"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 26."
Processing 00000000.tx.605: Lynch, K. 

Phrase: "Lynch,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.606: W., and Maniatis, T (1996) Genes Dev. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Maniatis,"

Phrase: "T (1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.607: 10, 2089-2101[Abstract] 27. 

Phrase: "10,"

Phrase: "2089-2101"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 27."
Processing 00000000.tx.608: Staffa, A., Acheson, N. 

Phrase: "Staffa,"

Phrase: "A.,"

Phrase: "Acheson,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.609: H., and Cochrane, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Cochrane,"

Phrase: "A."
Processing 00000000.tx.610: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.611: Biol. 

Phrase: "Biol."
Processing 00000000.tx.612: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.613: 272, 33394-33401[Abstract/Free FullText] 28. 

Phrase: "272,"

Phrase: "33394-33401"

Phrase: "[Abstract/Free FullText"

Phrase: "] 28."
Processing 00000000.tx.614: Staffa, A., and Cochrane, A. 

Phrase: "Staffa,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Cochrane,"

Phrase: "A."
Processing 00000000.tx.615: (1995) Mol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.616: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.617: Biol. 

Phrase: "Biol."
Processing 00000000.tx.618: 15, 4597-4605[Abstract] 29. 

Phrase: "15,"

Phrase: "4597-4605"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 29."
Processing 00000000.tx.619: Amendt, B. 

Phrase: "Amendt,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.620: A., Si, Z.-H., and Stoltzfus, C. 

Phrase: "A.,"

Phrase: "Si,"

Phrase: "Z.-H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Stoltzfus,"

Phrase: "C."
Processing 00000000.tx.621: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.622: (1995) Mol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.623: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.624: Biol. 

Phrase: "Biol."
Processing 00000000.tx.625: 15, 4606-4615[Abstract] 30. 

Phrase: "15,"

Phrase: "4606-4615"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 30."
Processing 00000000.tx.626: Schaal, T. 

Phrase: "Schaal,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.627: D., and Maniatis, T. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Maniatis,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.628: (1999) Mol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.629: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.630: Biol. 

Phrase: "Biol."
Processing 00000000.tx.631: 19, 1705-1719[Abstract/Free FullText] 31. 

Phrase: "19,"

Phrase: "1705-1719"

Phrase: "[Abstract/Free FullText"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.632: Tarn, W.-Y., and Steitz, J. 

Phrase: "Tarn,"

Phrase: "W.-Y.,"

Phrase: "and"

Phrase: "Steitz,"

Phrase: "J."
Processing 00000000.tx.633: A. 

Phrase: "A."
Processing 00000000.tx.634: (1994) Genes Dev. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.635: 8, 2704-2717[Abstract] 32. 

Phrase: "8,"

Phrase: "2704-2717"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 32."
Processing 00000000.tx.636: Varani, L., Hasegawa, M., Spillantini, M. 

Phrase: "Varani,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.637: G., Smith, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.638: J., Murrell, J. 

Phrase: "J.,"

Phrase: "Murrell,"

Phrase: "J."
Processing 00000000.tx.639: R., Ghetti, B., Klug, A., Goedert, M., and Varani, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ghetti,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Klug,"

Phrase: "A.,"

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Varani,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.640: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.641: Natl. 

Phrase: "Natl."
Processing 00000000.tx.642: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.643: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.644: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.645: 96, 8229-8234[Abstract/Free FullText] 33. 

Phrase: "96,"

Phrase: "8229-8234"

Phrase: "[Abstract/Free FullText"

Phrase: "] 33."
Processing 00000000.tx.646: Grover, A., Houlden, H., Baker, M., Adamson, J., Lewist, J., Prihart, G., Pickering-Brown, S., Duff, K., and Hutton, M. 

Phrase: "Grover,"

Phrase: "A.,"

Phrase: "Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Adamson,"

Phrase: "J.,"

Phrase: "Lewist,"

Phrase: "J.,"

Phrase: "Prihart,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Pickering-Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "S."

Phrase: ","

Phrase: "Duff,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.647: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.648: Biol. 

Phrase: "Biol."
Processing 00000000.tx.649: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.650: 274, 15134-15143[Abstract/Free FullText] 34. 

Phrase: "274,"

Phrase: "15134-15143"

Phrase: "[Abstract/Free FullText"

Phrase: "] 34."
Processing 00000000.tx.651: Hertel, K. 

Phrase: "Hertel,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.652: J., Lynch, K. 

Phrase: "J.,"

Phrase: "Lynch,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.653: W., Hsiao, E. 

Phrase: "W., Hsiao,"

Phrase: "E."
Processing 00000000.tx.654: C., Liu, E. 

Phrase: "C., Liu,"

Phrase: "E."
Processing 00000000.tx.655: H.T, and Maniatis, T. 

Phrase: "H.T,"

Phrase: "and"

Phrase: "Maniatis,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.656: (1996) RNA (NY) 2, 969-981[Abstract] 35. 

Phrase: "(1996"

Phrase: ")"

Phrase: "RNA (NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027976:NY [Geographic Area]
   861   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "969-981"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 35."
Processing 00000000.tx.657: Cooper, T. 

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.658: A., and Mattox, W. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Mattox,"

Phrase: "W."
Processing 00000000.tx.659: (1997) Am. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.660: J.Hum. 

Phrase: "J.Hum."
Processing 00000000.tx.661: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.662: 61, 259-266[Medline] [OrderarticleviaInfotrieve] Copyright  2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "61,"

Phrase: "259-266"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Copyright  2000 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

